pmid,date,mesh,journal,affil,athrs,pt,gr
30304504,<DateCompleted>  <Year>2019</Year>  <Month>09</Month>  <Day>03</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000368"" MajorTopicYN=""N"">Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000369"" MajorTopicYN=""N"">Aged, 80 and over</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003198"" MajorTopicYN=""N"">Computer Simulation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008017"" MajorTopicYN=""N"">Life Expectancy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008175"" MajorTopicYN=""N"">Lung Neoplasms</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>    <QualifierName UI=""Q000401"" MajorTopicYN=""Y"">mortality</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015995"" MajorTopicYN=""N"">Prevalence</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012907"" MajorTopicYN=""N"">Smoking</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>    <QualifierName UI=""Q000639"" MajorTopicYN=""N"">trends</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016540"" MajorTopicYN=""N"">Smoking Cessation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"" Type=""Geographic"">United States</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1539-3704</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>169</Volume>    <Issue>10</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>20</Day>    </PubDate>  </JournalIssue>  <Title>Annals of internal medicine</Title>  <ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>University of Michigan, Ann Arbor, Michigan (J.J., P.C., J.T., R.M.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Jeon</LastName>    <ForeName>Jihyoun</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>University of Michigan, Ann Arbor, Michigan (J.J., P.C., J.T., R.M.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Holford</LastName>    <ForeName>Theodore R</ForeName>    <Initials>TR</Initials>    <AffiliationInfo>      <Affiliation>Yale University, New Haven, Connecticut (T.R.H.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Levy</LastName>    <ForeName>David T</ForeName>    <Initials>DT</Initials>    <AffiliationInfo>      <Affiliation>Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (D.T.L.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Feuer</LastName>    <ForeName>Eric J</ForeName>    <Initials>EJ</Initials>    <AffiliationInfo>      <Affiliation>National Cancer Institute, Bethesda, Maryland (E.J.F.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cao</LastName>    <ForeName>Pianpian</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>University of Michigan, Ann Arbor, Michigan (J.J., P.C., J.T., R.M.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tam</LastName>    <ForeName>Jamie</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>University of Michigan, Ann Arbor, Michigan (J.J., P.C., J.T., R.M.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Clarke</LastName>    <ForeName>Lauren</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Cornerstone Systems Northwest, Lynden, Washington (L.C., J.C.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Clarke</LastName>    <ForeName>John</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Cornerstone Systems Northwest, Lynden, Washington (L.C., J.C.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kong</LastName>    <ForeName>Chung Yin</ForeName>    <Initials>CY</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (C.Y.K.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Meza</LastName>    <ForeName>Rafael</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>University of Michigan, Ann Arbor, Michigan (J.J., P.C., J.T., R.M.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>U01 CA152956</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U01 CA199284</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30304651,<DateCompleted>  <Year>2018</Year>  <Month>10</Month>  <Day>30</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000368"" MajorTopicYN=""N"">Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D034462"" MajorTopicYN=""N"">Dissent and Disputes</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058625"" MajorTopicYN=""N"">End Stage Liver Disease</DescriptorName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005190"" MajorTopicYN=""N"">Family</DescriptorName>    <QualifierName UI=""Q000523"" MajorTopicYN=""N"">psychology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007676"" MajorTopicYN=""N"">Kidney Failure, Chronic</DescriptorName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011368"" MajorTopicYN=""Y"">Professional-Family Relations</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016414"" MajorTopicYN=""N"">Resuscitation Orders</DescriptorName>    <QualifierName UI=""Q000523"" MajorTopicYN=""N"">psychology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013727"" MajorTopicYN=""Y"">Terminal Care</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D028761"" MajorTopicYN=""Y"">Withholding Treatment</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>15</Issue>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>11</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the Ear, Nose, and Throat Department, Guy's and St. Thomas' Hospital, London; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Rotterdam, the Netherlands; and the Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Caulley</LastName>    <ForeName>Lisa</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>From the Ear, Nose, and Throat Department, Guy's and St. Thomas' Hospital, London; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Rotterdam, the Netherlands; and the Ottawa Hospital Research Institute, Ottawa, Canada.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D062210"">Personal Narrative</PublicationType></PublicationTypeList>",NA
30304655,<DateCompleted>  <Year>2018</Year>  <Month>10</Month>  <Day>30</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D001499"" MajorTopicYN=""N"">Bayes Theorem</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D037282"" MajorTopicYN=""N"">Calreticulin</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004273"" MajorTopicYN=""N"">DNA, Neoplasm</DescriptorName>    <QualifierName UI=""Q000032"" MajorTopicYN=""N"">analysis</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018450"" MajorTopicYN=""N"">Disease Progression</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018572"" MajorTopicYN=""N"">Disease-Free Survival</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D053614"" MajorTopicYN=""N"">Janus Kinase 2</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015999"" MajorTopicYN=""N"">Multivariate Analysis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009154"" MajorTopicYN=""Y"">Mutation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009196"" MajorTopicYN=""N"">Myeloproliferative Disorders</DescriptorName>    <QualifierName UI=""Q000145"" MajorTopicYN=""N"">classification</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010641"" MajorTopicYN=""N"">Phenotype</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D057285"" MajorTopicYN=""Y"">Precision Medicine</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011379"" MajorTopicYN=""N"">Prognosis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016016"" MajorTopicYN=""N"">Proportional Hazards Models</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D053628"" MajorTopicYN=""N"">Receptors, Thrombopoietin</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017422"" MajorTopicYN=""N"">Sequence Analysis, DNA</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>15</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>11</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Grinfeld</LastName>    <ForeName>Jacob</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nangalia</LastName>    <ForeName>Jyoti</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Baxter</LastName>    <ForeName>E Joanna</ForeName>    <Initials>EJ</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wedge</LastName>    <ForeName>David C</ForeName>    <Initials>DC</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Angelopoulos</LastName>    <ForeName>Nicos</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cantrill</LastName>    <ForeName>Robert</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Godfrey</LastName>    <ForeName>Anna L</ForeName>    <Initials>AL</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Papaemmanuil</LastName>    <ForeName>Elli</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gundem</LastName>    <ForeName>Gunes</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>MacLean</LastName>    <ForeName>Cathy</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cook</LastName>    <ForeName>Julia</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>O'Neil</LastName>    <ForeName>Laura</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>O'Meara</LastName>    <ForeName>Sarah</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Teague</LastName>    <ForeName>Jon W</ForeName>    <Initials>JW</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Butler</LastName>    <ForeName>Adam P</ForeName>    <Initials>AP</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Massie</LastName>    <ForeName>Charlie E</ForeName>    <Initials>CE</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Williams</LastName>    <ForeName>Nicholas</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nice</LastName>    <ForeName>Francesca L</ForeName>    <Initials>FL</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Andersen</LastName>    <ForeName>Christen L</ForeName>    <Initials>CL</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hasselbalch</LastName>    <ForeName>Hans C</ForeName>    <Initials>HC</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Guglielmelli</LastName>    <ForeName>Paola</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>McMullin</LastName>    <ForeName>Mary F</ForeName>    <Initials>MF</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Vannucchi</LastName>    <ForeName>Alessandro M</ForeName>    <Initials>AM</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Harrison</LastName>    <ForeName>Claire N</ForeName>    <Initials>CN</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gerstung</LastName>    <ForeName>Moritz</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Green</LastName>    <ForeName>Anthony R</ForeName>    <Initials>AR</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Campbell</LastName>    <ForeName>Peter J</ForeName>    <Initials>PJ</Initials>    <AffiliationInfo>      <Affiliation>From the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B., N.W., P.J.C.), and the European Molecular Biology Laboratory, European Bioinformatics Institute (R.C., M.G.), Hinxton, Big Data Institute, University of Oxford, Oxford (D.C.W.), the Department of Haematology, Queen's University Belfast, Belfast (M.F.M.), and the Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom; the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (E.P., G.G.); the Department of Hematology, Zealand University Hospital, Roskilde, and the University of Copenhagen, Copenhagen (C.L.A., H.C.H.); and the Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy (P.G., A.M.V.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016448"">Multicenter Study</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <Acronym>WT_</Acronym>    <Agency>Wellcome Trust</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>203151</GrantID>    <Acronym>WT_</Acronym>    <Agency>Wellcome Trust</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>MC_PC_12009</GrantID>    <Acronym>MRC_</Acronym>    <Agency>Medical Research Council</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>P30 CA008748</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30304660,<DateCompleted>  <Year>2018</Year>  <Month>10</Month>  <Day>30</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001552"" MajorTopicYN=""N"">Benzazepines</DescriptorName>    <QualifierName UI=""Q000494"" MajorTopicYN=""Y"">pharmacology</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D045744"" MajorTopicYN=""N"">Cell Line, Tumor</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002648"" MajorTopicYN=""N"">Child</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000073398"" MajorTopicYN=""N"">Demethylation</DescriptorName>    <QualifierName UI=""Q000187"" MajorTopicYN=""Y"">drug effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015870"" MajorTopicYN=""N"">Gene Expression</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006657"" MajorTopicYN=""N"">Histones</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""Y"">antagonists &amp; inhibitors</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D056484"" MajorTopicYN=""N"">Jumonji Domain-Containing Histone Demethylases</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""N"">antagonists &amp; inhibitors</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D023421"" MajorTopicYN=""N"">Models, Animal</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009447"" MajorTopicYN=""N"">Neuroblastoma</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""Y"">drug therapy</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011743"" MajorTopicYN=""N"">Pyrimidines</DescriptorName>    <QualifierName UI=""Q000494"" MajorTopicYN=""Y"">pharmacology</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>15</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>11</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston (S.G.D.); and the Department of Pediatrics, Seattle Children's Hospital and University of Washington School of Medicine, Seattle (J.R.P.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>DuBois</LastName>    <ForeName>Steven G</ForeName>    <Initials>SG</Initials>    <AffiliationInfo>      <Affiliation>From the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston (S.G.D.); and the Department of Pediatrics, Seattle Children's Hospital and University of Washington School of Medicine, Seattle (J.R.P.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Park</LastName>    <ForeName>Julie R</ForeName>    <Initials>JR</Initials>    <AffiliationInfo>      <Affiliation>From the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston (S.G.D.); and the Department of Pediatrics, Seattle Children's Hospital and University of Washington School of Medicine, Seattle (J.R.P.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30305269,<DateCompleted>  <Year>2019</Year>  <Month>02</Month>  <Day>25</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D015331"" MajorTopicYN=""N"">Cohort Studies</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003430"" MajorTopicYN=""N"">Cross-Sectional Studies</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004032"" MajorTopicYN=""Y"">Diet</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020022"" MajorTopicYN=""Y"">Genetic Predisposition to Disease</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006073"" MajorTopicYN=""N"">Gout</DescriptorName>    <QualifierName UI=""Q000178"" MajorTopicYN=""Y"">diet therapy</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"" Type=""Geographic"">United States</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014527"" MajorTopicYN=""N"">Uric Acid</DescriptorName>    <QualifierName UI=""Q000097"" MajorTopicYN=""Y"">blood</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D044465"" MajorTopicYN=""N"">Whites</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>10</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Biochemistry, University of Otago, 710 Cumberland Street, Dunedin 9054, New Zealand.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Major</LastName>    <ForeName>Tanya J</ForeName>    <Initials>TJ</Initials>    <AffiliationInfo>      <Affiliation>Department of Biochemistry, University of Otago, 710 Cumberland Street, Dunedin 9054, New Zealand.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Topless</LastName>    <ForeName>Ruth K</ForeName>    <Initials>RK</Initials>    <AffiliationInfo>      <Affiliation>Department of Biochemistry, University of Otago, 710 Cumberland Street, Dunedin 9054, New Zealand.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dalbeth</LastName>    <ForeName>Nicola</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, University of Auckland, Auckland, New Zealand.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Merriman</LastName>    <ForeName>Tony R</ForeName>    <Initials>TR</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0003-0844-8726</Identifier>    <AffiliationInfo>      <Affiliation>Department of Biochemistry, University of Otago, 710 Cumberland Street, Dunedin 9054, New Zealand tony.merriman@otago.ac.nz.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D017418"">Meta-Analysis</PublicationType></PublicationTypeList>",NA
30305295,<DateCompleted>  <Year>2019</Year>  <Month>02</Month>  <Day>25</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002648"" MajorTopicYN=""N"">Child</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003139"" MajorTopicYN=""N"">Common Cold</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""Y"">drug therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006633"" MajorTopicYN=""N"">Histamine Antagonists</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014663"" MajorTopicYN=""N"">Nasal Decongestants</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004366"" MajorTopicYN=""N"">Nonprescription Drugs</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017410"" MajorTopicYN=""N"">Practice Guidelines as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010818"" MajorTopicYN=""Y"">Practice Patterns, Physicians'</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>10</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Faculty of Medicine, University of Queensland, Brisbane, Australia m.vandriel@uq.edu.au.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>van Driel</LastName>    <ForeName>Mieke L</ForeName>    <Initials>ML</Initials>    <AffiliationInfo>      <Affiliation>Faculty of Medicine, University of Queensland, Brisbane, Australia m.vandriel@uq.edu.au.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Scheire</LastName>    <ForeName>Sophie</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Deckx</LastName>    <ForeName>Laura</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Faculty of Medicine, University of Queensland, Brisbane, Australia.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gevaert</LastName>    <ForeName>Philippe</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Department of Ear, Nose and Throat, Ghent University, Ghent, Belgium.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>De Sutter</LastName>    <ForeName>An</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Family Medicine and Primary Health Care, Ghent University, Ghent, Belgium.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30305735,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>08</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003964"" MajorTopicYN=""N"">Diaphragm</DescriptorName>    <QualifierName UI=""Q000294"" MajorTopicYN=""N"">innervation</QualifierName>    <QualifierName UI=""Q000502"" MajorTopicYN=""N"">physiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001239"" MajorTopicYN=""N"">Inhalation</DescriptorName>    <QualifierName UI=""Q000502"" MajorTopicYN=""N"">physiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007395"" MajorTopicYN=""N"">Interneurons</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000502"" MajorTopicYN=""Y"">physiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009046"" MajorTopicYN=""N"">Motor Neurons</DescriptorName>    <QualifierName UI=""Q000502"" MajorTopicYN=""N"">physiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012119"" MajorTopicYN=""Y"">Respiration</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013119"" MajorTopicYN=""N"">Spinal Cord Injuries</DescriptorName>    <QualifierName UI=""Q000503"" MajorTopicYN=""Y"">physiopathology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>562</Volume>    <Issue>7727</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Krembil Research Institute, University Health Network, Toronto, Ontario, Canada. kajanasatkune@gmail.com.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Satkunendrarajah</LastName>    <ForeName>Kajana</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Krembil Research Institute, University Health Network, Toronto, Ontario, Canada. kajanasatkune@gmail.com.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Karadimas</LastName>    <ForeName>Spyridon K</ForeName>    <Initials>SK</Initials>    <AffiliationInfo>      <Affiliation>Division of Neurosurgery, Department of Surgery, University of Toronto, Ontario, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Laliberte</LastName>    <ForeName>Alex M</ForeName>    <Initials>AM</Initials>    <AffiliationInfo>      <Affiliation>Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Montandon</LastName>    <ForeName>Gaspard</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>St Michael's Hospital, Toronto, Ontario, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Medicine, University of Toronto, Ontario, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fehlings</LastName>    <ForeName>Michael G</ForeName>    <Initials>MG</Initials>    <AffiliationInfo>      <Affiliation>Krembil Research Institute, University Health Network, Toronto, Ontario, Canada. michael.fehlings@uhn.ca.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Neurosurgery, Department of Surgery, University of Toronto, Ontario, Canada. michael.fehlings@uhn.ca.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>",NA
30305736,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>01</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001407"" MajorTopicYN=""N"">Bacillus</DescriptorName>    <QualifierName UI=""Q000502"" MajorTopicYN=""Y"">physiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055666"" MajorTopicYN=""N"">Lipopeptides</DescriptorName>    <QualifierName UI=""Q000096"" MajorTopicYN=""N"">biosynthesis</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D023421"" MajorTopicYN=""N"">Models, Animal</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019936"" MajorTopicYN=""N"">Probiotics</DescriptorName>    <QualifierName UI=""Q000494"" MajorTopicYN=""Y"">pharmacology</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D053038"" MajorTopicYN=""N"">Quorum Sensing</DescriptorName>    <QualifierName UI=""Q000187"" MajorTopicYN=""Y"">drug effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015398"" MajorTopicYN=""N"">Signal Transduction</DescriptorName>    <QualifierName UI=""Q000187"" MajorTopicYN=""N"">drug effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013171"" MajorTopicYN=""N"">Spores, Bacterial</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013203"" MajorTopicYN=""N"">Staphylococcal Infections</DescriptorName>    <QualifierName UI=""Q000382"" MajorTopicYN=""Y"">microbiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013211"" MajorTopicYN=""N"">Staphylococcus aureus</DescriptorName>    <QualifierName UI=""Q000187"" MajorTopicYN=""Y"">drug effects</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000472"" MajorTopicYN=""Y"">pathogenicity</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013785"" MajorTopicYN=""N"" Type=""Geographic"">Thailand</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>562</Volume>    <Issue>7728</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Piewngam</LastName>    <ForeName>Pipat</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zheng</LastName>    <ForeName>Yue</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nguyen</LastName>    <ForeName>Thuan H</ForeName>    <Initials>TH</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dickey</LastName>    <ForeName>Seth W</ForeName>    <Initials>SW</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Joo</LastName>    <ForeName>Hwang-Soo</ForeName>    <Initials>HS</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Pre-PharmMed, College of Natural Sciences, Duksung Women's University, Seoul, South Korea.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Villaruz</LastName>    <ForeName>Amer E</ForeName>    <Initials>AE</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Glose</LastName>    <ForeName>Kyle A</ForeName>    <Initials>KA</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fisher</LastName>    <ForeName>Emilie L</ForeName>    <Initials>EL</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hunt</LastName>    <ForeName>Rachelle L</ForeName>    <Initials>RL</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Li</LastName>    <ForeName>Barry</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chiou</LastName>    <ForeName>Janice</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pharkjaksu</LastName>    <ForeName>Sujiraphong</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Khongthong</LastName>    <ForeName>Sunisa</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Faculty of Veterinary Science, Rajamangala University of Technology Srivijaya, Nakhon Si Thammarat, Thailand.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cheung</LastName>    <ForeName>Gordon Y C</ForeName>    <Initials>GYC</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kiratisin</LastName>    <ForeName>Pattarachai</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Otto</LastName>    <ForeName>Michael</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. motto@niaid.nih.gov.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>Z01 AI000904-07</GrantID>    <Acronym>ImNIH</Acronym>    <Agency>Intramural NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>ZIA AI000904</GrantID>    <Acronym>ImNIH</Acronym>    <Agency>Intramural NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30305738,<DateCompleted>  <Year>2019</Year>  <Month>03</Month>  <Day>18</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D026923"" MajorTopicYN=""N"">Amino Acid Transport Systems, Basic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001201"" MajorTopicYN=""N"">Ascites</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019069"" MajorTopicYN=""N"">Cell Respiration</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018450"" MajorTopicYN=""N"">Disease Progression</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D059865"" MajorTopicYN=""N"">Endoplasmic Reticulum Stress</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004722"" MajorTopicYN=""N"">Endoribonucleases</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015972"" MajorTopicYN=""N"">Gene Expression Regulation, Neoplastic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005947"" MajorTopicYN=""N"">Glucose</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005973"" MajorTopicYN=""N"">Glutamine</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006031"" MajorTopicYN=""N"">Glycosylation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007371"" MajorTopicYN=""N"">Interferon-gamma</DescriptorName>    <QualifierName UI=""Q000096"" MajorTopicYN=""N"">biosynthesis</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008928"" MajorTopicYN=""N"">Mitochondria</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009362"" MajorTopicYN=""N"">Neoplasm Metastasis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009368"" MajorTopicYN=""N"">Neoplasm Transplantation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010051"" MajorTopicYN=""N"">Ovarian Neoplasms</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017346"" MajorTopicYN=""N"">Protein Serine-Threonine Kinases</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015398"" MajorTopicYN=""N"">Signal Transduction</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015996"" MajorTopicYN=""N"">Survival Rate</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013601"" MajorTopicYN=""N"">T-Lymphocytes</DescriptorName>    <QualifierName UI=""Q000166"" MajorTopicYN=""Y"">cytology</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019139"" MajorTopicYN=""N"">Tumor Escape</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D056811"" MajorTopicYN=""N"">Unfolded Protein Response</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000071717"" MajorTopicYN=""N"">X-Box Binding Protein 1</DescriptorName>    <QualifierName UI=""Q000096"" MajorTopicYN=""N"">biosynthesis</QualifierName>    <QualifierName UI=""Q000172"" MajorTopicYN=""N"">deficiency</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>562</Volume>    <Issue>7727</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Song</LastName>    <ForeName>Minkyung</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sandoval</LastName>    <ForeName>Tito A</ForeName>    <Initials>TA</Initials>    <AffiliationInfo>      <Affiliation>Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chae</LastName>    <ForeName>Chang-Suk</ForeName>    <Initials>CS</Initials>    <AffiliationInfo>      <Affiliation>Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chopra</LastName>    <ForeName>Sahil</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tan</LastName>    <ForeName>Chen</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rutkowski</LastName>    <ForeName>Melanie R</ForeName>    <Initials>MR</Initials>    <AffiliationInfo>      <Affiliation>Department of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Raundhal</LastName>    <ForeName>Mahesh</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chaurio</LastName>    <ForeName>Ricardo A</ForeName>    <Initials>RA</Initials>    <AffiliationInfo>      <Affiliation>Department of Immunology, H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Payne</LastName>    <ForeName>Kyle K</ForeName>    <Initials>KK</Initials>    <AffiliationInfo>      <Affiliation>Department of Immunology, H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Konrad</LastName>    <ForeName>Csaba</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bettigole</LastName>    <ForeName>Sarah E</ForeName>    <Initials>SE</Initials>    <AffiliationInfo>      <Affiliation>Quentis Therapeutics, Inc, New York, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Shin</LastName>    <ForeName>Hee Rae</ForeName>    <Initials>HR</Initials>    <AffiliationInfo>      <Affiliation>Quentis Therapeutics, Inc, New York, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Crowley</LastName>    <ForeName>Michael J P</ForeName>    <Initials>MJP</Initials>    <AffiliationInfo>      <Affiliation>Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cerliani</LastName>    <ForeName>Juan P</ForeName>    <Initials>JP</Initials>    <AffiliationInfo>      <Affiliation>Laboratorio de Inmunopatologa, Instituto de Biologa y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Cientficas y Tcnicas (CONICET), Buenos Aires, Argentina.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kossenkov</LastName>    <ForeName>Andrew V</ForeName>    <Initials>AV</Initials>    <AffiliationInfo>      <Affiliation>Center for Systems and Computational Biology, The Wistar Institute, Philadelphia, PA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Motorykin</LastName>    <ForeName>Ievgen</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>Proteomics &amp; Mass Spectrometry Facility, Institute of Biotechnology, Cornell University, Ithaca, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Sheng</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Proteomics &amp; Mass Spectrometry Facility, Institute of Biotechnology, Cornell University, Ithaca, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Manfredi</LastName>    <ForeName>Giovanni</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zamarin</LastName>    <ForeName>Dmitriy</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Holcomb</LastName>    <ForeName>Kevin</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rodriguez</LastName>    <ForeName>Paulo C</ForeName>    <Initials>PC</Initials>    <AffiliationInfo>      <Affiliation>Department of Immunology, H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rabinovich</LastName>    <ForeName>Gabriel A</ForeName>    <Initials>GA</Initials>    <AffiliationInfo>      <Affiliation>Laboratorio de Inmunopatologa, Instituto de Biologa y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Cientficas y Tcnicas (CONICET), Buenos Aires, Argentina.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Departamento de Qumica Biolgica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Conejo-Garcia</LastName>    <ForeName>Jose R</ForeName>    <Initials>JR</Initials>    <AffiliationInfo>      <Affiliation>Department of Immunology, H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Glimcher</LastName>    <ForeName>Laurie H</ForeName>    <Initials>LH</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. laurie_glimcher@dfci.harvard.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA. laurie_glimcher@dfci.harvard.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cubillos-Ruiz</LastName>    <ForeName>Juan R</ForeName>    <Initials>JR</Initials>    <AffiliationInfo>      <Affiliation>Weill Cornell Graduate School of Medical Sciences, New York, NY, USA. jur2016@med.cornell.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA. jur2016@med.cornell.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. jur2016@med.cornell.edu.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>R01 CA112663</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P30 CA010815</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>T32 CA009140</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P30 CA008748</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R50 CA211199</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>1S10 OD017992-01 </GrantID>    <Acronym>OD</Acronym>    <Agency>NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA184185</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>S10 OD017992</GrantID>    <Acronym>OD</Acronym>    <Agency>NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30309915,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D061067"" MajorTopicYN=""N"">Antibodies, Monoclonal, Humanized</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000074322"" MajorTopicYN=""N"">Antineoplastic Agents, Immunological</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014408"" MajorTopicYN=""N"">Biomarkers, Tumor</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D059447"" MajorTopicYN=""N"">Cell Cycle Checkpoints</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005819"" MajorTopicYN=""N"">Genetic Markers</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007167"" MajorTopicYN=""N"">Immunotherapy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007249"" MajorTopicYN=""N"">Inflammation</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058990"" MajorTopicYN=""N"">Molecular Targeted Therapy</DescriptorName>    <QualifierName UI=""Q000379"" MajorTopicYN=""Y"">methods</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009154"" MajorTopicYN=""N"">Mutation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009369"" MajorTopicYN=""N"">Neoplasms</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D061026"" MajorTopicYN=""N"">Programmed Cell Death 1 Receptor</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""Y"">antagonists &amp; inhibitors</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013601"" MajorTopicYN=""N"">T-Lymphocytes</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D059467"" MajorTopicYN=""N"">Transcriptome</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D047368"" MajorTopicYN=""N"">Tumor Burden</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6411</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>12</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA. razvan_cristescu@merck.com.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Cristescu</LastName>    <ForeName>Razvan</ForeName>    <Initials>R</Initials>    <Identifier Source=""ORCID"">0000-0002-9978-0339</Identifier>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA. razvan_cristescu@merck.com.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mogg</LastName>    <ForeName>Robin</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ayers</LastName>    <ForeName>Mark</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Albright</LastName>    <ForeName>Andrew</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Murphy</LastName>    <ForeName>Erin</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yearley</LastName>    <ForeName>Jennifer</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sher</LastName>    <ForeName>Xinwei</ForeName>    <Initials>X</Initials>    <Identifier Source=""ORCID"">0000-0003-3977-3695</Identifier>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Xiao Qiao</ForeName>    <Initials>XQ</Initials>    <Identifier Source=""ORCID"">0000-0002-6371-6503</Identifier>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lu</LastName>    <ForeName>Hongchao</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nebozhyn</LastName>    <ForeName>Michael</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Chunsheng</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lunceford</LastName>    <ForeName>Jared K</ForeName>    <Initials>JK</Initials>    <Identifier Source=""ORCID"">0000-0001-8120-2277</Identifier>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Joe</LastName>    <ForeName>Andrew</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cheng</LastName>    <ForeName>Jonathan</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Webber</LastName>    <ForeName>Andrea L</ForeName>    <Initials>AL</Initials>    <Identifier Source=""ORCID"">0000-0003-2463-0878</Identifier>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ibrahim</LastName>    <ForeName>Nageatte</ForeName>    <Initials>N</Initials>    <Identifier Source=""ORCID"">0000-0003-0794-949X</Identifier>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Plimack</LastName>    <ForeName>Elizabeth R</ForeName>    <Initials>ER</Initials>    <Identifier Source=""ORCID"">0000-0002-7618-0744</Identifier>    <AffiliationInfo>      <Affiliation>Fox Chase Cancer Center, Philadelphia, PA 19111, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ott</LastName>    <ForeName>Patrick A</ForeName>    <Initials>PA</Initials>    <AffiliationInfo>      <Affiliation>Dana-Farber Cancer Institute, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Seiwert</LastName>    <ForeName>Tanguy Y</ForeName>    <Initials>TY</Initials>    <Identifier Source=""ORCID"">0000-0001-7919-8272</Identifier>    <AffiliationInfo>      <Affiliation>University of Chicago, Chicago, IL 60637, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ribas</LastName>    <ForeName>Antoni</ForeName>    <Initials>A</Initials>    <Identifier Source=""ORCID"">0000-0003-3669-8458</Identifier>    <AffiliationInfo>      <Affiliation>University of California, Los Angeles, Los Angeles, CA 90095, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>McClanahan</LastName>    <ForeName>Terrill K</ForeName>    <Initials>TK</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tomassini</LastName>    <ForeName>Joanne E</ForeName>    <Initials>JE</Initials>    <Identifier Source=""ORCID"">0000-0002-9399-2867</Identifier>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Loboda</LastName>    <ForeName>Andrey</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kaufman</LastName>    <ForeName>David</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Merck &amp; Co., Kenilworth, NJ 07033, USA.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>R35 CA197633</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30309927,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D060467"" MajorTopicYN=""Y"">Disease Resistance</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005602"" MajorTopicYN=""N"">France</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010575"" MajorTopicYN=""N"">Pesticides</DescriptorName>    <QualifierName UI=""Q000633"" MajorTopicYN=""Y"">toxicity</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010935"" MajorTopicYN=""N"">Plant Diseases</DescriptorName>    <QualifierName UI=""Q000382"" MajorTopicYN=""Y"">microbiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D027843"" MajorTopicYN=""N"">Vitis</DescriptorName>    <QualifierName UI=""Q000382"" MajorTopicYN=""Y"">microbiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014920"" MajorTopicYN=""Y"">Wine</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6411</Issue>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>12</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Stokstad</LastName>    <ForeName>Erik</ForeName>    <Initials>E</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30309943,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D002135"" MajorTopicYN=""N"">Calcium-Binding Proteins</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002947"" MajorTopicYN=""N"" Type=""Geographic"">Cities</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003105"" MajorTopicYN=""N"" Type=""Geographic"">Colombia</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005600"" MajorTopicYN=""N"">Fragile X Syndrome</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008562"" MajorTopicYN=""N"">Membrane Glycoproteins</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009030"" MajorTopicYN=""N"">Mosaicism</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009077"" MajorTopicYN=""N"">Mucins</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009154"" MajorTopicYN=""N"">Mutation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010375"" MajorTopicYN=""N"">Pedigree</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D043562"" MajorTopicYN=""N"">Receptors, G-Protein-Coupled</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6411</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>12</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Ricaurte, Colombia.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Furfaro</LastName>    <ForeName>Hannah</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Ricaurte, Colombia.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <CollectiveName>Spectrum</CollectiveName>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30316458,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>02</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D014943"" MajorTopicYN=""N"">Global Health</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009765"" MajorTopicYN=""N"">Obesity</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""Y"">epidemiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1474-547X</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>392</Volume>    <Issue>10156</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>20</Day>    </PubDate>  </JournalIssue>  <Title>Lancet (London, England)</Title>  <ISOAbbreviation>Lancet</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>World Obesity Federation, London WC1 X8TZ, UK. Electronic address: jralston@worldobesity.org.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Ralston</LastName>    <ForeName>Johanna</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>World Obesity Federation, London WC1 X8TZ, UK. Electronic address: jralston@worldobesity.org.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Brinsden</LastName>    <ForeName>Hannah</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>World Obesity Federation, London WC1 X8TZ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Buse</LastName>    <ForeName>Kent</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>UNAIDS, Geneva, Switzerland.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Candeias</LastName>    <ForeName>Vanessa</ForeName>    <Initials>V</Initials>    <AffiliationInfo>      <Affiliation>World Economic Forum, Cologny, Switzerland.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Caterson</LastName>    <ForeName>Ian</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>Boden Institute, Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hassell</LastName>    <ForeName>Trevor</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Healthy Caribbean Coalition, St Michael, Barbados.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kumanyika</LastName>    <ForeName>Shiriki</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Drexel University Dornsife School of Public Health, Philadelphia, PA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nece</LastName>    <ForeName>Patricia</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Obesity Action Coalition, Alexandria, VA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nishtar</LastName>    <ForeName>Sania</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Heartfile, Chak Shahzad Islamabad, Pakistan.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Patton</LastName>    <ForeName>Ian</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>Obesity Canada, York University, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Proietto</LastName>    <ForeName>Joseph</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Salas</LastName>    <ForeName>Ximena Ramos</ForeName>    <Initials>XR</Initials>    <AffiliationInfo>      <Affiliation>Obesity Canada, Li Ka Shing Centre for Health Research Innovation, University of Alberta, Edmonton, AB, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Reddy</LastName>    <ForeName>Srinath</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Public Health Foundation of India, Gurgaon, Haryana, India.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ryan</LastName>    <ForeName>Donna</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Pennington Biomedical, Baton Rouge, LA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sharma</LastName>    <ForeName>Arya M</ForeName>    <Initials>AM</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, University of Alberta, Edmonton, AB, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Swinburn</LastName>    <ForeName>Boyd</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>School of Population Health, University of Auckland, Auckland, New Zealand; WHO Collaborating Centre for Obesity Prevention, Deakin University, Burwood, VIC, Australia.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wilding</LastName>    <ForeName>John</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Woodward</LastName>    <ForeName>Euan</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>European Association for the Study of Obesity (EASO), Teddington, UK.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30318146,<DateCompleted>  <Year>2019</Year>  <Month>07</Month>  <Day>29</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D025181"" MajorTopicYN=""N"">ATP Synthetase Complexes</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001921"" MajorTopicYN=""N"">Brain</DescriptorName>    <QualifierName UI=""Q000254"" MajorTopicYN=""N"">growth &amp; development</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002478"" MajorTopicYN=""N"">Cells, Cultured</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D057809"" MajorTopicYN=""N"">HEK293 Cells</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D050956"" MajorTopicYN=""N"">HSP40 Heat-Shock Proteins</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008253"" MajorTopicYN=""N"">Macaca mulatta</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008810"" MajorTopicYN=""N"">Mice, Inbred C57BL</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008928"" MajorTopicYN=""N"">Mitochondria</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010085"" MajorTopicYN=""N"">Oxidative Phosphorylation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018980"" MajorTopicYN=""N"">Williams Syndrome</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>175</Volume>    <Issue>4</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>01</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Tebbenkamp</LastName>    <ForeName>Andrew T N</ForeName>    <Initials>ATN</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Varela</LastName>    <ForeName>Luis</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Program in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Choi</LastName>    <ForeName>Jinmyung</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Paredes</LastName>    <ForeName>Miguel I</ForeName>    <Initials>MI</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Giani</LastName>    <ForeName>Alice M</ForeName>    <Initials>AM</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Song</LastName>    <ForeName>Jae Eun</ForeName>    <Initials>JE</Initials>    <AffiliationInfo>      <Affiliation>Program in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sestan-Pesa</LastName>    <ForeName>Matija</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Program in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Franjic</LastName>    <ForeName>Daniel</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sousa</LastName>    <ForeName>Andr M M</ForeName>    <Initials>AMM</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Zhong-Wu</ForeName>    <Initials>ZW</Initials>    <AffiliationInfo>      <Affiliation>Program in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Li</LastName>    <ForeName>Mingfeng</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bichsel</LastName>    <ForeName>Candace</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Koch</LastName>    <ForeName>Marco</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Program in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Szigeti-Buck</LastName>    <ForeName>Klara</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Program in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Fuchen</ForeName>    <Initials>F</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Li</LastName>    <ForeName>Zhuo</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kawasawa</LastName>    <ForeName>Yuka I</ForeName>    <Initials>YI</Initials>    <AffiliationInfo>      <Affiliation>Institute for Personalized Medicine and Departments of Biochemistry and Molecular Biology and Pharmacology, Penn State College of Medicine, Hershey, PA 17033, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Paspalas</LastName>    <ForeName>Constantinos D</ForeName>    <Initials>CD</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mineur</LastName>    <ForeName>Yann S</ForeName>    <Initials>YS</Initials>    <AffiliationInfo>      <Affiliation>Department of Psychiatry, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Prontera</LastName>    <ForeName>Paolo</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Medical Genetics Unit, Hospital ""Santa Maria della Misericordia,"" 06129 Perugia, Italy.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Merla</LastName>    <ForeName>Giuseppe</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Division of Medical Genetics, IRCCS Casa Sollievo della Sofferenza Hospital, 71013 San Giovanni Rotondo, Foggia, Italy.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Picciotto</LastName>    <ForeName>Marina R</ForeName>    <Initials>MR</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Arnsten</LastName>    <ForeName>Amy F T</ForeName>    <Initials>AFT</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT 06510, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Horvath</LastName>    <ForeName>Tamas L</ForeName>    <Initials>TL</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510, USA; Department of Anatomy and Histology, University of Veterinary Medicine, 1078 Budapest, Hungary.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sestan</LastName>    <ForeName>Nenad</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT 06510, USA; Departments of Genetics and of Comparative Medicine, Program in Cellular Neuroscience, Neurodegeneration and Repair, and Yale Child Study Center, Yale School of Medicine, New Haven, CT 06510, USA. Electronic address: nenad.sestan@yale.edu.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>T32 NS007224</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R56 AG052986</GrantID>    <Acronym>AG</Acronym>    <Agency>NIA NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 AG052986</GrantID>    <Acronym>AG</Acronym>    <Agency>NIA NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>DP1 AG047744</GrantID>    <Acronym>AG</Acronym>    <Agency>NIA NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P01 AG051459</GrantID>    <Acronym>AG</Acronym>    <Agency>NIA NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 MH109904</GrantID>    <Acronym>MH</Acronym>    <Agency>NIMH NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U01 MH106874</GrantID>    <Acronym>MH</Acronym>    <Agency>NIMH NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 MH110926</GrantID>    <Acronym>MH</Acronym>    <Agency>NIMH NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 DK111178</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U01 MH116488</GrantID>    <Acronym>MH</Acronym>    <Agency>NIMH NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 AG052005</GrantID>    <Acronym>AG</Acronym>    <Agency>NIA NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P50 MH106934</GrantID>    <Acronym>MH</Acronym>    <Agency>NIMH NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30319114,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>05</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D003906"" MajorTopicYN=""N"">Developing Countries</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000071219"" MajorTopicYN=""Y"">Global Burden of Disease</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006293"" MajorTopicYN=""N"">Health Promotion</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011322"" MajorTopicYN=""N"">Primary Prevention</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018570"" MajorTopicYN=""N"">Risk Assessment</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012307"" MajorTopicYN=""N"">Risk Factors</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055502"" MajorTopicYN=""N"">Secondary Prevention</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020521"" MajorTopicYN=""N"">Stroke</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014944"" MajorTopicYN=""N"">World Health Organization</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1474-547X</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>392</Volume>    <Issue>10154</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>06</Day>    </PubDate>  </JournalIssue>  <Title>Lancet (London, England)</Title>  <ISOAbbreviation>Lancet</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Neurology, Christian Medical College and Hospital, Ludhiana, India. Electronic address: jeyarajpandian@hotmail.com.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Pandian</LastName>    <ForeName>Jeyaraj D</ForeName>    <Initials>JD</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurology, Christian Medical College and Hospital, Ludhiana, India. Electronic address: jeyarajpandian@hotmail.com.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gall</LastName>    <ForeName>Seana L</ForeName>    <Initials>SL</Initials>    <AffiliationInfo>      <Affiliation>Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kate</LastName>    <ForeName>Mahesh P</ForeName>    <Initials>MP</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurology, Christian Medical College and Hospital, Ludhiana, India.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Silva</LastName>    <ForeName>Gisele S</ForeName>    <Initials>GS</Initials>    <AffiliationInfo>      <Affiliation>Programa Integrado de Neurologia, Hospital Israelita Albert Einstein, So Paulo, Brazil.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Akinyemi</LastName>    <ForeName>Rufus O</ForeName>    <Initials>RO</Initials>    <AffiliationInfo>      <Affiliation>Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ovbiagele</LastName>    <ForeName>Bruce I</ForeName>    <Initials>BI</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lavados</LastName>    <ForeName>Pablo M</ForeName>    <Initials>PM</Initials>    <AffiliationInfo>      <Affiliation>Vascular Neurology Unit, Neurology Service, Department of Neurology and Psychiatry, Clnica Alemana de Santiago, Santiago, Chile; Facultad de Medicina, Clnica Alemana Universidad del Desarrollo, Santiago, Chile; Department of Neurological Sciences, Facultad de Medicina, Universidad de Chile, Santiago, Chile.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gandhi</LastName>    <ForeName>Dorcas B C</ForeName>    <Initials>DBC</Initials>    <AffiliationInfo>      <Affiliation>College of Physiotherapy, Christian Medical College and Hospital Ludhiana, Ludhiana, India.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Thrift</LastName>    <ForeName>Amanda G</ForeName>    <Initials>AG</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016454"">Review</PublicationType></PublicationTypeList>",NA
30322725,<DateCompleted>  <Year>2019</Year>  <Month>01</Month>  <Day>16</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D002981"" MajorTopicYN=""Y"">Clindamycin</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004311"" MajorTopicYN=""N"">Double-Blind Method</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007231"" MajorTopicYN=""N"">Infant, Newborn</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011251"" MajorTopicYN=""N"">Pregnancy Complications, Infectious</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D047928"" MajorTopicYN=""N"">Premature Birth</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016585"" MajorTopicYN=""Y"">Vaginosis, Bacterial</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1474-547X</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>392</Volume>    <Issue>10160</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>17</Day>    </PubDate>  </JournalIssue>  <Title>Lancet (London, England)</Title>  <ISOAbbreviation>Lancet</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43215, USA; Department of Pediatrics, Department of Obstetrics and Gynecology, and Division of Epidemiology, The Ohio State University, Columbus, OH, USA. Electronic address: mark.klebanoff@nationwidechildrens.org.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Klebanoff</LastName>    <ForeName>Mark A</ForeName>    <Initials>MA</Initials>    <AffiliationInfo>      <Affiliation>Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43215, USA; Department of Pediatrics, Department of Obstetrics and Gynecology, and Division of Epidemiology, The Ohio State University, Columbus, OH, USA. Electronic address: mark.klebanoff@nationwidechildrens.org.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Brotman</LastName>    <ForeName>Rebecca M</ForeName>    <Initials>RM</Initials>    <AffiliationInfo>      <Affiliation>Department of Epidemiology and Public Health, Institute for Genome Sciences, The University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016420"">Comment</PublicationType></PublicationTypeList>",NA
30326083,<DateCompleted>  <Year>2019</Year>  <Month>08</Month>  <Day>19</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000900"" MajorTopicYN=""Y"">Anti-Bacterial Agents</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015415"" MajorTopicYN=""N"">Biomarkers</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000077740"" MajorTopicYN=""N"">Procalcitonin</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012141"" MajorTopicYN=""Y"">Respiratory Tract Infections</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1539-3704</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>169</Volume>    <Issue>8</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>16</Day>    </PubDate>  </JournalIssue>  <Title>Annals of internal medicine</Title>  <ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Tansarli</LastName>    <ForeName>Giannoula S</ForeName>    <Initials>GS</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Mylonakis</LastName>    <ForeName>Eleftherios</ForeName>    <Initials>E</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016420"">Comment</PublicationType></PublicationTypeList>",NA
30326087,<DateCompleted>  <Year>2019</Year>  <Month>08</Month>  <Day>19</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D019274"" MajorTopicYN=""Y"">Botulinum Toxins, Type A</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002220"" MajorTopicYN=""N"">Carbamazepine</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008012"" MajorTopicYN=""N"">Lidocaine</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000071076"" MajorTopicYN=""N"">Network Meta-Analysis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014277"" MajorTopicYN=""Y"">Trigeminal Neuralgia</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1539-3704</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>169</Volume>    <Issue>8</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>16</Day>    </PubDate>  </JournalIssue>  <Title>Annals of internal medicine</Title>  <ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Steinberg</LastName>    <ForeName>Daniel I</ForeName>    <Initials>DI</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016420"">Comment</PublicationType></PublicationTypeList>",NA
30326088,<DateCompleted>  <Year>2019</Year>  <Month>08</Month>  <Day>19</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D005492"" MajorTopicYN=""N"">Folic Acid</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008903"" MajorTopicYN=""N"">Minerals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020521"" MajorTopicYN=""Y"">Stroke</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014803"" MajorTopicYN=""Y"">Vitamin B Complex</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1539-3704</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>169</Volume>    <Issue>8</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>16</Day>    </PubDate>  </JournalIssue>  <Title>Annals of internal medicine</Title>  <ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Aung</LastName>    <ForeName>KoKo</ForeName>    <Initials>K</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Htay</LastName>    <ForeName>Thwe</ForeName>    <Initials>T</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016420"">Comment</PublicationType></PublicationTypeList>",NA
30326091,<DateCompleted>  <Year>2019</Year>  <Month>08</Month>  <Day>19</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000138"" MajorTopicYN=""Y"">Acidosis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000140"" MajorTopicYN=""Y"">Acidosis, Lactic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015331"" MajorTopicYN=""N"">Cohort Studies</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D066246"" MajorTopicYN=""N"">ErbB Receptors</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006760"" MajorTopicYN=""N"">Hospitalization</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007004"" MajorTopicYN=""N"">Hypoglycemic Agents</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008687"" MajorTopicYN=""Y"">Metformin</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1539-3704</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>169</Volume>    <Issue>8</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>16</Day>    </PubDate>  </JournalIssue>  <Title>Annals of internal medicine</Title>  <ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Leung</LastName>    <ForeName>Alexander A</ForeName>    <Initials>AA</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Padwal</LastName>    <ForeName>Raj S</ForeName>    <Initials>RS</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016420"">Comment</PublicationType></PublicationTypeList>",NA
30326501,<DateCompleted>  <Year>2018</Year>  <Month>10</Month>  <Day>29</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019440"" MajorTopicYN=""N"">Anti-Obesity Agents</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001521"" MajorTopicYN=""Y"">Behavior Therapy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003131"" MajorTopicYN=""N"">Combined Modality Therapy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003924"" MajorTopicYN=""N"">Diabetes Mellitus, Type 2</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015438"" MajorTopicYN=""Y"">Health Behavior</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009765"" MajorTopicYN=""N"">Obesity</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""N"">complications</QualifierName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000073319"" MajorTopicYN=""N"">Obesity Management</DescriptorName>    <QualifierName UI=""Q000379"" MajorTopicYN=""Y"">methods</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011314"" MajorTopicYN=""N"">Preventive Health Services</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016032"" MajorTopicYN=""N"">Randomized Controlled Trials as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"">United States</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015431"" MajorTopicYN=""Y"">Weight Loss</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1538-3598</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>320</Volume>    <Issue>11</Issue>    <PubDate>      <Year>2018</Year>      <Month>09</Month>      <Day>18</Day>    </PubDate>  </JournalIssue>  <Title>JAMA</Title>  <ISOAbbreviation>JAMA</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>LeBlanc</LastName>    <ForeName>Erin S</ForeName>    <Initials>ES</Initials>    <AffiliationInfo>      <Affiliation>Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Patnode</LastName>    <ForeName>Carrie D</ForeName>    <Initials>CD</Initials>    <AffiliationInfo>      <Affiliation>Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Webber</LastName>    <ForeName>Elizabeth M</ForeName>    <Initials>EM</Initials>    <AffiliationInfo>      <Affiliation>Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Redmond</LastName>    <ForeName>Nadia</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rushkin</LastName>    <ForeName>Megan</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>O'Connor</LastName>    <ForeName>Elizabeth A</ForeName>    <Initials>EA</Initials>    <AffiliationInfo>      <Affiliation>Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D017418"">Meta-Analysis</PublicationType>  <PublicationType UI=""D013487"">Research Support, U.S. Gov't, P.H.S.</PublicationType>  <PublicationType UI=""D016454"">Review</PublicationType>  <PublicationType UI=""D000078182"">Systematic Review</PublicationType></PublicationTypeList>",NA
30326502,<DateCompleted>  <Year>2018</Year>  <Month>10</Month>  <Day>29</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019440"" MajorTopicYN=""N"">Anti-Obesity Agents</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001521"" MajorTopicYN=""Y"">Behavior Therapy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003131"" MajorTopicYN=""N"">Combined Modality Therapy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003924"" MajorTopicYN=""N"">Diabetes Mellitus, Type 2</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015438"" MajorTopicYN=""Y"">Health Behavior</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009765"" MajorTopicYN=""N"">Obesity</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""N"">complications</QualifierName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000073319"" MajorTopicYN=""N"">Obesity Management</DescriptorName>    <QualifierName UI=""Q000379"" MajorTopicYN=""N"">methods</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011314"" MajorTopicYN=""N"">Preventive Health Services</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"">United States</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015431"" MajorTopicYN=""N"">Weight Loss</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1538-3598</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>320</Volume>    <Issue>11</Issue>    <PubDate>      <Year>2018</Year>      <Month>09</Month>      <Day>18</Day>    </PubDate>  </JournalIssue>  <Title>JAMA</Title>  <ISOAbbreviation>JAMA</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>University of Iowa, Iowa City.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <CollectiveName>US Preventive Services Task Force</CollectiveName>  </Author>  <Author ValidYN=""Y"">    <LastName>Curry</LastName>    <ForeName>Susan J</ForeName>    <Initials>SJ</Initials>    <AffiliationInfo>      <Affiliation>University of Iowa, Iowa City.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Krist</LastName>    <ForeName>Alex H</ForeName>    <Initials>AH</Initials>    <AffiliationInfo>      <Affiliation>Fairfax Family Practice Residency, Fairfax, Virginia.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Virginia Commonwealth University, Richmond.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Owens</LastName>    <ForeName>Douglas K</ForeName>    <Initials>DK</Initials>    <AffiliationInfo>      <Affiliation>Veterans Affairs Palo Alto Health Care System, Palo Alto, California.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Stanford University, Stanford, California.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Barry</LastName>    <ForeName>Michael J</ForeName>    <Initials>MJ</Initials>    <AffiliationInfo>      <Affiliation>Harvard Medical School, Boston, Massachusetts.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Caughey</LastName>    <ForeName>Aaron B</ForeName>    <Initials>AB</Initials>    <AffiliationInfo>      <Affiliation>Oregon Health &amp; Science University, Portland.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Davidson</LastName>    <ForeName>Karina W</ForeName>    <Initials>KW</Initials>    <AffiliationInfo>      <Affiliation>Columbia University, New York, New York.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Doubeni</LastName>    <ForeName>Chyke A</ForeName>    <Initials>CA</Initials>    <AffiliationInfo>      <Affiliation>University of Pennsylvania, Philadelphia.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Epling</LastName>    <ForeName>John W</ForeName>    <Initials>JW</Initials>    <Suffix>Jr</Suffix>    <AffiliationInfo>      <Affiliation>Virginia Tech Carilion School of Medicine, Roanoke.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Grossman</LastName>    <ForeName>David C</ForeName>    <Initials>DC</Initials>    <AffiliationInfo>      <Affiliation>Kaiser Permanente Washington Health Research Institute, Seattle.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kemper</LastName>    <ForeName>Alex R</ForeName>    <Initials>AR</Initials>    <AffiliationInfo>      <Affiliation>Nationwide Children's Hospital, Columbus, Ohio.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kubik</LastName>    <ForeName>Martha</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Temple University, Philadelphia, Pennsylvania.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Landefeld</LastName>    <ForeName>C Seth</ForeName>    <Initials>CS</Initials>    <AffiliationInfo>      <Affiliation>University of Alabama at Birmingham.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mangione</LastName>    <ForeName>Carol M</ForeName>    <Initials>CM</Initials>    <AffiliationInfo>      <Affiliation>University of California, Los Angeles.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Phipps</LastName>    <ForeName>Maureen G</ForeName>    <Initials>MG</Initials>    <AffiliationInfo>      <Affiliation>Brown University, Providence, Rhode Island.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Silverstein</LastName>    <ForeName>Michael</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Boston University, Boston, Massachusetts.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Simon</LastName>    <ForeName>Melissa A</ForeName>    <Initials>MA</Initials>    <AffiliationInfo>      <Affiliation>Northwestern University, Evanston, Illinois.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tseng</LastName>    <ForeName>Chien-Wen</ForeName>    <Initials>CW</Initials>    <AffiliationInfo>      <Affiliation>University of Hawaii, Honolulu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Pacific Health Research and Education Institute, Honolulu, Hawaii.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wong</LastName>    <ForeName>John B</ForeName>    <Initials>JB</Initials>    <AffiliationInfo>      <Affiliation>Tufts University, Medford, Massachusetts.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D017065"">Practice Guideline</PublicationType>  <PublicationType UI=""D013487"">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList>",NA
30326511,<DateCompleted>  <Year>2018</Year>  <Month>10</Month>  <Day>29</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000970"" MajorTopicYN=""N"">Antineoplastic Agents</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D050071"" MajorTopicYN=""N"">Bone Density Conservation Agents</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004164"" MajorTopicYN=""N"">Diphosphonates</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D050723"" MajorTopicYN=""N"">Fractures, Bone</DescriptorName>    <QualifierName UI=""Q000209"" MajorTopicYN=""N"">etiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007093"" MajorTopicYN=""N"">Imidazoles</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009101"" MajorTopicYN=""N"">Multiple Myeloma</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""N"">complications</QualifierName>    <QualifierName UI=""Q000188"" MajorTopicYN=""Y"">drug therapy</QualifierName>    <QualifierName UI=""Q000401"" MajorTopicYN=""N"">mortality</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016032"" MajorTopicYN=""N"">Randomized Controlled Trials as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012196"" MajorTopicYN=""N"">Review Literature as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000077211"" MajorTopicYN=""N"">Zoledronic Acid</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1538-3598</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>320</Volume>    <Issue>14</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>09</Day>    </PubDate>  </JournalIssue>  <Title>JAMA</Title>  <ISOAbbreviation>JAMA</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Morsani College of Medicine, Division of Evidence Based Medicine, Department of Internal Medicine, University of South Florida, Tampa.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Mhaskar</LastName>    <ForeName>Rahul</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Morsani College of Medicine, Division of Evidence Based Medicine, Department of Internal Medicine, University of South Florida, Tampa.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Djulbegovic</LastName>    <ForeName>Benjamin</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Evidence-Based Medicine and Comparative Effectiveness Research Program, Departments of Supportive Medicine and Hematology, City of Hope, Duarte, California.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D017418"">Meta-Analysis</PublicationType></PublicationTypeList>",NA
30327294,<DateCompleted>  <Year>2019</Year>  <Month>02</Month>  <Day>25</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D002648"" MajorTopicYN=""N"">Child</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002662"" MajorTopicYN=""N"">Child Health Services</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002675"" MajorTopicYN=""N"">Child, Preschool</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015928"" MajorTopicYN=""N"">Cognitive Behavioral Therapy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007223"" MajorTopicYN=""N"">Infant</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007231"" MajorTopicYN=""N"">Infant, Newborn</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017410"" MajorTopicYN=""N"">Practice Guidelines as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007319"" MajorTopicYN=""N"">Sleep Initiation and Maintenance Disorders</DescriptorName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>16</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Division of Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK cmh2@soton.ac.uk.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Hill</LastName>    <ForeName>Catherine M</ForeName>    <Initials>CM</Initials>    <AffiliationInfo>      <Affiliation>Division of Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK cmh2@soton.ac.uk.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Southampton Children's Hospital, Southampton, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Everitt</LastName>    <ForeName>Hazel</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Division of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, UK.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30332564,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000293"" MajorTopicYN=""N"">Adolescent</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001499"" MajorTopicYN=""N"">Bayes Theorem</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004197"" MajorTopicYN=""N"">Disease Reservoirs</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014644"" MajorTopicYN=""N"">Genetic Variation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016679"" MajorTopicYN=""Y"">Genome, Viral</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007835"" MajorTopicYN=""N"">Lassa Fever</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>    <QualifierName UI=""Q000635"" MajorTopicYN=""N"">transmission</QualifierName>    <QualifierName UI=""Q000821"" MajorTopicYN=""Y"">virology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007836"" MajorTopicYN=""N"">Lassa virus</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008390"" MajorTopicYN=""N"">Markov Chains</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009549"" MajorTopicYN=""N"">Nigeria</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010802"" MajorTopicYN=""N"">Phylogeny</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058974"" MajorTopicYN=""N"">Phylogeography</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012367"" MajorTopicYN=""N"">RNA, Viral</DescriptorName>    <QualifierName UI=""Q000032"" MajorTopicYN=""Y"">analysis</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012377"" MajorTopicYN=""N"">Rodentia</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017423"" MajorTopicYN=""N"">Sequence Analysis, RNA</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015047"" MajorTopicYN=""N"">Zoonoses</DescriptorName>    <QualifierName UI=""Q000635"" MajorTopicYN=""N"">transmission</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>18</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>01</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Siddle</LastName>    <ForeName>Katherine J</ForeName>    <Initials>KJ</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Eromon</LastName>    <ForeName>Philomena</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Barnes</LastName>    <ForeName>Kayla G</ForeName>    <Initials>KG</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mehta</LastName>    <ForeName>Samar</ForeName>    <Initials>S</Initials>    <Identifier Source=""ORCID"">0000-0002-9181-8363</Identifier>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Oguzie</LastName>    <ForeName>Judith U</ForeName>    <Initials>JU</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Odia</LastName>    <ForeName>Ikponmwosa</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Schaffner</LastName>    <ForeName>Stephen F</ForeName>    <Initials>SF</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Winnicki</LastName>    <ForeName>Sarah M</ForeName>    <Initials>SM</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Shah</LastName>    <ForeName>Rickey R</ForeName>    <Initials>RR</Initials>    <Identifier Source=""ORCID"">0000-0002-3231-0367</Identifier>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Qu</LastName>    <ForeName>James</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wohl</LastName>    <ForeName>Shirlee</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Brehio</LastName>    <ForeName>Patrick</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Iruolagbe</LastName>    <ForeName>Christopher</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Aiyepada</LastName>    <ForeName>John</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Uyigue</LastName>    <ForeName>Eghosa</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Akhilomen</LastName>    <ForeName>Patience</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Okonofua</LastName>    <ForeName>Grace</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ye</LastName>    <ForeName>Simon</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kayode</LastName>    <ForeName>Tolulope</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ajogbasile</LastName>    <ForeName>Fehintola</ForeName>    <Initials>F</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Uwanibe</LastName>    <ForeName>Jessica</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gaye</LastName>    <ForeName>Amy</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Momoh</LastName>    <ForeName>Mambu</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chak</LastName>    <ForeName>Bridget</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kotliar</LastName>    <ForeName>Dylan</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Carter</LastName>    <ForeName>Amber</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gladden-Young</LastName>    <ForeName>Adrianne</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Freije</LastName>    <ForeName>Catherine A</ForeName>    <Initials>CA</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Omoregie</LastName>    <ForeName>Omigie</ForeName>    <Initials>O</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Osiemi</LastName>    <ForeName>Blessing</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Muoebonam</LastName>    <ForeName>Ekene B</ForeName>    <Initials>EB</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Airende</LastName>    <ForeName>Michael</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Enigbe</LastName>    <ForeName>Rachael</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ebo</LastName>    <ForeName>Benevolence</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nosamiefan</LastName>    <ForeName>Iguosadolo</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Oluniyi</LastName>    <ForeName>Paul</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nekoui</LastName>    <ForeName>Mahan</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ogbaini-Emovon</LastName>    <ForeName>Ephraim</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Garry</LastName>    <ForeName>Robert F</ForeName>    <Initials>RF</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Andersen</LastName>    <ForeName>Kristian G</ForeName>    <Initials>KG</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Park</LastName>    <ForeName>Daniel J</ForeName>    <Initials>DJ</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yozwiak</LastName>    <ForeName>Nathan L</ForeName>    <Initials>NL</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Akpede</LastName>    <ForeName>George</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ihekweazu</LastName>    <ForeName>Chikwe</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tomori</LastName>    <ForeName>Oyewale</ForeName>    <Initials>O</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Okogbenin</LastName>    <ForeName>Sylvanus</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Folarin</LastName>    <ForeName>Onikepe A</ForeName>    <Initials>OA</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Okokhere</LastName>    <ForeName>Peter O</ForeName>    <Initials>PO</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>MacInnis</LastName>    <ForeName>Bronwyn L</ForeName>    <Initials>BL</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sabeti</LastName>    <ForeName>Pardis C</ForeName>    <Initials>PC</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Happi</LastName>    <ForeName>Christian T</ForeName>    <Initials>CT</Initials>    <AffiliationInfo>      <Affiliation>From the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University (K.J.S., K.G.B., S.M., S.F.S., S.M.W., R.R.S., J.Q., S.W., P.B., S.Y., B.C., D.K., A.C., A.G.-Y., C.A.F., D.J.P., N.L.Y., B.L.M., P.C.S.), the Center for Systems Biology, Department of Organismic and Evolutionary Biology (K.J.S., K.G.B., S.F.S., S.W., B.C., D.K., C.A.F., N.L.Y., P.C.S.), and the Faculty of Arts and Sciences (M.N.), Harvard University, Harvard University Extension School (R.R.S.), and Harvard-MIT Health Sciences and Technology, MIT (S.Y., P.C.S.), Cambridge, and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (K.G.B., S.F.S., B.L.M., P.C.S., C.T.H.), and Beth Israel Deaconess Medical Center, Division of Infectious Diseases (S.M.), Boston - all in Massachusetts; the African Center of Excellence for Genomics of Infectious Diseases (P.E., J.U.O., E.U., T.K., F.A., J.U., A.G., M.M., I.N., P.O., O.T., O.A.F., C.T.H.) and the Department of Biological Sciences, College of Natural Sciences (J.U.O., E.U., T.K., F.A., J.U., P.O., O.A.F., C.T.H.), Redeemer's University, Ede, the Institute of Lassa Fever Research and Control (I.O., C. Iruolagbe, J.A., E.U., P.A., G.O., O.O., B.O., E.B.M., M.A., R.E., B.E., E.O.-E., G.A., S.O., P.O.O., C.T.H.) and the Department of Medicine (P.O.O.), Irrua Specialist Teaching Hospital, Irrua, the Nigeria Center for Disease Control, Abuja (C. Ihekweazu), and the Department of Medicine, Faculty of Clinical Sciences, Ambrose Alli University, Ekpoma (P.O.O.) - all in Nigeria; the Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, Dakar, Senegal (A.G.); Kenema Government Hospital, Kenema, Sierra Leone (M.M.); Tulane Health Sciences Center, Tulane University, New Orleans (R.F.G.); the Departments of Immunology and Microbial Science and Integrative Structural and Computational Biology, Scripps Research Institute, and the Scripps Translational Science Institute, La Jolla, CA (K.G.A.); and Howard Hughes Medical Institute, Chevy Chase, MD (P.C.S.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>U19 AI115589</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>UL1 TR001114</GrantID>    <Acronym>TR</Acronym>    <Agency>NCATS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U01 HG007480</GrantID>    <Acronym>HG</Acronym>    <Agency>NHGRI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>T32 GM007753</GrantID>    <Acronym>GM</Acronym>    <Agency>NIGMS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 AI114855</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U19 AI135995</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <Acronym>HHMI</Acronym>    <Agency>Howard Hughes Medical Institute</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R44 AI115754</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U54 HG007480</GrantID>    <Acronym>HG</Acronym>    <Agency>NHGRI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U19 AI110818</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30332569,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>05</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000900"" MajorTopicYN=""N"">Anti-Bacterial Agents</DescriptorName>    <QualifierName UI=""Q000266"" MajorTopicYN=""N"">history</QualifierName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001208"" MajorTopicYN=""N"">Asia</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002648"" MajorTopicYN=""N"">Child</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004196"" MajorTopicYN=""N"">Disease Outbreaks</DescriptorName>    <QualifierName UI=""Q000266"" MajorTopicYN=""N"">history</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D024901"" MajorTopicYN=""N"">Drug Resistance, Multiple, Bacterial</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006239"" MajorTopicYN=""N"">Haplotypes</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D049673"" MajorTopicYN=""N"">History, 20th Century</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D049674"" MajorTopicYN=""N"">History, 21st Century</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017589"" MajorTopicYN=""N"">Immunization Programs</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010154"" MajorTopicYN=""N"">Pakistan</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012485"" MajorTopicYN=""N"">Salmonella typhi</DescriptorName>    <QualifierName UI=""Q000187"" MajorTopicYN=""N"">drug effects</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014435"" MajorTopicYN=""N"">Typhoid Fever</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014436"" MajorTopicYN=""Y"">Typhoid-Paratyphoid Vaccines</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018074"" MajorTopicYN=""Y"">Vaccines, Conjugate</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>16</Issue>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>18</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA (J.R.A.); the Department of Pediatric and Child Health, the Aga Khan University, Karachi, Pakistan (F.N.Q.); and the Division of Infectious Diseases, Massachusetts General Hospital (R.C.C., E.T.R.), the Department of Medicine, Harvard Medical School (R.C.C., E.T.R.), and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (E.T.R.) - all in Boston.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Andrews</LastName>    <ForeName>Jason R</ForeName>    <Initials>JR</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA (J.R.A.); the Department of Pediatric and Child Health, the Aga Khan University, Karachi, Pakistan (F.N.Q.); and the Division of Infectious Diseases, Massachusetts General Hospital (R.C.C., E.T.R.), the Department of Medicine, Harvard Medical School (R.C.C., E.T.R.), and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (E.T.R.) - all in Boston.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Qamar</LastName>    <ForeName>Farah N</ForeName>    <Initials>FN</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA (J.R.A.); the Department of Pediatric and Child Health, the Aga Khan University, Karachi, Pakistan (F.N.Q.); and the Division of Infectious Diseases, Massachusetts General Hospital (R.C.C., E.T.R.), the Department of Medicine, Harvard Medical School (R.C.C., E.T.R.), and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (E.T.R.) - all in Boston.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Charles</LastName>    <ForeName>Richelle C</ForeName>    <Initials>RC</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA (J.R.A.); the Department of Pediatric and Child Health, the Aga Khan University, Karachi, Pakistan (F.N.Q.); and the Division of Infectious Diseases, Massachusetts General Hospital (R.C.C., E.T.R.), the Department of Medicine, Harvard Medical School (R.C.C., E.T.R.), and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (E.T.R.) - all in Boston.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ryan</LastName>    <ForeName>Edward T</ForeName>    <Initials>ET</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA (J.R.A.); the Department of Pediatric and Child Health, the Aga Khan University, Karachi, Pakistan (F.N.Q.); and the Division of Infectious Diseases, Massachusetts General Hospital (R.C.C., E.T.R.), the Department of Medicine, Harvard Medical School (R.C.C., E.T.R.), and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (E.T.R.) - all in Boston.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016456"">Historical Article</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30332573,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>05</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D016739"" MajorTopicYN=""Y"">Behavior, Addictive</DescriptorName>    <QualifierName UI=""Q000503"" MajorTopicYN=""N"">physiopathology</QualifierName>    <QualifierName UI=""Q000523"" MajorTopicYN=""N"">psychology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001921"" MajorTopicYN=""N"">Brain</DescriptorName>    <QualifierName UI=""Q000503"" MajorTopicYN=""Y"">physiopathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001927"" MajorTopicYN=""N"">Brain Diseases</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007858"" MajorTopicYN=""Y"">Learning</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008960"" MajorTopicYN=""N"">Models, Psychological</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D057545"" MajorTopicYN=""N"">Social Stigma</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019966"" MajorTopicYN=""N"">Substance-Related Disorders</DescriptorName>    <QualifierName UI=""Q000503"" MajorTopicYN=""N"">physiopathology</QualifierName>    <QualifierName UI=""Q000523"" MajorTopicYN=""Y"">psychology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>16</Issue>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>18</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the University of Toronto, Toronto.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Lewis</LastName>    <ForeName>Marc</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>From the University of Toronto, Toronto.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016454"">Review</PublicationType></PublicationTypeList>",NA
30332574,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>05</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D059350"" MajorTopicYN=""N"">Chronic Pain</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""Y"">drug therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020918"" MajorTopicYN=""N"">Complex Regional Pain Syndromes</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""Y"">drug therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D064086"" MajorTopicYN=""N"">Medical Marijuana</DescriptorName>    <QualifierName UI=""Q000008"" MajorTopicYN=""N"">administration &amp; dosage</QualifierName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>16</Issue>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>18</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Caulley</LastName>    <ForeName>Lisa</ForeName>    <Initials>L</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Caplan</LastName>    <ForeName>Benjamin</ForeName>    <Initials>B</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Ross</LastName>    <ForeName>Edgar</ForeName>    <Initials>E</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D002363"">Case Reports</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30332576,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>05</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000970"" MajorTopicYN=""N"">Antineoplastic Agents</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016393"" MajorTopicYN=""N"">Lymphoma, B-Cell</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009260"" MajorTopicYN=""N"">Nail Diseases</DescriptorName>    <QualifierName UI=""Q000139"" MajorTopicYN=""Y"">chemically induced</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009262"" MajorTopicYN=""N"">Nails</DescriptorName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>16</Issue>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>18</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>King Saud University, Riyadh, Saudi Arabia malzahrani@ksu.edu.sa.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Alzahrani</LastName>    <ForeName>Musa F</ForeName>    <Initials>MF</Initials>    <AffiliationInfo>      <Affiliation>King Saud University, Riyadh, Saudi Arabia malzahrani@ksu.edu.sa.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>AlJasser</LastName>    <ForeName>Mohammed I</ForeName>    <Initials>MI</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0003-1759-1057</Identifier>    <AffiliationInfo>      <Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D002363"">Case Reports</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30332577,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>05</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000230"" MajorTopicYN=""N"">Adenocarcinoma</DescriptorName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>    <QualifierName UI=""Q000556"" MajorTopicYN=""N"">secondary</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""N"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017668"" MajorTopicYN=""N"">Age of Onset</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001706"" MajorTopicYN=""N"">Biopsy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003110"" MajorTopicYN=""N"">Colonic Neoplasms</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""N"">complications</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017809"" MajorTopicYN=""N"">Fatal Outcome</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008099"" MajorTopicYN=""N"">Liver</DescriptorName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008113"" MajorTopicYN=""N"">Liver Neoplasms</DescriptorName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>    <QualifierName UI=""Q000556"" MajorTopicYN=""Y"">secondary</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010922"" MajorTopicYN=""N"">Placenta Diseases</DescriptorName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011252"" MajorTopicYN=""N"">Pregnancy Complications, Neoplastic</DescriptorName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014057"" MajorTopicYN=""N"">Tomography, X-Ray Computed</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016312"" MajorTopicYN=""N"">Treatment Refusal</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>16</Issue>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>18</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the Departments of Medicine (J.E.M., J.W.C.), Radiology (K.S.), Obstetrics and Gynecology (L.E.R.), and Pathology (K.M.B.), Massachusetts General Hospital, and the Departments of Medicine (J.E.M., J.W.C.), Radiology (K.S.), Obstetrics and Gynecology (L.E.R.), and Pathology (K.M.B.), Harvard Medical School - both in Boston.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Murphy</LastName>    <ForeName>Janet E</ForeName>    <Initials>JE</Initials>    <AffiliationInfo>      <Affiliation>From the Departments of Medicine (J.E.M., J.W.C.), Radiology (K.S.), Obstetrics and Gynecology (L.E.R.), and Pathology (K.M.B.), Massachusetts General Hospital, and the Departments of Medicine (J.E.M., J.W.C.), Radiology (K.S.), Obstetrics and Gynecology (L.E.R.), and Pathology (K.M.B.), Harvard Medical School - both in Boston.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Shampain</LastName>    <ForeName>Kimberly</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>From the Departments of Medicine (J.E.M., J.W.C.), Radiology (K.S.), Obstetrics and Gynecology (L.E.R.), and Pathology (K.M.B.), Massachusetts General Hospital, and the Departments of Medicine (J.E.M., J.W.C.), Radiology (K.S.), Obstetrics and Gynecology (L.E.R.), and Pathology (K.M.B.), Harvard Medical School - both in Boston.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Riley</LastName>    <ForeName>Laura E</ForeName>    <Initials>LE</Initials>    <AffiliationInfo>      <Affiliation>From the Departments of Medicine (J.E.M., J.W.C.), Radiology (K.S.), Obstetrics and Gynecology (L.E.R.), and Pathology (K.M.B.), Massachusetts General Hospital, and the Departments of Medicine (J.E.M., J.W.C.), Radiology (K.S.), Obstetrics and Gynecology (L.E.R.), and Pathology (K.M.B.), Harvard Medical School - both in Boston.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Clark</LastName>    <ForeName>Jeffrey W</ForeName>    <Initials>JW</Initials>    <AffiliationInfo>      <Affiliation>From the Departments of Medicine (J.E.M., J.W.C.), Radiology (K.S.), Obstetrics and Gynecology (L.E.R.), and Pathology (K.M.B.), Massachusetts General Hospital, and the Departments of Medicine (J.E.M., J.W.C.), Radiology (K.S.), Obstetrics and Gynecology (L.E.R.), and Pathology (K.M.B.), Harvard Medical School - both in Boston.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Basnet</LastName>    <ForeName>Kristen M</ForeName>    <Initials>KM</Initials>    <AffiliationInfo>      <Affiliation>From the Departments of Medicine (J.E.M., J.W.C.), Radiology (K.S.), Obstetrics and Gynecology (L.E.R.), and Pathology (K.M.B.), Massachusetts General Hospital, and the Departments of Medicine (J.E.M., J.W.C.), Radiology (K.S.), Obstetrics and Gynecology (L.E.R.), and Pathology (K.M.B.), Harvard Medical School - both in Boston.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D002363"">Case Reports</PublicationType>  <PublicationType UI=""D016429"">Clinical Conference</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30333104,<DateCompleted>  <Year>2019</Year>  <Month>02</Month>  <Day>25</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000368"" MajorTopicYN=""N"">Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000375"" MajorTopicYN=""Y"">Aging</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002318"" MajorTopicYN=""N"">Cardiovascular Diseases</DescriptorName>    <QualifierName UI=""Q000097"" MajorTopicYN=""N"">blood</QualifierName>    <QualifierName UI=""Q000453"" MajorTopicYN=""Y"">epidemiology</QualifierName>    <QualifierName UI=""Q000209"" MajorTopicYN=""N"">etiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015331"" MajorTopicYN=""N"">Cohort Studies</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015525"" MajorTopicYN=""N"">Fatty Acids, Omega-3</DescriptorName>    <QualifierName UI=""Q000097"" MajorTopicYN=""Y"">blood</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006299"" MajorTopicYN=""Y"">Health Services for the Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011446"" MajorTopicYN=""N"">Prospective Studies</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012959"" MajorTopicYN=""N"">Socioeconomic Factors</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"" Type=""Geographic"">United States</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>17</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Friedman School of Nutrition Science and Policy, Tufts University, 150 Harrison Avenue, Boston, MA 02111, USA Heidi.Lai@tufts.edu.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Lai</LastName>    <ForeName>Heidi Tm</ForeName>    <Initials>HT</Initials>    <AffiliationInfo>      <Affiliation>Friedman School of Nutrition Science and Policy, Tufts University, 150 Harrison Avenue, Boston, MA 02111, USA Heidi.Lai@tufts.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>de Oliveira Otto</LastName>    <ForeName>Marcia C</ForeName>    <Initials>MC</Initials>    <AffiliationInfo>      <Affiliation>Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lemaitre</LastName>    <ForeName>Rozenn N</ForeName>    <Initials>RN</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Cardiovascular Health Research Unit, University of Washington, Seattle, WA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>McKnight</LastName>    <ForeName>Barbara</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Department of Biostatistics, University of Washington, Seattle, WA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Song</LastName>    <ForeName>Xiaoling</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>King</LastName>    <ForeName>Irena B</ForeName>    <Initials>IB</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chaves</LastName>    <ForeName>Paulo Hm</ForeName>    <Initials>PH</Initials>    <AffiliationInfo>      <Affiliation>Benjamin Leon Center for Geriatric Research and Education at Florida International University, Herbert Wertheim College of Medicine, Miami, FL, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Odden</LastName>    <ForeName>Michelle C</ForeName>    <Initials>MC</Initials>    <AffiliationInfo>      <Affiliation>School of Biological and Population Health Sciences, Oregon State University, Corvallis, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Newman</LastName>    <ForeName>Anne B</ForeName>    <Initials>AB</Initials>    <AffiliationInfo>      <Affiliation>Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Siscovick</LastName>    <ForeName>David S</ForeName>    <Initials>DS</Initials>    <AffiliationInfo>      <Affiliation>The New York Academy of Medicine, New York City, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mozaffarian</LastName>    <ForeName>Dariush</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Friedman School of Nutrition Science and Policy, Tufts University, 150 Harrison Avenue, Boston, MA 02111, USA.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>U01 HL130114</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 HL085710</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>N01HC55222</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>N01HC85079</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>N01HC85080</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>N01HC85081</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>N01HC85082</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>N01HC85083</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>N01HC85086</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U01 HL080295</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 AG023629</GrantID>    <Acronym>AG</Acronym>    <Agency>NIA NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30333603,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>05</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D035843"" MajorTopicYN=""N"">Biomedical Research</DescriptorName>    <QualifierName UI=""Q000458"" MajorTopicYN=""Y"">organization &amp; administration</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003256"" MajorTopicYN=""Y"">Community Participation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003223"" MajorTopicYN=""N"" Type=""Geographic"">Congo</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014943"" MajorTopicYN=""N"">Global Health</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008288"" MajorTopicYN=""Y"">Malaria</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011639"" MajorTopicYN=""N"">Public Opinion</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012108"" MajorTopicYN=""N"">Research Personnel</DescriptorName>    <QualifierName UI=""Q000523"" MajorTopicYN=""Y"">psychology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D035502"" MajorTopicYN=""Y"">Trust</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015024"" MajorTopicYN=""N"" Type=""Geographic"">Zambia</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>562</Volume>    <Issue>7727</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Laursen</LastName>    <ForeName>Lucas</ForeName>    <Initials>L</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30333625,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>01</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001057"" MajorTopicYN=""N"">Apolipoproteins E</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001119"" MajorTopicYN=""N"">Arginase</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015496"" MajorTopicYN=""N"">CD4-Positive T-Lymphocytes</DescriptorName>    <QualifierName UI=""Q000166"" MajorTopicYN=""N"">cytology</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018414"" MajorTopicYN=""N"">CD8-Positive T-Lymphocytes</DescriptorName>    <QualifierName UI=""Q000166"" MajorTopicYN=""N"">cytology</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002465"" MajorTopicYN=""N"">Cell Movement</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D049109"" MajorTopicYN=""N"">Cell Proliferation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007108"" MajorTopicYN=""N"">Immune Tolerance</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015470"" MajorTopicYN=""N"">Leukemia, Myeloid, Acute</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008562"" MajorTopicYN=""N"">Membrane Glycoproteins</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008810"" MajorTopicYN=""N"">Mice, Inbred C57BL</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016688"" MajorTopicYN=""N"">Mice, Inbred NOD</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016513"" MajorTopicYN=""N"">Mice, SCID</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011485"" MajorTopicYN=""N"">Protein Binding</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D054592"" MajorTopicYN=""N"">Protein Tyrosine Phosphatase, Non-Receptor Type 11</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011956"" MajorTopicYN=""N"">Receptors, Cell Surface</DescriptorName>    <QualifierName UI=""Q000172"" MajorTopicYN=""N"">deficiency</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011971"" MajorTopicYN=""N"">Receptors, Immunologic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055293"" MajorTopicYN=""N"">Receptors, Urokinase Plasminogen Activator</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015398"" MajorTopicYN=""Y"">Signal Transduction</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019139"" MajorTopicYN=""N"">Tumor Escape</DescriptorName>    <QualifierName UI=""Q000187"" MajorTopicYN=""N"">drug effects</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D023041"" MajorTopicYN=""N"">Xenograft Model Antitumor Assays</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>562</Volume>    <Issue>7728</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Deng</LastName>    <ForeName>Mi</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gui</LastName>    <ForeName>Xun</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kim</LastName>    <ForeName>Jaehyup</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Xie</LastName>    <ForeName>Li</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Weina</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Li</LastName>    <ForeName>Zunling</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Taishan Immunology Program, Basic Medicine School, Binzhou Medical University, Yantai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>He</LastName>    <ForeName>Licai</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medical and Life Science, Wenzhou Medical University, Wenzhou, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Yuanzhi</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>School of Public Health, Xiamen University, Xiamen, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Heyu</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Luo</LastName>    <ForeName>Weiguang</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Immunology, Xiangya Medical School, Central South University, Changsha, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lu</LastName>    <ForeName>Zhigang</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Institute of Biomedical Sciences and the Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Xie</LastName>    <ForeName>Jingjing</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Taishan Immunology Program, Basic Medicine School, Binzhou Medical University, Yantai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Churchill</LastName>    <ForeName>Hywyn</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Xu</LastName>    <ForeName>Yixiang</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhou</LastName>    <ForeName>Zhan</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wu</LastName>    <ForeName>Guojin</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yu</LastName>    <ForeName>Chenyi</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Xiangya Medical School, Central South University, Changsha, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>John</LastName>    <ForeName>Samuel</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hirayasu</LastName>    <ForeName>Kouyuki</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Department of Immunochemistry, Research Institute for Microbial Diseases and Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nguyen</LastName>    <ForeName>Nam</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Xiaoye</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Huang</LastName>    <ForeName>Fangfang</ForeName>    <Initials>F</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Hematology, Zhongshan Hospital, Xiamen University, Xiamen, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Li</LastName>    <ForeName>Leike</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Deng</LastName>    <ForeName>Hui</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tang</LastName>    <ForeName>Haidong</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sadek</LastName>    <ForeName>Ali H</ForeName>    <Initials>AH</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Lingbo</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Xiangya Medical School, Central South University, Changsha, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Huang</LastName>    <ForeName>Tao</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Immune-Onc Therapeutics, Inc., Palo Alto, CA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zou</LastName>    <ForeName>Yizhou</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Immunology, Xiangya Medical School, Central South University, Changsha, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Benjamin</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhu</LastName>    <ForeName>Hong</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Arase</LastName>    <ForeName>Hisashi</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Department of Immunochemistry, Research Institute for Microbial Diseases and Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Xia</LastName>    <ForeName>Ningshao</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>School of Public Health, Xiamen University, Xiamen, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jiang</LastName>    <ForeName>Youxing</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Collins</LastName>    <ForeName>Robert</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>You</LastName>    <ForeName>M James</ForeName>    <Initials>MJ</Initials>    <AffiliationInfo>      <Affiliation>Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Homsi</LastName>    <ForeName>Jade</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Unni</LastName>    <ForeName>Nisha</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lewis</LastName>    <ForeName>Cheryl</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Guo-Qiang</ForeName>    <Initials>GQ</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fu</LastName>    <ForeName>Yang-Xin</ForeName>    <Initials>YX</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liao</LastName>    <ForeName>X Charlene</ForeName>    <Initials>XC</Initials>    <AffiliationInfo>      <Affiliation>Immune-Onc Therapeutics, Inc., Palo Alto, CA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>An</LastName>    <ForeName>Zhiqiang</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA. zhiqiang.an@uth.tmc.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zheng</LastName>    <ForeName>Junke</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China. zhengjunke@sjtu.edu.cn.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Ningyan</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA. ningyan.zhang@uth.tmc.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Cheng Cheng</ForeName>    <Initials>CC</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA. alec.zhang@utsouthwestern.edu.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>K12 HD068369</GrantID>    <Acronym>HD</Acronym>    <Agency>NICHD NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P30 CA142543</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA172268</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30333627,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>01</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D050676"" MajorTopicYN=""N"">Core Binding Factor Alpha 2 Subunit</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004248"" MajorTopicYN=""N"">DNA (Cytosine-5-)-Methyltransferases</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000090205"" MajorTopicYN=""N"">DNA Methyltransferase 3A</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D066264"" MajorTopicYN=""N"">Datasets as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D059472"" MajorTopicYN=""N"">Exome</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015972"" MajorTopicYN=""N"">Gene Expression Regulation, Neoplastic</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015894"" MajorTopicYN=""N"">Genome, Human</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D023281"" MajorTopicYN=""Y"">Genomics</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015470"" MajorTopicYN=""N"">Leukemia, Myeloid, Acute</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058990"" MajorTopicYN=""N"">Molecular Targeted Therapy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009687"" MajorTopicYN=""N"">Nuclear Proteins</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000090243"" MajorTopicYN=""N"">Nucleophosmin</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011518"" MajorTopicYN=""N"">Proto-Oncogene Proteins</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012097"" MajorTopicYN=""N"">Repressor Proteins</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017423"" MajorTopicYN=""N"">Sequence Analysis, RNA</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000068103"" MajorTopicYN=""N"">Serine-Arginine Splicing Factors</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>562</Volume>    <Issue>7728</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Cell, Developmental &amp; Cancer Biology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Tyner</LastName>    <ForeName>Jeffrey W</ForeName>    <Initials>JW</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell, Developmental &amp; Cancer Biology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tognon</LastName>    <ForeName>Cristina E</ForeName>    <Initials>CE</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Howard Hughes Medical Institute, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bottomly</LastName>    <ForeName>Daniel</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wilmot</LastName>    <ForeName>Beth</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Oregon Clinical &amp; Translational Research Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kurtz</LastName>    <ForeName>Stephen E</ForeName>    <Initials>SE</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Savage</LastName>    <ForeName>Samantha L</ForeName>    <Initials>SL</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell, Developmental &amp; Cancer Biology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Long</LastName>    <ForeName>Nicola</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Schultz</LastName>    <ForeName>Anna Reister</ForeName>    <Initials>AR</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell, Developmental &amp; Cancer Biology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Traer</LastName>    <ForeName>Elie</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Abel</LastName>    <ForeName>Melissa</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell, Developmental &amp; Cancer Biology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Agarwal</LastName>    <ForeName>Anupriya</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Molecular &amp; Medical Genetics, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Blucher</LastName>    <ForeName>Aurora</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Borate</LastName>    <ForeName>Uma</ForeName>    <Initials>U</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bryant</LastName>    <ForeName>Jade</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell, Developmental &amp; Cancer Biology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Burke</LastName>    <ForeName>Russell</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Carlos</LastName>    <ForeName>Amy</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Integrated Genomics Laboratories, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Carpenter</LastName>    <ForeName>Richie</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Carroll</LastName>    <ForeName>Joseph</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Technology Transfer &amp; Business Development, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chang</LastName>    <ForeName>Bill H</ForeName>    <Initials>BH</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology and Oncology, Department of Pediatrics, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Coblentz</LastName>    <ForeName>Cody</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>d'Almeida</LastName>    <ForeName>Amanda</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell, Developmental &amp; Cancer Biology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cook</LastName>    <ForeName>Rachel</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Danilov</LastName>    <ForeName>Alexey</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dao</LastName>    <ForeName>Kim-Hien T</ForeName>    <Initials>KT</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Degnin</LastName>    <ForeName>Michie</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Devine</LastName>    <ForeName>Deirdre</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dibb</LastName>    <ForeName>James</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Edwards</LastName>    <ForeName>David K</ForeName>    <Initials>DK</Initials>    <Suffix>5th</Suffix>    <AffiliationInfo>      <Affiliation>Department of Cell, Developmental &amp; Cancer Biology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Eide</LastName>    <ForeName>Christopher A</ForeName>    <Initials>CA</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Howard Hughes Medical Institute, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>English</LastName>    <ForeName>Isabel</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Glover</LastName>    <ForeName>Jason</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology and Oncology, Department of Pediatrics, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Henson</LastName>    <ForeName>Rachel</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Integrated Genomics Laboratories, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ho</LastName>    <ForeName>Hibery</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jemal</LastName>    <ForeName>Abdusebur</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology and Oncology, Department of Pediatrics, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Johnson</LastName>    <ForeName>Kara</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Johnson</LastName>    <ForeName>Ryan</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Junio</LastName>    <ForeName>Brian</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kaempf</LastName>    <ForeName>Andy</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Biostatistics Shared Resource, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Leonard</LastName>    <ForeName>Jessica</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lin</LastName>    <ForeName>Chenwei</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Integrated Genomics Laboratories, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Selina Qiuying</ForeName>    <Initials>SQ</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lo</LastName>    <ForeName>Pierrette</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Loriaux</LastName>    <ForeName>Marc M</ForeName>    <Initials>MM</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Dapartment of Pathology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Luty</LastName>    <ForeName>Samuel</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Macey</LastName>    <ForeName>Tara</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>MacManiman</LastName>    <ForeName>Jason</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell, Developmental &amp; Cancer Biology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Martinez</LastName>    <ForeName>Jacqueline</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell, Developmental &amp; Cancer Biology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mori</LastName>    <ForeName>Motomi</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Biostatistics Shared Resource, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Oregon Health &amp; Science University-Portland State University School of Public Health, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nelson</LastName>    <ForeName>Dylan</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>High-Throughput Screening Services Laboratory, Oregon State University, Corvalis, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nichols</LastName>    <ForeName>Ceilidh</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Peters</LastName>    <ForeName>Jill</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ramsdill</LastName>    <ForeName>Justin</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Oregon Clinical &amp; Translational Research Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rofelty</LastName>    <ForeName>Angela</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell, Developmental &amp; Cancer Biology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Schuff</LastName>    <ForeName>Robert</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Oregon Clinical &amp; Translational Research Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Searles</LastName>    <ForeName>Robert</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Integrated Genomics Laboratories, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Segerdell</LastName>    <ForeName>Erik</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Smith</LastName>    <ForeName>Rebecca L</ForeName>    <Initials>RL</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Spurgeon</LastName>    <ForeName>Stephen E</ForeName>    <Initials>SE</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sweeney</LastName>    <ForeName>Tyler</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Thapa</LastName>    <ForeName>Aashis</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Visser</LastName>    <ForeName>Corinne</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wagner</LastName>    <ForeName>Jake</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Watanabe-Smith</LastName>    <ForeName>Kevin</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Werth</LastName>    <ForeName>Kristen</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wolf</LastName>    <ForeName>Joelle</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology and Oncology, Department of Pediatrics, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>White</LastName>    <ForeName>Libbey</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yates</LastName>    <ForeName>Amy</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Oregon Clinical &amp; Translational Research Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Haijiao</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell, Developmental &amp; Cancer Biology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cogle</LastName>    <ForeName>Christopher R</ForeName>    <Initials>CR</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Division of Hematology and Oncology, University of Florida, Gainesville, FL, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Collins</LastName>    <ForeName>Robert H</ForeName>    <Initials>RH</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine/Hematology Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Connolly</LastName>    <ForeName>Denise C</ForeName>    <Initials>DC</Initials>    <AffiliationInfo>      <Affiliation>Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Fox Chase Cancer Center Biosample Repository Facility, Philadelphia, PA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Deininger</LastName>    <ForeName>Michael W</ForeName>    <Initials>MW</Initials>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Drusbosky</LastName>    <ForeName>Leylah</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Division of Hematology and Oncology, University of Florida, Gainesville, FL, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hourigan</LastName>    <ForeName>Christopher S</ForeName>    <Initials>CS</Initials>    <AffiliationInfo>      <Affiliation>National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jordan</LastName>    <ForeName>Craig T</ForeName>    <Initials>CT</Initials>    <AffiliationInfo>      <Affiliation>Division of Hematology, University of Colorado, Denver, CO, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kropf</LastName>    <ForeName>Patricia</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Bone Marrow Transplant Program, Fox Chase Cancer Center, Philadelphia, PA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lin</LastName>    <ForeName>Tara L</ForeName>    <Initials>TL</Initials>    <AffiliationInfo>      <Affiliation>Division of Hematologic Malignancies &amp; Cellular Therapeutics, University of Kansas, Kansas City, KS, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Martinez</LastName>    <ForeName>Micaela E</ForeName>    <Initials>ME</Initials>    <AffiliationInfo>      <Affiliation>Clinical Research Services, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Medeiros</LastName>    <ForeName>Bruno C</ForeName>    <Initials>BC</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine-Hematology, Stanford University, Stanford, CA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pallapati</LastName>    <ForeName>Rachel R</ForeName>    <Initials>RR</Initials>    <AffiliationInfo>      <Affiliation>Clinical Research Services, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pollyea</LastName>    <ForeName>Daniel A</ForeName>    <Initials>DA</Initials>    <AffiliationInfo>      <Affiliation>Division of Hematology, University of Colorado, Denver, CO, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Swords</LastName>    <ForeName>Ronan T</ForeName>    <Initials>RT</Initials>    <AffiliationInfo>      <Affiliation>Department of Hematology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Watts</LastName>    <ForeName>Justin M</ForeName>    <Initials>JM</Initials>    <AffiliationInfo>      <Affiliation>Department of Hematology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Weir</LastName>    <ForeName>Scott J</ForeName>    <Initials>SJ</Initials>    <AffiliationInfo>      <Affiliation>Department of Toxicology, Pharmacology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Medicine, Division of Medical Oncology, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wiest</LastName>    <ForeName>David L</ForeName>    <Initials>DL</Initials>    <AffiliationInfo>      <Affiliation>Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Winters</LastName>    <ForeName>Ryan M</ForeName>    <Initials>RM</Initials>    <AffiliationInfo>      <Affiliation>Fox Chase Cancer Center Biosample Repository Facility, Philadelphia, PA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>McWeeney</LastName>    <ForeName>Shannon K</ForeName>    <Initials>SK</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA. mcweeney@ohsu.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, OR, USA. mcweeney@ohsu.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Oregon Clinical &amp; Translational Research Institute, Oregon Health &amp; Science University, Portland, OR, USA. mcweeney@ohsu.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Druker</LastName>    <ForeName>Brian J</ForeName>    <Initials>BJ</Initials>    <AffiliationInfo>      <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA. drukerb@ohsu.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Hematology &amp; Medical Oncology, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA. drukerb@ohsu.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Howard Hughes Medical Institute, Portland, OR, USA. drukerb@ohsu.edu.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D003160"">Comparative Study</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>KL2 TR002370</GrantID>    <Acronym>TR</Acronym>    <Agency>NCATS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>UL1 TR002369</GrantID>    <Acronym>TR</Acronym>    <Agency>NCATS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U54 CA224019</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA214428</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>KL2 TR000152</GrantID>    <Acronym>TR</Acronym>    <Agency>NCATS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA183974</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R37 AI110985</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>T15 LM007088</GrantID>    <Acronym>LM</Acronym>    <Agency>NLM NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U01 CA217862</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>K99 CA237630</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>UL1 TR002366</GrantID>    <Acronym>TR</Acronym>    <Agency>NCATS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <Acronym>HHMI</Acronym>    <Agency>Howard Hughes Medical Institute</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P30 CA069533</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30337411,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>13</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002176"" MajorTopicYN=""N"">Candida albicans</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002177"" MajorTopicYN=""N"">Candidiasis</DescriptorName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003713"" MajorTopicYN=""N"">Dendritic Cells</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D037181"" MajorTopicYN=""N"">Lectins, C-Type</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000502"" MajorTopicYN=""Y"">physiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008817"" MajorTopicYN=""N"">Mice, Mutant Strains</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009336"" MajorTopicYN=""N"">Necrosis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020556"" MajorTopicYN=""N"">Neutrophil Infiltration</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010179"" MajorTopicYN=""N"">Pancreas</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000382"" MajorTopicYN=""N"">microbiology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019283"" MajorTopicYN=""N"">Pancreatitis, Acute Necrotizing</DescriptorName>    <QualifierName UI=""Q000382"" MajorTopicYN=""N"">microbiology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011971"" MajorTopicYN=""N"">Receptors, Immunologic</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000502"" MajorTopicYN=""Y"">physiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6412</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>19</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. dsancho@cnic.es cdelfresno@cnic.es.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"" EqualContrib=""Y"">    <LastName>Del Fresno</LastName>    <ForeName>Carlos</ForeName>    <Initials>C</Initials>    <Identifier Source=""ORCID"">0000-0003-1771-7254</Identifier>    <AffiliationInfo>      <Affiliation>Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. dsancho@cnic.es cdelfresno@cnic.es.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"" EqualContrib=""Y"">    <LastName>Saz-Leal</LastName>    <ForeName>Paula</ForeName>    <Initials>P</Initials>    <Identifier Source=""ORCID"">0000-0002-6263-4709</Identifier>    <AffiliationInfo>      <Affiliation>Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Enamorado</LastName>    <ForeName>Michel</ForeName>    <Initials>M</Initials>    <Identifier Source=""ORCID"">0000-0001-7748-454X</Identifier>    <AffiliationInfo>      <Affiliation>Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wculek</LastName>    <ForeName>Stefanie K</ForeName>    <Initials>SK</Initials>    <Identifier Source=""ORCID"">0000-0001-5565-8561</Identifier>    <AffiliationInfo>      <Affiliation>Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Martnez-Cano</LastName>    <ForeName>Sarai</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Blanco-Menndez</LastName>    <ForeName>Noelia</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Schulz</LastName>    <ForeName>Oliver</ForeName>    <Initials>O</Initials>    <AffiliationInfo>      <Affiliation>Immunobiology Laboratory, The Francis Crick Institute, London, UK. dsancho@cnic.es cdelfresno@cnic.es.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gallizioli</LastName>    <ForeName>Mattia</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Institut d'Investigacions Biomdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mir-Mur</LastName>    <ForeName>Francesc</ForeName>    <Initials>F</Initials>    <Identifier Source=""ORCID"">0000-0003-3936-2693</Identifier>    <AffiliationInfo>      <Affiliation>Institut d'Investigacions Biomdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cano</LastName>    <ForeName>Eva</ForeName>    <Initials>E</Initials>    <Identifier Source=""ORCID"">0000-0003-2750-6135</Identifier>    <AffiliationInfo>      <Affiliation>Chronic Disease Programme-CROSADIS, Instituto De Salud Carlos III, Madrid, Spain.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Planas</LastName>    <ForeName>Anna</ForeName>    <Initials>A</Initials>    <Identifier Source=""ORCID"">0000-0002-6147-1880</Identifier>    <AffiliationInfo>      <Affiliation>Institut d'Investigacions Biomdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomdiques de Barcelona (IIBB-CSIC), Barcelona, Spain.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sancho</LastName>    <ForeName>David</ForeName>    <Initials>D</Initials>    <Identifier Source=""ORCID"">0000-0003-2890-3984</Identifier>    <AffiliationInfo>      <Affiliation>Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. dsancho@cnic.es cdelfresno@cnic.es.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>",NA
30337457,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>08</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000368"" MajorTopicYN=""N"">Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000375"" MajorTopicYN=""N"">Aging</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002999"" MajorTopicYN=""N"">Clone Cells</DescriptorName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004938"" MajorTopicYN=""N"">Esophageal Neoplasms</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004947"" MajorTopicYN=""N"">Esophagus</DescriptorName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009154"" MajorTopicYN=""N"">Mutation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051881"" MajorTopicYN=""N"">Receptor, Notch1</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012641"" MajorTopicYN=""Y"">Selection, Genetic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016159"" MajorTopicYN=""N"">Tumor Suppressor Protein p53</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055815"" MajorTopicYN=""N"">Young Adult</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6417</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>23</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK. im3@sanger.ac.uk pj3@sanger.ac.uk.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Martincorena</LastName>    <ForeName>Iigo</ForeName>    <Initials>I</Initials>    <Identifier Source=""ORCID"">0000-0003-1122-4416</Identifier>    <AffiliationInfo>      <Affiliation>Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK. im3@sanger.ac.uk pj3@sanger.ac.uk.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fowler</LastName>    <ForeName>Joanna C</ForeName>    <Initials>JC</Initials>    <Identifier Source=""ORCID"">0000-0001-7546-369X</Identifier>    <AffiliationInfo>      <Affiliation>Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wabik</LastName>    <ForeName>Agnieszka</ForeName>    <Initials>A</Initials>    <Identifier Source=""ORCID"">0000-0001-7231-2343</Identifier>    <AffiliationInfo>      <Affiliation>Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lawson</LastName>    <ForeName>Andrew R J</ForeName>    <Initials>ARJ</Initials>    <Identifier Source=""ORCID"">0000-0003-3592-1005</Identifier>    <AffiliationInfo>      <Affiliation>Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Abascal</LastName>    <ForeName>Federico</ForeName>    <Initials>F</Initials>    <Identifier Source=""ORCID"">0000-0002-6201-1587</Identifier>    <AffiliationInfo>      <Affiliation>Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hall</LastName>    <ForeName>Michael W J</ForeName>    <Initials>MWJ</Initials>    <Identifier Source=""ORCID"">0000-0003-2904-6902</Identifier>    <AffiliationInfo>      <Affiliation>Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>MRC Cancer Unit, Hutchison-MRC Research Centre, University of Cambridge, Cambridge CB2 0XZ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cagan</LastName>    <ForeName>Alex</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Murai</LastName>    <ForeName>Kasumi</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mahbubani</LastName>    <ForeName>Krishnaa</ForeName>    <Initials>K</Initials>    <Identifier Source=""ORCID"">0000-0002-1327-2334</Identifier>    <AffiliationInfo>      <Affiliation>Department of Surgery and Cambridge NIHR Biomedical Research Centre, Biomedical Campus, University of Cambridge, Cambridge CB2 2QQ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Stratton</LastName>    <ForeName>Michael R</ForeName>    <Initials>MR</Initials>    <Identifier Source=""ORCID"">0000-0001-6035-153X</Identifier>    <AffiliationInfo>      <Affiliation>Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fitzgerald</LastName>    <ForeName>Rebecca C</ForeName>    <Initials>RC</Initials>    <AffiliationInfo>      <Affiliation>MRC Cancer Unit, Hutchison-MRC Research Centre, University of Cambridge, Cambridge CB2 0XZ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Handford</LastName>    <ForeName>Penny A</ForeName>    <Initials>PA</Initials>    <Identifier Source=""ORCID"">0000-0002-0590-7651</Identifier>    <AffiliationInfo>      <Affiliation>Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Campbell</LastName>    <ForeName>Peter J</ForeName>    <Initials>PJ</Initials>    <AffiliationInfo>      <Affiliation>Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Haematology, University of Cambridge, Cambridge CB2 2XY, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Saeb-Parsy</LastName>    <ForeName>Kourosh</ForeName>    <Initials>K</Initials>    <Identifier Source=""ORCID"">0000-0002-0633-3696</Identifier>    <AffiliationInfo>      <Affiliation>Department of Surgery and Cambridge NIHR Biomedical Research Centre, Biomedical Campus, University of Cambridge, Cambridge CB2 2QQ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jones</LastName>    <ForeName>Philip H</ForeName>    <Initials>PH</Initials>    <Identifier Source=""ORCID"">0000-0002-5904-795X</Identifier>    <AffiliationInfo>      <Affiliation>Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK. im3@sanger.ac.uk pj3@sanger.ac.uk.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>MC_UU_12022/3</GrantID>    <Acronym>MRC_</Acronym>    <Agency>Medical Research Council</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>206194</GrantID>    <Acronym>WT_</Acronym>    <Agency>Wellcome Trust</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>098051</GrantID>    <Acronym>WT_</Acronym>    <Agency>Wellcome Trust</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>MC_UU_12022/2</GrantID>    <Acronym>MRC_</Acronym>    <Agency>Medical Research Council</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <Acronym>WT_</Acronym>    <Agency>Wellcome Trust</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <Acronym>CRUK_</Acronym>    <Agency>Cancer Research UK</Agency>    <Country>United Kingdom</Country>  </Grant></GrantList>"
30340032,<DateCompleted>  <Year>2019</Year>  <Month>07</Month>  <Day>29</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D050260"" MajorTopicYN=""N"">Carbohydrate Metabolism</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D066126"" MajorTopicYN=""N"">Cardiotoxicity</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002318"" MajorTopicYN=""N"">Cardiovascular Diseases</DescriptorName>    <QualifierName UI=""Q000209"" MajorTopicYN=""Y"">etiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004040"" MajorTopicYN=""N"">Dietary Carbohydrates</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>175</Volume>    <Issue>3</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>18</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Equipe 11 labellise par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Campus, Villejuif, France; INSERM, U1138, Paris, France; Universit Paris Descartes, Sorbonne Paris Cit, Paris, France; Universit Pierre et Marie Curie, Paris, France; Ple de Biologie, Hpital Europen Georges Pompidou, AP-HP, Paris, France; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden. Electronic address: kroemer@orange.fr.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Kroemer</LastName>    <ForeName>Guido</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Equipe 11 labellise par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Campus, Villejuif, France; INSERM, U1138, Paris, France; Universit Paris Descartes, Sorbonne Paris Cit, Paris, France; Universit Pierre et Marie Curie, Paris, France; Ple de Biologie, Hpital Europen Georges Pompidou, AP-HP, Paris, France; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden. Electronic address: kroemer@orange.fr.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lpez-Otn</LastName>    <ForeName>Carlos</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Departamento de Bioqumica y Biologa Molecular, Facultad de Medicina, Instituto Universitario de Oncologa (IUOPA), Universidad de Oviedo, 33006 Oviedo, Spain; Centro de Investigacin Biomdica en Red de Cncer, Madrid, Spain.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Madeo</LastName>    <ForeName>Frank</ForeName>    <Initials>F</Initials>    <AffiliationInfo>      <Affiliation>Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria; BioTechMed Graz, Graz, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>de Cabo</LastName>    <ForeName>Rafael</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Experimental Gerontology Section, Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD 21224, USA. Electronic address: decabora@grc.nia.nih.gov.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052060"">Research Support, N.I.H., Intramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType>  <PublicationType UI=""D016454"">Review</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>Z01 AG000363-01</GrantID>    <Agency>Intramural NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>Z99 AG999999</GrantID>    <Agency>Intramural NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>ZIA AG000335-02</GrantID>    <Agency>Intramural NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>ZIA AG000363-11</GrantID>    <Agency>Intramural NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30340040,<DateCompleted>  <Year>2019</Year>  <Month>07</Month>  <Day>29</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006528"" MajorTopicYN=""N"">Carcinoma, Hepatocellular</DescriptorName>    <QualifierName UI=""Q000209"" MajorTopicYN=""Y"">etiology</QualifierName>    <QualifierName UI=""Q000382"" MajorTopicYN=""N"">microbiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D045744"" MajorTopicYN=""N"">Cell Line, Tumor</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002779"" MajorTopicYN=""N"">Cholestasis</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""Y"">complications</QualifierName>    <QualifierName UI=""Q000382"" MajorTopicYN=""N"">microbiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D059305"" MajorTopicYN=""N"">Diet, High-Fat</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004043"" MajorTopicYN=""N"">Dietary Fiber</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D064806"" MajorTopicYN=""N"">Dysbiosis</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""Y"">complications</QualifierName>    <QualifierName UI=""Q000382"" MajorTopicYN=""N"">microbiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005285"" MajorTopicYN=""Y"">Fermentation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000069196"" MajorTopicYN=""Y"">Gastrointestinal Microbiome</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007444"" MajorTopicYN=""N"">Inulin</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008113"" MajorTopicYN=""N"">Liver Neoplasms</DescriptorName>    <QualifierName UI=""Q000209"" MajorTopicYN=""Y"">etiology</QualifierName>    <QualifierName UI=""Q000382"" MajorTopicYN=""N"">microbiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008810"" MajorTopicYN=""N"">Mice, Inbred C57BL</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>175</Volume>    <Issue>3</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>18</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>UT-Microbiome Consortium, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Singh</LastName>    <ForeName>Vishal</ForeName>    <Initials>V</Initials>    <AffiliationInfo>      <Affiliation>UT-Microbiome Consortium, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yeoh</LastName>    <ForeName>Beng San</ForeName>    <Initials>BS</Initials>    <AffiliationInfo>      <Affiliation>Graduate Program in Immunology and Infectious Diseases, Pennsylvania State University, State College, PA 16802, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chassaing</LastName>    <ForeName>Benoit</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Neuroscience Institute, Georgia State University, Atlanta, GA 30303, USA; Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Xiao</LastName>    <ForeName>Xia</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Department of Nutritional Sciences, Pennsylvania State University, State College, PA 16802, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Saha</LastName>    <ForeName>Piu</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>UT-Microbiome Consortium, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Aguilera Olvera</LastName>    <ForeName>Rodrigo</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Department of Nutritional Sciences, Pennsylvania State University, State College, PA 16802, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lapek</LastName>    <ForeName>John D</ForeName>    <Initials>JD</Initials>    <Suffix>Jr</Suffix>    <AffiliationInfo>      <Affiliation>Department of Pharmacology, University of California, San Diego, CA 92093, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Limin</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Department of Veterinary and Biomedical Sciences, Pennsylvania State University, State College, PA 16802, USA; CAS and State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Wei-Bei</ForeName>    <Initials>WB</Initials>    <AffiliationInfo>      <Affiliation>Department of Veterinary and Biomedical Sciences, Pennsylvania State University, State College, PA 16802, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hao</LastName>    <ForeName>Sijie</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Biomedical Engineering, Pennsylvania State University, State College, PA 16802, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Flythe</LastName>    <ForeName>Michael D</ForeName>    <Initials>MD</Initials>    <AffiliationInfo>      <Affiliation>USDA-Agriculture Research Service, University of Kentucky, Lexington, KY 40546, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gonzalez</LastName>    <ForeName>David J</ForeName>    <Initials>DJ</Initials>    <AffiliationInfo>      <Affiliation>Department of Pharmacology, University of California, San Diego, CA 92093, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cani</LastName>    <ForeName>Patrice D</ForeName>    <Initials>PD</Initials>    <AffiliationInfo>      <Affiliation>WELBIO (Walloon Excellence in Life Sciences and Biotechnology), Louvain Drug Research Institute, Universit Catholique de Louvain, Brussels, Belgium.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Conejo-Garcia</LastName>    <ForeName>Jose R</ForeName>    <Initials>JR</Initials>    <AffiliationInfo>      <Affiliation>Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Xiong</LastName>    <ForeName>Na</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Department of Veterinary and Biomedical Sciences, Pennsylvania State University, State College, PA 16802, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kennett</LastName>    <ForeName>Mary J</ForeName>    <Initials>MJ</Initials>    <AffiliationInfo>      <Affiliation>Department of Veterinary and Biomedical Sciences, Pennsylvania State University, State College, PA 16802, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Joe</LastName>    <ForeName>Bina</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>UT-Microbiome Consortium, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Patterson</LastName>    <ForeName>Andrew D</ForeName>    <Initials>AD</Initials>    <AffiliationInfo>      <Affiliation>Department of Veterinary and Biomedical Sciences, Pennsylvania State University, State College, PA 16802, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gewirtz</LastName>    <ForeName>Andrew T</ForeName>    <Initials>AT</Initials>    <AffiliationInfo>      <Affiliation>Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Vijay-Kumar</LastName>    <ForeName>Matam</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>UT-Microbiome Consortium, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA; Department of Medical Microbiology and Immunology, University of Toledo, Toledo, OH 43614, USA. Electronic address: matamvijay.kumar@utoledo.edu.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>R01 CA219144</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 DK097865</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 DK061417</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P30 CA010815</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 DK083890</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R03 DK094864</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA178687</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30341067,<DateCompleted>  <Year>2019</Year>  <Month>03</Month>  <Day>25</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000368"" MajorTopicYN=""N"">Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002908"" MajorTopicYN=""N"">Chronic Disease</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000066491"" MajorTopicYN=""N"">Clinical Decision-Making</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003422"" MajorTopicYN=""N"">Critical Care</DescriptorName>    <QualifierName UI=""Q000706"" MajorTopicYN=""Y"">statistics &amp; numerical data</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004739"" MajorTopicYN=""N"" Type=""Geographic"">England</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000078336"" MajorTopicYN=""N"">Facilities and Services Utilization</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005192"" MajorTopicYN=""N"">Family Health</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016330"" MajorTopicYN=""N"">Frail Elderly</DescriptorName>    <QualifierName UI=""Q000523"" MajorTopicYN=""N"">psychology</QualifierName>    <QualifierName UI=""Q000706"" MajorTopicYN=""N"">statistics &amp; numerical data</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000073496"" MajorTopicYN=""N"">Frailty</DescriptorName>    <QualifierName UI=""Q000523"" MajorTopicYN=""N"">psychology</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007902"" MajorTopicYN=""N"">Length of Stay</DescriptorName>    <QualifierName UI=""Q000706"" MajorTopicYN=""N"">statistics &amp; numerical data</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058996"" MajorTopicYN=""N"">Quality Improvement</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011788"" MajorTopicYN=""N"">Quality of Life</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012017"" MajorTopicYN=""N"">Referral and Consultation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018570"" MajorTopicYN=""N"">Risk Assessment</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013727"" MajorTopicYN=""N"">Terminal Care</DescriptorName>    <QualifierName UI=""Q000592"" MajorTopicYN=""N"">standards</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>19</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>London North West University Healthcare NHS Trust, Watford Road, Harrow HA1 3UJ, UK j.gross@nhs.net.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Gross</LastName>    <ForeName>Jamie</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>London North West University Healthcare NHS Trust, Watford Road, Harrow HA1 3UJ, UK j.gross@nhs.net.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Williams</LastName>    <ForeName>Barry</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Bishops Caundle, Dorset.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fade</LastName>    <ForeName>Premila</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>London North West University Healthcare NHS Trust, Watford Road, Harrow HA1 3UJ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Brett</LastName>    <ForeName>Stephen J</ForeName>    <Initials>SJ</Initials>    <AffiliationInfo>      <Affiliation>Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D059040"">Video-Audio Media</PublicationType></PublicationTypeList>",NA
30343848,<DateCompleted>  <Year>2018</Year>  <Month>10</Month>  <Day>30</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D006073"" MajorTopicYN=""Y"">Gout</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006074"" MajorTopicYN=""N"">Gout Suppressants</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010353"" MajorTopicYN=""N"">Patient Education as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014527"" MajorTopicYN=""Y"">Uric Acid</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1474-547X</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>392</Volume>    <Issue>10156</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>20</Day>    </PubDate>  </JournalIssue>  <Title>Lancet (London, England)</Title>  <ISOAbbreviation>Lancet</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Boston University School of Medicine, Clinical Epidemiology Unit, Boston, MA 02118, USA. Electronic address: tneogi@bu.edu.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Neogi</LastName>    <ForeName>Tuhina</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Boston University School of Medicine, Clinical Epidemiology Unit, Boston, MA 02118, USA. Electronic address: tneogi@bu.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dalbeth</LastName>    <ForeName>Nicola</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, University of Auckland, Auckland, New Zealand.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016420"">Comment</PublicationType></PublicationTypeList>",NA
30343849,<DateCompleted>  <Year>2018</Year>  <Month>10</Month>  <Day>30</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D002689"" MajorTopicYN=""Y"">Chlamydia</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002690"" MajorTopicYN=""Y"">Chlamydia Infections</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002692"" MajorTopicYN=""N"">Chlamydia trachomatis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008403"" MajorTopicYN=""N"">Mass Screening</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011320"" MajorTopicYN=""N"">Primary Health Care</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1474-547X</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>392</Volume>    <Issue>10156</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>20</Day>    </PubDate>  </JournalIssue>  <Title>Lancet (London, England)</Title>  <ISOAbbreviation>Lancet</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Division of Infectious Diseases, David Geffen School of Medicine at University of California, Los Angeles, CA 90025, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Adamson</LastName>    <ForeName>Paul C</ForeName>    <Initials>PC</Initials>    <AffiliationInfo>      <Affiliation>Division of Infectious Diseases, David Geffen School of Medicine at University of California, Los Angeles, CA 90025, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Klausner</LastName>    <ForeName>Jeffrey D</ForeName>    <Initials>JD</Initials>    <AffiliationInfo>      <Affiliation>Division of Infectious Diseases, David Geffen School of Medicine at University of California, Los Angeles, CA 90025, USA. Electronic address: jdklausner@mednet.ucla.edu.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016420"">Comment</PublicationType></PublicationTypeList>",NA
30343896,<DateCompleted>  <Year>2019</Year>  <Month>08</Month>  <Day>27</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001812"" MajorTopicYN=""N"">Blood-Brain Barrier</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001932"" MajorTopicYN=""Y"">Brain Neoplasms</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016503"" MajorTopicYN=""N"">Drug Delivery Systems</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005091"" MajorTopicYN=""Y"">Exons</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005909"" MajorTopicYN=""Y"">Glioblastoma</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008807"" MajorTopicYN=""N"">Mice, Inbred BALB C</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008819"" MajorTopicYN=""N"">Mice, Nude</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009154"" MajorTopicYN=""Y"">Mutation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D047428"" MajorTopicYN=""Y"">Protein Kinase Inhibitors</DescriptorName>    <QualifierName UI=""Q000493"" MajorTopicYN=""N"">pharmacokinetics</QualifierName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019859"" MajorTopicYN=""Y"">Proto-Oncogene Proteins c-met</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""N"">antagonists &amp; inhibitors</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017207"" MajorTopicYN=""N"">Rats, Sprague-Dawley</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016159"" MajorTopicYN=""N"">Tumor Suppressor Protein p53</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D023041"" MajorTopicYN=""N"">Xenograft Model Antitumor Assays</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>175</Volume>    <Issue>6</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>29</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Hu</LastName>    <ForeName>Huimin</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mu</LastName>    <ForeName>Quanhua</ForeName>    <Initials>Q</Initials>    <AffiliationInfo>      <Affiliation>Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Hong Kong, China; Center of Systems Biology and Human Health, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bao</LastName>    <ForeName>Zhaoshi</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Yiyun</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong, China; Center of Systems Biology and Human Health, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Yanwei</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China; Department of Radio-therapy, Beijing Tiantan Hospital, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Jing</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Kuanyu</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Zheng</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nam</LastName>    <ForeName>Yoonhee</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jiang</LastName>    <ForeName>Biaobin</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Hong Kong, China; Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong, China; Institute for Advanced Study, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sa</LastName>    <ForeName>Jason K</ForeName>    <Initials>JK</Initials>    <AffiliationInfo>      <Affiliation>Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cho</LastName>    <ForeName>Hee-Jin</ForeName>    <Initials>HJ</Initials>    <AffiliationInfo>      <Affiliation>Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Her</LastName>    <ForeName>Nam-Gu</ForeName>    <Initials>NG</Initials>    <AffiliationInfo>      <Affiliation>Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Chuanbao</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhao</LastName>    <ForeName>Zheng</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Ying</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zeng</LastName>    <ForeName>Fan</ForeName>    <Initials>F</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wu</LastName>    <ForeName>Fan</ForeName>    <Initials>F</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kang</LastName>    <ForeName>Xun</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Department of Oncology, Beijing Shijitan Hospital, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Yuqing</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Qian</LastName>    <ForeName>Zenghui</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Zhiliang</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Huang</LastName>    <ForeName>Ruoyu</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Qiangwei</ForeName>    <Initials>Q</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Wei</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Qiu</LastName>    <ForeName>Xiaoguang</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Department of Radio-therapy, Beijing Tiantan Hospital, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Li</LastName>    <ForeName>Wenbin</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>Department of Oncology, Beijing Shijitan Hospital, Capital Medical University, 100050 Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nam</LastName>    <ForeName>Do-Hyun</ForeName>    <Initials>DH</Initials>    <AffiliationInfo>      <Affiliation>Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea; Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fan</LastName>    <ForeName>Xiaolong</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Laboratory of Neuroscience and Brain Development, Beijing Key Laboratory of Gene Resource and Molecular Development, Beijing Normal University, 100875 Beijing, China. Electronic address: xfan@bnu.edu.cn.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Jiguang</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Hong Kong, China; Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong, China; Center of Systems Biology and Human Health, The Hong Kong University of Science and Technology, Hong Kong, China. Electronic address: jgwang@ust.hk.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jiang</LastName>    <ForeName>Tao</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Beijing Neurosurgical Institute, Capital Medical University, 100050 Beijing, China; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 100050 Beijing, China; Center of Brain Tumor, Beijing Institute for Brain Disorders, 100069 Beijing, China; China National Clinical Research Center for Neurological Diseases, 100050 Beijing, China. Electronic address: taojiang1964@163.com.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>",NA
30343897,<DateCompleted>  <Year>2019</Year>  <Month>08</Month>  <Day>27</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D004843"" MajorTopicYN=""Y"">Epistasis, Genetic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020022"" MajorTopicYN=""Y"">Genetic Predisposition to Disease</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055106"" MajorTopicYN=""N"">Genome-Wide Association Study</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015810"" MajorTopicYN=""Y"">Linkage Disequilibrium</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009103"" MajorTopicYN=""N"">Multiple Sclerosis</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009154"" MajorTopicYN=""Y"">Mutation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016366"" MajorTopicYN=""Y"">Open Reading Frames</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012307"" MajorTopicYN=""N"">Risk Factors</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>175</Volume>    <Issue>6</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>29</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <CollectiveName>International Multiple Sclerosis Genetics Consortium. Electronic address: chris.cotsapas@yale.edu</CollectiveName>  </Author>  <Author ValidYN=""Y"">    <CollectiveName>International Multiple Sclerosis Genetics Consortium</CollectiveName>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016448"">Multicenter Study</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>R01 NS096212</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 NS049477</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>068545/Z/02</GrantID>    <Acronym>WT_</Acronym>    <Agency>Wellcome Trust</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <Acronym>DH_</Acronym>    <Agency>Department of Health</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>085475/B/08/Z</GrantID>    <Acronym>WT_</Acronym>    <Agency>Wellcome Trust</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>G0000934</GrantID>    <Acronym>MRC_</Acronym>    <Agency>Medical Research Council</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>U01 NS069208</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 NS082347</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID> 085475/Z/08/Z</GrantID>    <Acronym>WT_</Acronym>    <Agency>Wellcome Trust</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>R01 NS026799</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>G1100125</GrantID>    <Acronym>MRC_</Acronym>    <Agency>Medical Research Council</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <Acronym>WT_</Acronym>    <Agency>Wellcome Trust</Agency>    <Country>United Kingdom</Country>  </Grant></GrantList>"
30345907,<DateCompleted>  <Year>2019</Year>  <Month>01</Month>  <Day>09</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000368"" MajorTopicYN=""N"">Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001172"" MajorTopicYN=""N"">Arthritis, Rheumatoid</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""N"">complications</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000073659"" MajorTopicYN=""Y"">Gain of Function Mutation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020022"" MajorTopicYN=""N"">Genetic Predisposition to Disease</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005838"" MajorTopicYN=""N"">Genotype</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D054990"" MajorTopicYN=""N"">Idiopathic Pulmonary Fibrosis</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008168"" MajorTopicYN=""N"">Lung</DescriptorName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017563"" MajorTopicYN=""N"">Lung Diseases, Interstitial</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""N"">complications</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055257"" MajorTopicYN=""N"">Mucin-5B</DescriptorName>    <QualifierName UI=""Q000032"" MajorTopicYN=""N"">analysis</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016017"" MajorTopicYN=""N"">Odds Ratio</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011401"" MajorTopicYN=""N"">Promoter Regions, Genetic</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>23</Issue>    <PubDate>      <Year>2018</Year>      <Month>12</Month>      <Day>06</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Juge</LastName>    <ForeName>Pierre-Antoine</ForeName>    <Initials>PA</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lee</LastName>    <ForeName>Joyce S</ForeName>    <Initials>JS</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ebstein</LastName>    <ForeName>Esther</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Furukawa</LastName>    <ForeName>Hiroshi</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dobrinskikh</LastName>    <ForeName>Evgenia</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gazal</LastName>    <ForeName>Steven</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kannengiesser</LastName>    <ForeName>Caroline</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ottaviani</LastName>    <ForeName>Sbastien</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Oka</LastName>    <ForeName>Shomi</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tohma</LastName>    <ForeName>Shigeto</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tsuchiya</LastName>    <ForeName>Naoyuki</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rojas-Serrano</LastName>    <ForeName>Jorge</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gonzlez-Prez</LastName>    <ForeName>Montserrat I</ForeName>    <Initials>MI</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Meja</LastName>    <ForeName>Mayra</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Buenda-Roldn</LastName>    <ForeName>Ivette</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Falfn-Valencia</LastName>    <ForeName>Ramcs</ForeName>    <Initials>R</Initials>    <Identifier Source=""ORCID"">0000-0001-6877-8124</Identifier>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ambrocio-Ortiz</LastName>    <ForeName>Enrique</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Manali</LastName>    <ForeName>Effrosyni</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Papiris</LastName>    <ForeName>Spyros A</ForeName>    <Initials>SA</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Karageorgas</LastName>    <ForeName>Theofanis</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Boumpas</LastName>    <ForeName>Dimitrios</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Antoniou</LastName>    <ForeName>Katarina</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>van Moorsel</LastName>    <ForeName>Coline H M</ForeName>    <Initials>CHM</Initials>    <Identifier Source=""ORCID"">0000-0002-2957-1670</Identifier>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>van der Vis</LastName>    <ForeName>Joanne</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>de Man</LastName>    <ForeName>Yal A</ForeName>    <Initials>YA</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Grutters</LastName>    <ForeName>Jan C</ForeName>    <Initials>JC</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Yaping</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Borie</LastName>    <ForeName>Raphal</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wemeau-Stervinou</LastName>    <ForeName>Lidwine</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wallaert</LastName>    <ForeName>Benot</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Flipo</LastName>    <ForeName>Ren-Marc</ForeName>    <Initials>RM</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nunes</LastName>    <ForeName>Hilario</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Valeyre</LastName>    <ForeName>Dominique</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Saidenberg-Kermanac'h</LastName>    <ForeName>Nathalie</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Boissier</LastName>    <ForeName>Marie-Christophe</ForeName>    <Initials>MC</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Marchand-Adam</LastName>    <ForeName>Sylvain</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Frazier</LastName>    <ForeName>Aline</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Richette</LastName>    <ForeName>Pascal</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Allanore</LastName>    <ForeName>Yannick</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sibilia</LastName>    <ForeName>Jean</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dromer</LastName>    <ForeName>Claire</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Richez</LastName>    <ForeName>Christophe</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Schaeverbeke</LastName>    <ForeName>Thierry</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liot</LastName>    <ForeName>Huguette</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Thabut</LastName>    <ForeName>Gabriel</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nathan</LastName>    <ForeName>Nadia</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Amselem</LastName>    <ForeName>Serge</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Soubrier</LastName>    <ForeName>Martin</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cottin</LastName>    <ForeName>Vincent</ForeName>    <Initials>V</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Clment</LastName>    <ForeName>Annick</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Deane</LastName>    <ForeName>Kevin</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Walts</LastName>    <ForeName>Avram D</ForeName>    <Initials>AD</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fingerlin</LastName>    <ForeName>Tasha</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fischer</LastName>    <ForeName>Aryeh</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ryu</LastName>    <ForeName>Jay H</ForeName>    <Initials>JH</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Matteson</LastName>    <ForeName>Eric L</ForeName>    <Initials>EL</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Niewold</LastName>    <ForeName>Timothy B</ForeName>    <Initials>TB</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Assayag</LastName>    <ForeName>Deborah</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gross</LastName>    <ForeName>Andrew</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wolters</LastName>    <ForeName>Paul</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Schwarz</LastName>    <ForeName>Marvin I</ForeName>    <Initials>MI</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Holers</LastName>    <ForeName>Michael</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Solomon</LastName>    <ForeName>Joshua J</ForeName>    <Initials>JJ</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Doyle</LastName>    <ForeName>Tracy</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rosas</LastName>    <ForeName>Ivan O</ForeName>    <Initials>IO</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Blauwendraat</LastName>    <ForeName>Cornelis</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nalls</LastName>    <ForeName>Mike A</ForeName>    <Initials>MA</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Debray</LastName>    <ForeName>Marie-Pierre</ForeName>    <Initials>MP</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Boileau</LastName>    <ForeName>Catherine</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Crestani</LastName>    <ForeName>Bruno</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Schwartz</LastName>    <ForeName>David A</ForeName>    <Initials>DA</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dieud</LastName>    <ForeName>Philippe</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>From Assistance Publique-Hpitaux de Paris (AP-HP), Hpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Dpartement Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unit Mixte de Recherche (UMR) 1152, Universit Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Dveloppement (P.-A.J.), AP-HP, Hpital Lariboisire, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hpital Cochin, Service de Rhumatologie A, and INSERM, Unit 1016, UMR 8104 (Y.A.), AP-HP, Hpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pdiatrique et Centre de Rfrence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Dpartement de Gntique, Hpital Trousseau (S.A.), Paris, Centre Hospitalier Rgional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Comptence des Maladies Pulmonaires Rares, Fdratif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Universit Paris 13, Sorbonne Paris Cit (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Molculaire, Centre de Recherche en Histoire des Ides, Fdration de Mdecine Translationnelle de Strasbourg, Universit de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unit de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hpital Louis Pradel, Centre National de Rfrence des Maladies Pulmonaires Rares, and INRA, UMR 754, Universit Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Coso Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens ""Attikon,"" National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType>  <PublicationType UI=""D013486"">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>P01 HL092870</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>KL2 TR000143</GrantID>    <Acronym>TR</Acronym>    <Agency>NCATS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R21 HL120770</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>K23 AR051461</GrantID>    <Acronym>AR</Acronym>    <Agency>NIAMS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>UH2 HL123442</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U01 AI101981</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>K23 HL138131</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>Z01 AG000949</GrantID>    <Agency>Intramural NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 HL097163</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R33 HL120770</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>UH3 HL123442</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30354961,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>13</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000755"" MajorTopicYN=""N"">Anemia, Sickle Cell</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""Y"">drug therapy</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D064113"" MajorTopicYN=""N"">CRISPR-Cas Systems</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002352"" MajorTopicYN=""N"">Carrier Proteins</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D041905"" MajorTopicYN=""N"">Erythroid Cells</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005319"" MajorTopicYN=""N"">Fetal Hemoglobin</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005786"" MajorTopicYN=""Y"">Gene Expression Regulation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058990"" MajorTopicYN=""N"">Molecular Targeted Therapy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019892"" MajorTopicYN=""N"">eIF-2 Kinase</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""Y"">antagonists &amp; inhibitors</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>17</Issue>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>25</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the Walter and Eliza Hall Institute of Medical Research, the Department of Medical Biology, University of Melbourne, the Department of Diagnostic Haematology, Royal Melbourne Hospital, and Clinical Haematology at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital - all in Parkville, VIC, Australia (S.-R.P.); and the Weatherall Institute of Molecular Medicine, Medical Research Council Human Immunology Unit, and Haematology Theme, Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom (H.D.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Pasricha</LastName>    <ForeName>Sant-Rayn</ForeName>    <Initials>SR</Initials>    <AffiliationInfo>      <Affiliation>From the Walter and Eliza Hall Institute of Medical Research, the Department of Medical Biology, University of Melbourne, the Department of Diagnostic Haematology, Royal Melbourne Hospital, and Clinical Haematology at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital - all in Parkville, VIC, Australia (S.-R.P.); and the Weatherall Institute of Molecular Medicine, Medical Research Council Human Immunology Unit, and Haematology Theme, Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom (H.D.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Drakesmith</LastName>    <ForeName>Hal</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>From the Walter and Eliza Hall Institute of Medical Research, the Department of Medical Biology, University of Melbourne, the Department of Diagnostic Haematology, Royal Melbourne Hospital, and Clinical Haematology at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital - all in Parkville, VIC, Australia (S.-R.P.); and the Weatherall Institute of Molecular Medicine, Medical Research Council Human Immunology Unit, and Haematology Theme, Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom (H.D.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>G0901149</GrantID>    <Acronym>MRC_</Acronym>    <Agency>Medical Research Council</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>MC_UU_00008/10</GrantID>    <Acronym>MRC_</Acronym>    <Agency>Medical Research Council</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>MC_UU_12010/10</GrantID>    <Acronym>MRC_</Acronym>    <Agency>Medical Research Council</Agency>    <Country>United Kingdom</Country>  </Grant></GrantList>"
30355567,<DateCompleted>  <Year>2019</Year>  <Month>03</Month>  <Day>25</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000208"" MajorTopicYN=""N"">Acute Disease</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003365"" MajorTopicYN=""N"">Costs and Cost Analysis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003657"" MajorTopicYN=""N"">Decision Making</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005544"" MajorTopicYN=""N"">Forecasting</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009203"" MajorTopicYN=""N"">Myocardial Infarction</DescriptorName>    <QualifierName UI=""Q000097"" MajorTopicYN=""N"">blood</QualifierName>    <QualifierName UI=""Q000191"" MajorTopicYN=""N"">economics</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010092"" MajorTopicYN=""N"">Oximetry</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010100"" MajorTopicYN=""N"">Oxygen</DescriptorName>    <QualifierName UI=""Q000097"" MajorTopicYN=""N"">blood</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010102"" MajorTopicYN=""N"">Oxygen Inhalation Therapy</DescriptorName>    <QualifierName UI=""Q000191"" MajorTopicYN=""N"">economics</QualifierName>    <QualifierName UI=""Q000379"" MajorTopicYN=""Y"">methods</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020521"" MajorTopicYN=""N"">Stroke</DescriptorName>    <QualifierName UI=""Q000097"" MajorTopicYN=""N"">blood</QualifierName>    <QualifierName UI=""Q000191"" MajorTopicYN=""N"">economics</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>24</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton L8S 4K1, Canada reed.siemieniuk@medportal.ca.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Siemieniuk</LastName>    <ForeName>Reed A C</ForeName>    <Initials>RAC</Initials>    <AffiliationInfo>      <Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton L8S 4K1, Canada reed.siemieniuk@medportal.ca.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chu</LastName>    <ForeName>Derek K</ForeName>    <Initials>DK</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, McMaster University, Hamilton L8S 4K1, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kim</LastName>    <ForeName>Lisa Ha-Yeon</ForeName>    <Initials>LH</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, McMaster University, Hamilton L8S 4K1, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gell-Rous</LastName>    <ForeName>Maria-Rosa</ForeName>    <Initials>MR</Initials>    <AffiliationInfo>      <Affiliation>Departament de Pneumologia, Hospital de la Santa Creu I Sant Pau. Barcelona, Catalonia 08041, Spain.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Alhazzani</LastName>    <ForeName>Waleed</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton L8S 4K1, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Medicine, McMaster University, Hamilton L8S 4K1, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Soccal</LastName>    <ForeName>Paola M</ForeName>    <Initials>PM</Initials>    <AffiliationInfo>      <Affiliation>Division of Pulmonary Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Faculty of Medicine, Geneva University, 1206 Geneva, Switzerland.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Karanicolas</LastName>    <ForeName>Paul J</ForeName>    <Initials>PJ</Initials>    <AffiliationInfo>      <Affiliation>Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario M4N 3M5, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Farhoumand</LastName>    <ForeName>Pauline D</ForeName>    <Initials>PD</Initials>    <AffiliationInfo>      <Affiliation>Division General Internal Medicine, University Hospitals of Geneva, 1205 Geneva, Switzerland.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Siemieniuk</LastName>    <ForeName>Jillian L K</ForeName>    <Initials>JLK</Initials>    <AffiliationInfo>      <Affiliation>Alberta Health Services, Calgary, Alberta T1Y 6J4, Canada reed.siemieniuk@medportal.ca.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Satia</LastName>    <ForeName>Imran</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, McMaster University, Hamilton L8S 4K1, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Irusen</LastName>    <ForeName>Elvis M</ForeName>    <Initials>EM</Initials>    <AffiliationInfo>      <Affiliation>Divisions of Pulmonology and Medical Intensive Care, Stellenbosch University, Cape Town 7505, South Africa.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Refaat</LastName>    <ForeName>Marwan M</ForeName>    <Initials>MM</Initials>    <AffiliationInfo>      <Affiliation>Departments of Internal Medicine and Biochemistry &amp; Molecular Genetics, American University of Beirut Faculty of Medicine and Medical Center, Beirut 1107 2020, Lebanon.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mikita</LastName>    <ForeName>J Stephen</ForeName>    <Initials>JS</Initials>    <AffiliationInfo>      <Affiliation>Salt Lake City, Utah 84106, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Smith</LastName>    <ForeName>Maureen</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Ottawa, Ontario K2P 1C8, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cohen</LastName>    <ForeName>Dian N</ForeName>    <Initials>DN</Initials>    <AffiliationInfo>      <Affiliation>Hatley, Quebec J0B 4B0, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Vandvik</LastName>    <ForeName>Per O</ForeName>    <Initials>PO</Initials>    <AffiliationInfo>      <Affiliation>Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Agoritsas</LastName>    <ForeName>Thomas</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton L8S 4K1, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division General Internal Medicine, University Hospitals of Geneva, 1205 Geneva, Switzerland.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division Clinical Epidemiology, University Hospitals of Geneva, 1205 Geneva, 1205, Switzerland.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lytvyn</LastName>    <ForeName>Lyubov</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton L8S 4K1, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Guyatt</LastName>    <ForeName>Gordon H</ForeName>    <Initials>GH</Initials>    <AffiliationInfo>      <Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton L8S 4K1, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Medicine, McMaster University, Hamilton L8S 4K1, Canada.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D017065"">Practice Guideline</PublicationType></PublicationTypeList>",NA
30355745,<DateCompleted>  <Year>2019</Year>  <Month>03</Month>  <Day>25</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D057911"" MajorTopicYN=""N"">Angiotensin Receptor Antagonists</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000806"" MajorTopicYN=""N"">Angiotensin-Converting Enzyme Inhibitors</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000959"" MajorTopicYN=""N"">Antihypertensive Agents</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015331"" MajorTopicYN=""N"">Cohort Studies</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015994"" MajorTopicYN=""N"">Incidence</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008175"" MajorTopicYN=""N"">Lung Neoplasms</DescriptorName>    <QualifierName UI=""Q000139"" MajorTopicYN=""Y"">chemically induced</QualifierName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012307"" MajorTopicYN=""N"">Risk Factors</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006113"" MajorTopicYN=""N"" Type=""Geographic"">United Kingdom</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>24</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada, H3T 1E2.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Hicks</LastName>    <ForeName>Blnaid M</ForeName>    <Initials>BM</Initials>    <AffiliationInfo>      <Affiliation>Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada, H3T 1E2.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Filion</LastName>    <ForeName>Kristian B</ForeName>    <Initials>KB</Initials>    <AffiliationInfo>      <Affiliation>Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada, H3T 1E2.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Division of Clinical Epidemiology, Department of Medicine, McGill University, Montreal, QC, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yin</LastName>    <ForeName>Hui</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada, H3T 1E2.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sakr</LastName>    <ForeName>Lama</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Division of Pulmonary Diseases, Department of Medicine, Jewish General Hospital, Montreal, QC, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Udell</LastName>    <ForeName>Jacob A</ForeName>    <Initials>JA</Initials>    <AffiliationInfo>      <Affiliation>Women's College Research Institute and Cardiovascular Division, Department of Medicine, Women's College Hospital, University of Toronto, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Cardiovascular Division, Department of Medicine, Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Azoulay</LastName>    <ForeName>Laurent</ForeName>    <Initials>L</Initials>    <Identifier Source=""ORCID"">0000-0001-5162-3556</Identifier>    <AffiliationInfo>      <Affiliation>Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada, H3T 1E2 laurent.azoulay@mcgill.ca.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D003160"">Comparative Study</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <Agency>CIHR</Agency>    <Country>Canada</Country>  </Grant></GrantList>"
30356214,<DateCompleted>  <Year>2019</Year>  <Month>01</Month>  <Day>17</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D021581"" MajorTopicYN=""N"">Active Transport, Cell Nucleus</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018797"" MajorTopicYN=""N"">Cell Cycle Proteins</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""N"">antagonists &amp; inhibitors</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D045744"" MajorTopicYN=""N"">Cell Line, Tumor</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002467"" MajorTopicYN=""N"">Cell Nucleus</DescriptorName>    <QualifierName UI=""Q000201"" MajorTopicYN=""N"">enzymology</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002471"" MajorTopicYN=""N"">Cell Transformation, Neoplastic</DescriptorName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D053903"" MajorTopicYN=""N"">DNA Breaks, Double-Stranded</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004249"" MajorTopicYN=""N"">DNA Damage</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D057809"" MajorTopicYN=""N"">HEK293 Cells</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D047908"" MajorTopicYN=""N"">Intracellular Signaling Peptides and Proteins</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""N"">antagonists &amp; inhibitors</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008565"" MajorTopicYN=""N"">Membrane Proteins</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008810"" MajorTopicYN=""N"">Mice, Inbred C57BL</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009363"" MajorTopicYN=""N"">Neoplasm Proteins</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009369"" MajorTopicYN=""N"">Neoplasms</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009713"" MajorTopicYN=""N"">Nucleotidyltransferases</DescriptorName>    <QualifierName UI=""Q000172"" MajorTopicYN=""N"">deficiency</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010766"" MajorTopicYN=""N"">Phosphorylation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010793"" MajorTopicYN=""N"">Phthalazines</DescriptorName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010879"" MajorTopicYN=""N"">Piperazines</DescriptorName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000071137"" MajorTopicYN=""N"">Poly (ADP-Ribose) Polymerase-1</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""N"">antagonists &amp; inhibitors</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011485"" MajorTopicYN=""N"">Protein Binding</DescriptorName>    <QualifierName UI=""Q000187"" MajorTopicYN=""N"">drug effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D059767"" MajorTopicYN=""Y"">Recombinational DNA Repair</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019061"" MajorTopicYN=""N"">src-Family Kinases</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>563</Volume>    <Issue>7729</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"" EqualContrib=""Y"">    <LastName>Liu</LastName>    <ForeName>Haipeng</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"" EqualContrib=""Y"">    <LastName>Zhang</LastName>    <ForeName>Haiping</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Clinical and Translational Research Center of Shanghai First Maternity &amp; Infant Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"" EqualContrib=""Y"">    <LastName>Wu</LastName>    <ForeName>Xiangyang</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ma</LastName>    <ForeName>Dapeng</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wu</LastName>    <ForeName>Juehui</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Lin</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jiang</LastName>    <ForeName>Yan</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fei</LastName>    <ForeName>Yiyan</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Optical Science and Engineering, Shanghai Engineering Research Center of Ultra-Precision Optical Manufacturing, Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), Fudan University, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhu</LastName>    <ForeName>Chenggang</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Optical Science and Engineering, Shanghai Engineering Research Center of Ultra-Precision Optical Manufacturing, Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), Fudan University, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tan</LastName>    <ForeName>Rong</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jungblut</LastName>    <ForeName>Peter</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Protein Purification Core Facility, Max Planck Institute for Infection Biology, Berlin, Germany.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pei</LastName>    <ForeName>Gang</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dorhoi</LastName>    <ForeName>Anca</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald Insel Riems, Germany.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yan</LastName>    <ForeName>Qiaoling</ForeName>    <Initials>Q</Initials>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Fan</ForeName>    <Initials>F</Initials>    <AffiliationInfo>      <Affiliation>Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zheng</LastName>    <ForeName>Ruijuan</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Siyu</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liang</LastName>    <ForeName>Haijiao</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Zhonghua</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yang</LastName>    <ForeName>Hua</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Jianxia</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Peng</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tang</LastName>    <ForeName>Tianqi</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Peng</LastName>    <ForeName>Wenxia</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hu</LastName>    <ForeName>Zhangsen</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Clinical and Translational Research Center of Shanghai First Maternity &amp; Infant Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Xu</LastName>    <ForeName>Zhu</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Clinical and Translational Research Center of Shanghai First Maternity &amp; Infant Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Huang</LastName>    <ForeName>Xiaochen</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Jie</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Li</LastName>    <ForeName>Haohao</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhou</LastName>    <ForeName>Yilong</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Feng</ForeName>    <Initials>F</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yan</LastName>    <ForeName>Dapeng</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Key Laboratory of Medical Molecular Virology of MOE/MOH, Fudan University, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kaufmann</LastName>    <ForeName>Stefan H E</ForeName>    <Initials>SHE</Initials>    <AffiliationInfo>      <Affiliation>Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Chang</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mao</LastName>    <ForeName>Zhiyong</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Clinical and Translational Research Center of Shanghai First Maternity &amp; Infant Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China. zhiyong_mao@tongji.edu.cn.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ge</LastName>    <ForeName>Baoxue</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. baoxue_ge@tongji.edu.cn.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. baoxue_ge@tongji.edu.cn.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>",NA
30357262,<DateCompleted>  <Year>2019</Year>  <Month>08</Month>  <Day>27</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D001569"" MajorTopicYN=""N"">Benzodiazepines</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002047"" MajorTopicYN=""N"">Buprenorphine</DescriptorName>    <QualifierName UI=""Q000008"" MajorTopicYN=""N"">administration &amp; dosage</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002491"" MajorTopicYN=""N"">Central Nervous System Agents</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003376"" MajorTopicYN=""N"">Counseling</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004359"" MajorTopicYN=""N"">Drug Therapy, Combination</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019317"" MajorTopicYN=""Y"">Evidence-Based Medicine</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D060828"" MajorTopicYN=""N"">Induction Chemotherapy</DescriptorName>    <QualifierName UI=""Q000379"" MajorTopicYN=""N"">methods</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009292"" MajorTopicYN=""N"">Narcotic Antagonists</DescriptorName>    <QualifierName UI=""Q000008"" MajorTopicYN=""N"">administration &amp; dosage</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058850"" MajorTopicYN=""Y"">Opiate Substitution Treatment</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009293"" MajorTopicYN=""N"">Opioid-Related Disorders</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""Y"">drug therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018802"" MajorTopicYN=""N"">Patient-Centered Care</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017410"" MajorTopicYN=""N"">Practice Guidelines as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012008"" MajorTopicYN=""N"">Recurrence</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015813"" MajorTopicYN=""N"">Substance Abuse Detection</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1539-3704</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>169</Volume>    <Issue>9</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>06</Day>    </PubDate>  </JournalIssue>  <Title>Annals of internal medicine</Title>  <ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>University of Massachusetts Medical School and Barre Family Health Center, Barre, and CleanSlate Research and Education Foundation, Florence, Massachusetts (S.A.M.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Martin</LastName>    <ForeName>Stephen A</ForeName>    <Initials>SA</Initials>    <AffiliationInfo>      <Affiliation>University of Massachusetts Medical School and Barre Family Health Center, Barre, and CleanSlate Research and Education Foundation, Florence, Massachusetts (S.A.M.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chiodo</LastName>    <ForeName>Lisa M</ForeName>    <Initials>LM</Initials>    <AffiliationInfo>      <Affiliation>University of Massachusetts Amherst College of Nursing, Amherst, and CleanSlate Research and Education Foundation, Florence, Massachusetts (L.M.C., J.D.B.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bosse</LastName>    <ForeName>Jordon D</ForeName>    <Initials>JD</Initials>    <AffiliationInfo>      <Affiliation>University of Massachusetts Amherst College of Nursing, Amherst, and CleanSlate Research and Education Foundation, Florence, Massachusetts (L.M.C., J.D.B.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wilson</LastName>    <ForeName>Amanda</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>CleanSlate Research and Education Foundation, Florence, Massachusetts (A.W.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType>  <PublicationType UI=""D016454"">Review</PublicationType></PublicationTypeList>",NA
30357299,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>05</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D001741"" MajorTopicYN=""N"">African Americans</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000925"" MajorTopicYN=""N"">Anticoagulants</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016022"" MajorTopicYN=""N"">Case-Control Studies</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002896"" MajorTopicYN=""Y"">Chromosomes, Human, Pair 6</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055106"" MajorTopicYN=""N"">Genome-Wide Association Study</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006470"" MajorTopicYN=""N"">Hemorrhage</DescriptorName>    <QualifierName UI=""Q000139"" MajorTopicYN=""N"">chemically induced</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019934"" MajorTopicYN=""N"">International Normalized Ratio</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015810"" MajorTopicYN=""N"">Linkage Disequilibrium</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016017"" MajorTopicYN=""N"">Odds Ratio</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020641"" MajorTopicYN=""Y"">Polymorphism, Single Nucleotide</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014859"" MajorTopicYN=""N"">Warfarin</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1538-3598</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>320</Volume>    <Issue>16</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>23</Day>    </PubDate>  </JournalIssue>  <Title>JAMA</Title>  <ISOAbbreviation>JAMA</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Northwestern University, Department of Pharmacology, Chicago, Illinois.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>De</LastName>    <ForeName>Tanima</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Northwestern University, Department of Pharmacology, Chicago, Illinois.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Alarcon</LastName>    <ForeName>Cristina</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Northwestern University, Department of Pharmacology, Chicago, Illinois.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hernandez</LastName>    <ForeName>Wenndy</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>University of Chicago, Section of Genetic Medicine, Department of Medicine, Chicago, Illinois.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liko</LastName>    <ForeName>Ina</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>University of Illinois College of Pharmacy, Department of Pharmacy Practice, Chicago.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cavallari</LastName>    <ForeName>Larisa H</ForeName>    <Initials>LH</Initials>    <AffiliationInfo>      <Affiliation>University of Florida, College of Pharmacy, Center for Pharmacogenomics, Department of Pharmacotherapy and Translational Research, Gainesville.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Duarte</LastName>    <ForeName>Julio D</ForeName>    <Initials>JD</Initials>    <AffiliationInfo>      <Affiliation>University of Florida, College of Pharmacy, Center for Pharmacogenomics, Department of Pharmacotherapy and Translational Research, Gainesville.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Perera</LastName>    <ForeName>Minoli A</ForeName>    <Initials>MA</Initials>    <AffiliationInfo>      <Affiliation>Northwestern University, Department of Pharmacology, Chicago, Illinois.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>R21 HL106097</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>K23 GM112014</GrantID>    <Acronym>GM</Acronym>    <Agency>NIGMS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 MD009217</GrantID>    <Acronym>MD</Acronym>    <Agency>NIMHD NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>KL2 TR002387</GrantID>    <Acronym>TR</Acronym>    <Agency>NCATS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U54 MD010723</GrantID>    <Acronym>MD</Acronym>    <Agency>NIMHD NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>K23 HL089808</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30358968,<DateCompleted>  <Year>2018</Year>  <Month>10</Month>  <Day>30</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000971"" MajorTopicYN=""Y"">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001943"" MajorTopicYN=""Y"">Breast Neoplasms</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017024"" MajorTopicYN=""N"">Chemotherapy, Adjuvant</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015870"" MajorTopicYN=""N"">Gene Expression</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>17</Issue>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>25</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>McCaw</LastName>    <ForeName>Zachary R</ForeName>    <Initials>ZR</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Wei</LastName>    <ForeName>Lee-Jen</ForeName>    <Initials>LJ</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Kim</LastName>    <ForeName>Dae Hyun</ForeName>    <Initials>DH</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016420"">Comment</PublicationType></PublicationTypeList>",NA
30361202,<DateCompleted>  <Year>2019</Year>  <Month>02</Month>  <Day>25</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000276"" MajorTopicYN=""N"">Adjuvants, Immunologic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000368"" MajorTopicYN=""N"">Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006299"" MajorTopicYN=""N"">Health Services for the Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006562"" MajorTopicYN=""N"">Herpes Zoster</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D053061"" MajorTopicYN=""N"">Herpes Zoster Vaccine</DescriptorName>    <QualifierName UI=""Q000008"" MajorTopicYN=""N"">administration &amp; dosage</QualifierName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014613"" MajorTopicYN=""N"">Vaccines, Attenuated</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>25</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, 209 Victoria Street, East Building, Toronto, M5B 1W8, ON, Canada triccoa@smh.ca.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Tricco</LastName>    <ForeName>Andrea C</ForeName>    <Initials>AC</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0002-4114-8971</Identifier>    <AffiliationInfo>      <Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, 209 Victoria Street, East Building, Toronto, M5B 1W8, ON, Canada triccoa@smh.ca.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Epidemiology Division, Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, M5T 3M7, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zarin</LastName>    <ForeName>Wasifa</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, 209 Victoria Street, East Building, Toronto, M5B 1W8, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cardoso</LastName>    <ForeName>Roberta</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, 209 Victoria Street, East Building, Toronto, M5B 1W8, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Veroniki</LastName>    <ForeName>Areti-Angeliki</ForeName>    <Initials>AA</Initials>    <AffiliationInfo>      <Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, 209 Victoria Street, East Building, Toronto, M5B 1W8, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Khan</LastName>    <ForeName>Paul A</ForeName>    <Initials>PA</Initials>    <AffiliationInfo>      <Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, 209 Victoria Street, East Building, Toronto, M5B 1W8, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nincic</LastName>    <ForeName>Vera</ForeName>    <Initials>V</Initials>    <AffiliationInfo>      <Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, 209 Victoria Street, East Building, Toronto, M5B 1W8, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ghassemi</LastName>    <ForeName>Marco</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, 209 Victoria Street, East Building, Toronto, M5B 1W8, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Warren</LastName>    <ForeName>Rachel</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, 209 Victoria Street, East Building, Toronto, M5B 1W8, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sharpe</LastName>    <ForeName>Jane P</ForeName>    <Initials>JP</Initials>    <AffiliationInfo>      <Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, 209 Victoria Street, East Building, Toronto, M5B 1W8, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Page</LastName>    <ForeName>Andrea V</ForeName>    <Initials>AV</Initials>    <AffiliationInfo>      <Affiliation>Division of Infectious Diseases, Mount Sinai Hospital, Joseph and Wolf Lebovic Health Complex, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Straus</LastName>    <ForeName>Sharon E</ForeName>    <Initials>SE</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>St Michael's Hospital, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D017418"">Meta-Analysis</PublicationType>  <PublicationType UI=""D000078182"">Systematic Review</PublicationType></PublicationTypeList>",NA
30361341,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>19</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D002843"" MajorTopicYN=""N"">Chromatin</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018983"" MajorTopicYN=""N"">DNA Footprinting</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004742"" MajorTopicYN=""N"">Enhancer Elements, Genetic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015972"" MajorTopicYN=""Y"">Gene Expression Regulation, Neoplastic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D056426"" MajorTopicYN=""N"">Genetic Loci</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020022"" MajorTopicYN=""Y"">Genetic Predisposition to Disease</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007109"" MajorTopicYN=""N"">Immunity</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009369"" MajorTopicYN=""N"">Neoplasms</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012045"" MajorTopicYN=""Y"">Regulatory Sequences, Nucleic Acid</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014157"" MajorTopicYN=""N"">Transcription Factors</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019895"" MajorTopicYN=""N"">Transposases</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6413</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>26</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"" EqualContrib=""Y"">    <LastName>Corces</LastName>    <ForeName>M Ryan</ForeName>    <Initials>MR</Initials>    <Identifier Source=""ORCID"">0000-0001-7465-7652</Identifier>  </Author>  <Author ValidYN=""Y"" EqualContrib=""Y"">    <LastName>Granja</LastName>    <ForeName>Jeffrey M</ForeName>    <Initials>JM</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Shams</LastName>    <ForeName>Shadi</ForeName>    <Initials>S</Initials>    <Identifier Source=""ORCID"">0000-0003-4334-2820</Identifier>  </Author>  <Author ValidYN=""Y"">    <LastName>Louie</LastName>    <ForeName>Bryan H</ForeName>    <Initials>BH</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Seoane</LastName>    <ForeName>Jose A</ForeName>    <Initials>JA</Initials>    <Identifier Source=""ORCID"">0000-0002-3856-9177</Identifier>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhou</LastName>    <ForeName>Wanding</ForeName>    <Initials>W</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Silva</LastName>    <ForeName>Tiago C</ForeName>    <Initials>TC</Initials>    <Identifier Source=""ORCID"">0000-0003-1343-6850</Identifier>  </Author>  <Author ValidYN=""Y"">    <LastName>Groeneveld</LastName>    <ForeName>Clarice</ForeName>    <Initials>C</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Wong</LastName>    <ForeName>Christopher K</ForeName>    <Initials>CK</Initials>    <Identifier Source=""ORCID"">0000-0001-6012-7001</Identifier>  </Author>  <Author ValidYN=""Y"">    <LastName>Cho</LastName>    <ForeName>Seung Woo</ForeName>    <Initials>SW</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Satpathy</LastName>    <ForeName>Ansuman T</ForeName>    <Initials>AT</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Mumbach</LastName>    <ForeName>Maxwell R</ForeName>    <Initials>MR</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Hoadley</LastName>    <ForeName>Katherine A</ForeName>    <Initials>KA</Initials>    <Identifier Source=""ORCID"">0000-0002-1216-477X</Identifier>  </Author>  <Author ValidYN=""Y"">    <LastName>Robertson</LastName>    <ForeName>A Gordon</ForeName>    <Initials>AG</Initials>    <Identifier Source=""ORCID"">0000-0002-2839-596X</Identifier>  </Author>  <Author ValidYN=""Y"">    <LastName>Sheffield</LastName>    <ForeName>Nathan C</ForeName>    <Initials>NC</Initials>    <Identifier Source=""ORCID"">0000-0001-5643-4068</Identifier>  </Author>  <Author ValidYN=""Y"">    <LastName>Felau</LastName>    <ForeName>Ina</ForeName>    <Initials>I</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Castro</LastName>    <ForeName>Mauro A A</ForeName>    <Initials>MAA</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Berman</LastName>    <ForeName>Benjamin P</ForeName>    <Initials>BP</Initials>    <Identifier Source=""ORCID"">0000-0002-2099-9005</Identifier>  </Author>  <Author ValidYN=""Y"">    <LastName>Staudt</LastName>    <ForeName>Louis M</ForeName>    <Initials>LM</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Zenklusen</LastName>    <ForeName>Jean C</ForeName>    <Initials>JC</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Laird</LastName>    <ForeName>Peter W</ForeName>    <Initials>PW</Initials>    <Identifier Source=""ORCID"">0000-0001-9117-3641</Identifier>  </Author>  <Author ValidYN=""Y"">    <LastName>Curtis</LastName>    <ForeName>Christina</ForeName>    <Initials>C</Initials>  </Author>  <Author ValidYN=""Y"">    <CollectiveName>Cancer Genome Atlas Analysis Network</CollectiveName>  </Author>  <Author ValidYN=""Y"">    <LastName>Greenleaf</LastName>    <ForeName>William J</ForeName>    <Initials>WJ</Initials>    <Identifier Source=""ORCID"">0000-0003-1409-3095</Identifier>  </Author>  <Author ValidYN=""Y"">    <LastName>Chang</LastName>    <ForeName>Howard Y</ForeName>    <Initials>HY</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>U24 CA210978</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>K99 AG059918</GrantID>    <Acronym>AG</Acronym>    <Agency>NIA NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <Acronym>HHMI</Acronym>    <Agency>Howard Hughes Medical Institute</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U24 CA210950</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA194547</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U24 CA180951</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P50 HG007735</GrantID>    <Acronym>HG</Acronym>    <Agency>NHGRI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U24 CA210974</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U24 CA210989</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U24 CA210952</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>T32 HG000044</GrantID>    <Acronym>HG</Acronym>    <Agency>NHGRI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>UM1 HG009436</GrantID>    <Acronym>HG</Acronym>    <Agency>NHGRI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U24 CA210949</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U24 CA210990</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R35 CA209919</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U24 CA210969</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U24 CA210988</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30361354,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>19</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D061605"" MajorTopicYN=""N"">Administration, Intravenous</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D035843"" MajorTopicYN=""N"">Biomedical Research</DescriptorName>    <QualifierName UI=""Q000941"" MajorTopicYN=""Y"">ethics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006895"" MajorTopicYN=""N"">Hydroxyethyl Starch Derivatives</DescriptorName>    <QualifierName UI=""Q000008"" MajorTopicYN=""N"">administration &amp; dosage</QualifierName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007674"" MajorTopicYN=""N"">Kidney Diseases</DescriptorName>    <QualifierName UI=""Q000139"" MajorTopicYN=""Y"">chemically induced</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D061214"" MajorTopicYN=""Y"">Patient Safety</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019999"" MajorTopicYN=""N"">Pharmaceutical Solutions</DescriptorName>    <QualifierName UI=""Q000008"" MajorTopicYN=""N"">administration &amp; dosage</QualifierName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012306"" MajorTopicYN=""N"">Risk</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015871"" MajorTopicYN=""Y"">Scientific Misconduct</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6413</Issue>    <PubDate>      <Year>2018</Year>      <Month>Oct</Month>      <Day>26</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>",<AffiliationInfo>  <Affiliation>Retraction Watch.</Affiliation></AffiliationInfo>,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Marcus</LastName>    <ForeName>Adam</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Retraction Watch.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30361360,<DateCompleted>  <Year>2018</Year>  <Month>10</Month>  <Day>30</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D002843"" MajorTopicYN=""Y"">Chromatin</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D042002"" MajorTopicYN=""N"">Chromatin Assembly and Disassembly</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015972"" MajorTopicYN=""N"">Gene Expression Regulation, Neoplastic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006657"" MajorTopicYN=""N"">Histones</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009369"" MajorTopicYN=""N"">Neoplasms</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6413</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>26</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK. ajt208@cam.ac.uk.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Taipale</LastName>    <ForeName>Jussi</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK. ajt208@cam.ac.uk.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Genome-Scale Biology Program, University of Helsinki, Helsinki, Finland.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016420"">Comment</PublicationType></PublicationTypeList>",NA
30361362,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>19</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D001419"" MajorTopicYN=""N"">Bacteria</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>    <QualifierName UI=""Q000472"" MajorTopicYN=""N"">pathogenicity</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001483"" MajorTopicYN=""N"">Base Sequence</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018070"" MajorTopicYN=""N"">Biological Specimen Banks</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D021821"" MajorTopicYN=""N"">Communicable Diseases, Emerging</DescriptorName>    <QualifierName UI=""Q000382"" MajorTopicYN=""Y"">microbiology</QualifierName>    <QualifierName UI=""Q000821"" MajorTopicYN=""N"">virology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014943"" MajorTopicYN=""Y"">Global Health</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D033181"" MajorTopicYN=""Y"">Information Dissemination</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007391"" MajorTopicYN=""N"">International Cooperation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011634"" MajorTopicYN=""N"">Public Health</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014780"" MajorTopicYN=""N"">Viruses</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>    <QualifierName UI=""Q000472"" MajorTopicYN=""N"">pathogenicity</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6413</Issue>    <PubDate>      <Year>2018</Year>      <Month>10</Month>      <Day>26</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>The Netherlands National Institute for Public Health and the Environment (RIVM), Center for infectious Disease Control, Bilthoven, Netherlands. ribeirocds@hotmail.com.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Dos S Ribeiro</LastName>    <ForeName>Carolina</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>The Netherlands National Institute for Public Health and the Environment (RIVM), Center for infectious Disease Control, Bilthoven, Netherlands. ribeirocds@hotmail.com.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Athena Institute for Research on Innovation and Communication in Health and Life Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Koopmans</LastName>    <ForeName>Marion P</ForeName>    <Initials>MP</Initials>    <AffiliationInfo>      <Affiliation>Erasmus Medical Center, Department of Viroscience, Rotterdam, Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Haringhuizen</LastName>    <ForeName>George B</ForeName>    <Initials>GB</Initials>    <AffiliationInfo>      <Affiliation>The Netherlands National Institute for Public Health and the Environment (RIVM), Center for infectious Disease Control, Bilthoven, Netherlands.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>",NA
30361383,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051017"" MajorTopicYN=""N"">Apoptosis Regulatory Proteins</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001426"" MajorTopicYN=""N"">Bacterial Proteins</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D053181"" MajorTopicYN=""N"">Caspase 8</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016923"" MajorTopicYN=""N"">Cell Death</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D054884"" MajorTopicYN=""Y"">Host-Pathogen Interactions</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051550"" MajorTopicYN=""N"">I-kappa B Kinase</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058847"" MajorTopicYN=""N"">Inflammasomes</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D047908"" MajorTopicYN=""N"">Intracellular Signaling Peptides and Proteins</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020930"" MajorTopicYN=""N"">MAP Kinase Kinase Kinases</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008810"" MajorTopicYN=""N"">Mice, Inbred C57BL</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000071199"" MajorTopicYN=""N"">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D028044"" MajorTopicYN=""N"">Phosphate-Binding Proteins</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010930"" MajorTopicYN=""N"">Plague</DescriptorName>    <QualifierName UI=""Q000201"" MajorTopicYN=""N"">enzymology</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D059748"" MajorTopicYN=""N"">Proteolysis</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6418</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>30</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Program in Innate Immunity, Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Orning</LastName>    <ForeName>Pontus</ForeName>    <Initials>P</Initials>    <Identifier Source=""ORCID"">0000-0002-6177-6916</Identifier>    <AffiliationInfo>      <Affiliation>Program in Innate Immunity, Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Weng</LastName>    <ForeName>Dan</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Program in Innate Immunity, Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Center for Molecular Metabolism, Nanjing University of Science and Technology, Nanjing 210094, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Starheim</LastName>    <ForeName>Kristian</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Program in Innate Immunity, Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ratner</LastName>    <ForeName>Dmitry</ForeName>    <Initials>D</Initials>    <Identifier Source=""ORCID"">0000-0002-1706-2596</Identifier>    <AffiliationInfo>      <Affiliation>Program in Innate Immunity, Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Best</LastName>    <ForeName>Zachary</ForeName>    <Initials>Z</Initials>    <Identifier Source=""ORCID"">0000-0002-8645-6441</Identifier>    <AffiliationInfo>      <Affiliation>Program in Innate Immunity, Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lee</LastName>    <ForeName>Bettina</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiological Chemistry, Genentech, South San Francisco, CA 94080, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Brooks</LastName>    <ForeName>Alexandria</ForeName>    <Initials>A</Initials>    <Identifier Source=""ORCID"">0000-0002-1119-2568</Identifier>    <AffiliationInfo>      <Affiliation>Program in Innate Immunity, Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Xia</LastName>    <ForeName>Shiyu</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, and Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wu</LastName>    <ForeName>Hao</ForeName>    <Initials>H</Initials>    <Identifier Source=""ORCID"">0000-0002-7281-8579</Identifier>    <AffiliationInfo>      <Affiliation>Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, and Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kelliher</LastName>    <ForeName>Michelle A</ForeName>    <Initials>MA</Initials>    <Identifier Source=""ORCID"">0000-0001-9211-3659</Identifier>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Berger</LastName>    <ForeName>Scott B</ForeName>    <Initials>SB</Initials>    <AffiliationInfo>      <Affiliation>Pattern Recognition Receptor Discovery Performance Unit, Immuno-inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19426, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gough</LastName>    <ForeName>Peter J</ForeName>    <Initials>PJ</Initials>    <Identifier Source=""ORCID"">0000-0002-5110-9300</Identifier>    <AffiliationInfo>      <Affiliation>Pattern Recognition Receptor Discovery Performance Unit, Immuno-inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19426, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bertin</LastName>    <ForeName>John</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Pattern Recognition Receptor Discovery Performance Unit, Immuno-inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19426, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Proulx</LastName>    <ForeName>Megan M</ForeName>    <Initials>MM</Initials>    <Identifier Source=""ORCID"">0000-0002-9524-8302</Identifier>    <AffiliationInfo>      <Affiliation>Department of Microbiology and Physiology, University of Massachusetts Medical School, Worcester, MA 01655, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Goguen</LastName>    <ForeName>Jon D</ForeName>    <Initials>JD</Initials>    <AffiliationInfo>      <Affiliation>Department of Microbiology and Physiology, University of Massachusetts Medical School, Worcester, MA 01655, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kayagaki</LastName>    <ForeName>Nobuhiko</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Department of Physiological Chemistry, Genentech, South San Francisco, CA 94080, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fitzgerald</LastName>    <ForeName>Katherine A</ForeName>    <Initials>KA</Initials>    <AffiliationInfo>      <Affiliation>Program in Innate Immunity, Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lien</LastName>    <ForeName>Egil</ForeName>    <Initials>E</Initials>    <Identifier Source=""ORCID"">0000-0002-8536-2419</Identifier>    <AffiliationInfo>      <Affiliation>Program in Innate Immunity, Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605, USA. egil.lien@umassmed.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>R01 AI075318</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R21 AI128547</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R25 HL092610</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R56 AI075118</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>T32 AI007538</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>T32 AI095213</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>DP1 HD087988</GrantID>    <Acronym>HD</Acronym>    <Agency>NICHD NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 AI075118</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R37 AI067497</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R56 AI067497</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 AI124491</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>F30 AI129237</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 AI139914</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 AI067497</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 AI083713</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30380384,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000368"" MajorTopicYN=""N"">Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002404"" MajorTopicYN=""N"">Catheterization</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003015"" MajorTopicYN=""N"">Clostridium Infections</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""Y"">epidemiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003428"" MajorTopicYN=""N"">Cross Infection</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""Y"">epidemiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006742"" MajorTopicYN=""N"">Hospital Bed Capacity</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006757"" MajorTopicYN=""N"">Hospital Units</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006760"" MajorTopicYN=""N"">Hospitalization</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007231"" MajorTopicYN=""N"">Infant, Newborn</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015999"" MajorTopicYN=""N"">Multivariate Analysis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011014"" MajorTopicYN=""N"">Pneumonia</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015995"" MajorTopicYN=""N"">Prevalence</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012044"" MajorTopicYN=""N"">Regression Analysis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012121"" MajorTopicYN=""N"">Respiration, Artificial</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013530"" MajorTopicYN=""N"">Surgical Wound Infection</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"">United States</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014552"" MajorTopicYN=""N"">Urinary Tract Infections</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>18</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>01</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Magill</LastName>    <ForeName>Shelley S</ForeName>    <Initials>SS</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>O'Leary</LastName>    <ForeName>Erin</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Janelle</LastName>    <ForeName>Sarah J</ForeName>    <Initials>SJ</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Thompson</LastName>    <ForeName>Deborah L</ForeName>    <Initials>DL</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dumyati</LastName>    <ForeName>Ghinwa</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nadle</LastName>    <ForeName>Joelle</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wilson</LastName>    <ForeName>Lucy E</ForeName>    <Initials>LE</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kainer</LastName>    <ForeName>Marion A</ForeName>    <Initials>MA</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lynfield</LastName>    <ForeName>Ruth</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Greissman</LastName>    <ForeName>Samantha</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ray</LastName>    <ForeName>Susan M</ForeName>    <Initials>SM</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Beldavs</LastName>    <ForeName>Zintars</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gross</LastName>    <ForeName>Cindy</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bamberg</LastName>    <ForeName>Wendy</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sievers</LastName>    <ForeName>Marla</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Concannon</LastName>    <ForeName>Cathleen</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Buhr</LastName>    <ForeName>Nicolai</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Warnke</LastName>    <ForeName>Linn</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Maloney</LastName>    <ForeName>Meghan</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ocampo</LastName>    <ForeName>Valerie</ForeName>    <Initials>V</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Brooks</LastName>    <ForeName>Janet</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Oyewumi</LastName>    <ForeName>Tolulope</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sharmin</LastName>    <ForeName>Shamima</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Richards</LastName>    <ForeName>Katherine</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rainbow</LastName>    <ForeName>Jean</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Samper</LastName>    <ForeName>Monika</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hancock</LastName>    <ForeName>Emily B</ForeName>    <Initials>EB</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Leaptrot</LastName>    <ForeName>Denise</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Scalise</LastName>    <ForeName>Eileen</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Badrun</LastName>    <ForeName>Farzana</ForeName>    <Initials>F</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Phelps</LastName>    <ForeName>Ruby</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Edwards</LastName>    <ForeName>Jonathan R</ForeName>    <Initials>JR</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, (S.S.M., E.O., C.G., J.B., D.L., E.S., F.B., R.P., J.R.E.), the Department of Medicine, Emory University (S.M.R.), CACI (C.G., J.B., D.L., E.S.), and Eagle Medical Services (F.B.) - all in Atlanta; Colorado Department of Public Health and Environment, Denver (S.J.J., W.B., T.O.); New Mexico Department of Health, Santa Fe (D.L.T., M. Sievers, S.S.), and Presbyterian Healthcare Services (D.L.T.) and University of New Mexico (E.B.H.), Albuquerque; New York Emerging Infections Program and University of Rochester Medical Center, Rochester (G.D., C.C.); California Emerging Infections Program, Oakland (J.N.); Maryland Department of Health, Baltimore (L.E.W., N.B., K.R.); Tennessee Department of Health, Nashville (M.A.K.); Minnesota Department of Health, St. Paul (R.L., L.W., J.R.); Connecticut Emerging Infections Program, New Haven and Hartford (S.G., M.M.); Georgia Emerging Infections Program, Decatur (S.M.R.); and Oregon Health Authority, Portland (Z.B., V.O., M. Samper).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <CollectiveName>Emerging Infections Program Hospital Prevalence Survey Team</CollectiveName>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D003160"">Comparative Study</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013487"">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>CC999999</GrantID>    <Acronym>ImCDC</Acronym>    <Agency>Intramural CDC HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30380392,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018416"" MajorTopicYN=""N"">Bartonella henselae</DescriptorName>    <QualifierName UI=""Q000302"" MajorTopicYN=""Y"">isolation &amp; purification</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002372"" MajorTopicYN=""N"">Cat-Scratch Disease</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""Y"">complications</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002415"" MajorTopicYN=""N"">Cats</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002675"" MajorTopicYN=""N"">Child, Preschool</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003234"" MajorTopicYN=""N"">Conjunctivitis, Bacterial</DescriptorName>    <QualifierName UI=""Q000382"" MajorTopicYN=""Y"">microbiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008206"" MajorTopicYN=""N"">Lymphatic Diseases</DescriptorName>    <QualifierName UI=""Q000382"" MajorTopicYN=""Y"">microbiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013577"" MajorTopicYN=""N"">Syndrome</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014946"" MajorTopicYN=""N"">Wound Infection</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>18</Issue>    <PubDate>      <Year>2018</Year>      <Month>Nov</Month>      <Day>01</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Universidad de Antioquia, Medelln, Colombia catarango52@hotmail.com.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Arango-Ferreira</LastName>    <ForeName>Catalina</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Universidad de Antioquia, Medelln, Colombia catarango52@hotmail.com.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Castano</LastName>    <ForeName>Jorge</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Universidad de Antioquia, Medelln, Colombia catarango52@hotmail.com.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D002363"">Case Reports</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30380394,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D058186"" MajorTopicYN=""Y"">Acute Kidney Injury</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000293"" MajorTopicYN=""N"">Adolescent</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007668"" MajorTopicYN=""Y"">Kidney</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>18</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>01</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Massachusetts General Hospital, Boston, MA</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Sharma</LastName>    <ForeName>Amita</ForeName>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital, Boston, MA</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016420"">Comment</PublicationType></PublicationTypeList>",NA
30383132,<DateCompleted>  <Year>2019</Year>  <Month>09</Month>  <Day>03</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D005389"" MajorTopicYN=""N"">Firearms</DescriptorName>    <QualifierName UI=""Q000331"" MajorTopicYN=""N"">legislation &amp; jurisprudence</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006291"" MajorTopicYN=""Y"">Health Policy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006708"" MajorTopicYN=""N"">Homicide</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010819"" MajorTopicYN=""N"">Physician's Role</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013405"" MajorTopicYN=""N"">Suicide</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"" Type=""Geographic"">United States</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014754"" MajorTopicYN=""N"">Violence</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014948"" MajorTopicYN=""N"">Wounds, Gunshot</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>    <QualifierName UI=""Q000401"" MajorTopicYN=""N"">mortality</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1539-3704</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>169</Volume>    <Issue>10</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>20</Day>    </PubDate>  </JournalIssue>  <Title>Annals of internal medicine</Title>  <ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>American College of Physicians, Washington, DC (R.B., R.D.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Butkus</LastName>    <ForeName>Renee</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>American College of Physicians, Washington, DC (R.B., R.D.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Doherty</LastName>    <ForeName>Robert</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>American College of Physicians, Washington, DC (R.B., R.D.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bornstein</LastName>    <ForeName>Sue S</ForeName>    <Initials>SS</Initials>    <AffiliationInfo>      <Affiliation>Texas Medical Home Initiative, Dallas, Texas (S.S.B.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <CollectiveName>Health and Public Policy Committee of the American College of Physicians</CollectiveName>  </Author>  <Author ValidYN=""Y"">    <LastName>Carney</LastName>    <ForeName>Jan K</ForeName>    <Initials>JK</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Cooney</LastName>    <ForeName>Tom</ForeName>    <Initials>T</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Engel</LastName>    <ForeName>Lee</ForeName>    <Initials>L</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Gantzer</LastName>    <ForeName>Heather E</ForeName>    <Initials>HE</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Henry</LastName>    <ForeName>Tracey L</ForeName>    <Initials>TL</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Lenchus</LastName>    <ForeName>Joshua D</ForeName>    <Initials>JD</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>McCandless</LastName>    <ForeName>Bridget M</ForeName>    <Initials>BM</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Quinton</LastName>    <ForeName>Jacob</ForeName>    <Initials>J</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Southworth</LastName>    <ForeName>Molly</ForeName>    <Initials>M</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Valdrighi</LastName>    <ForeName>Alexandria</ForeName>    <Initials>A</Initials>  </Author>  <Author ValidYN=""Y"">    <LastName>Wallace</LastName>    <ForeName>Mary Anderson</ForeName>    <Initials>MA</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016431"">Guideline</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>",NA
30383133,<DateCompleted>  <Year>2019</Year>  <Month>08</Month>  <Day>30</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000925"" MajorTopicYN=""N"">Anticoagulants</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000991"" MajorTopicYN=""N"">Antithrombins</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020517"" MajorTopicYN=""N"">Atrial Appendage</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001281"" MajorTopicYN=""N"">Atrial Fibrillation</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""Y"">complications</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D057186"" MajorTopicYN=""N"">Comparative Effectiveness Research</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D065427"" MajorTopicYN=""N"">Factor Xa Inhibitors</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006470"" MajorTopicYN=""N"">Hemorrhage</DescriptorName>    <QualifierName UI=""Q000209"" MajorTopicYN=""N"">etiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055989"" MajorTopicYN=""N"">Septal Occluder Device</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020521"" MajorTopicYN=""N"">Stroke</DescriptorName>    <QualifierName UI=""Q000209"" MajorTopicYN=""N"">etiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013923"" MajorTopicYN=""N"">Thromboembolism</DescriptorName>    <QualifierName UI=""Q000209"" MajorTopicYN=""N"">etiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1539-3704</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>169</Volume>    <Issue>11</Issue>    <PubDate>      <Year>2018</Year>      <Month>12</Month>      <Day>04</Day>    </PubDate>  </JournalIssue>  <Title>Annals of internal medicine</Title>  <ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Duke University School of Medicine, Durham, North Carolina (A.L., S.M.A., L.S., R.C., E.D.B., G.R., A.G., K.L., R.S., A.S.K.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Lowenstern</LastName>    <ForeName>Angela</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine, Durham, North Carolina (A.L., S.M.A., L.S., R.C., E.D.B., G.R., A.G., K.L., R.S., A.S.K.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Al-Khatib</LastName>    <ForeName>Sana M</ForeName>    <Initials>SM</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine, Durham, North Carolina (A.L., S.M.A., L.S., R.C., E.D.B., G.R., A.G., K.L., R.S., A.S.K.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sharan</LastName>    <ForeName>Lauren</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine, Durham, North Carolina (A.L., S.M.A., L.S., R.C., E.D.B., G.R., A.G., K.L., R.S., A.S.K.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chatterjee</LastName>    <ForeName>Ranee</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine, Durham, North Carolina (A.L., S.M.A., L.S., R.C., E.D.B., G.R., A.G., K.L., R.S., A.S.K.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Allen LaPointe</LastName>    <ForeName>Nancy M</ForeName>    <Initials>NM</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine, Durham, and Premier, Charlotte, North Carolina (N.M.A.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Shah</LastName>    <ForeName>Bimal</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine, Durham, North Carolina, and Livongo, Mountain View, California (B.S.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Borre</LastName>    <ForeName>Ethan D</ForeName>    <Initials>ED</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine, Durham, North Carolina (A.L., S.M.A., L.S., R.C., E.D.B., G.R., A.G., K.L., R.S., A.S.K.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Raitz</LastName>    <ForeName>Giselle</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine, Durham, North Carolina (A.L., S.M.A., L.S., R.C., E.D.B., G.R., A.G., K.L., R.S., A.S.K.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Goode</LastName>    <ForeName>Adam</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine, Durham, North Carolina (A.L., S.M.A., L.S., R.C., E.D.B., G.R., A.G., K.L., R.S., A.S.K.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yapa</LastName>    <ForeName>Roshini</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>University of Colorado, Aurora, Colorado (R.Y.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Davis</LastName>    <ForeName>J Kelly</ForeName>    <Initials>JK</Initials>    <AffiliationInfo>      <Affiliation>Duke University, Durham, North Carolina (J.K.D.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lallinger</LastName>    <ForeName>Kathryn</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine, Durham, North Carolina (A.L., S.M.A., L.S., R.C., E.D.B., G.R., A.G., K.L., R.S., A.S.K.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Schmidt</LastName>    <ForeName>Robyn</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine, Durham, North Carolina (A.L., S.M.A., L.S., R.C., E.D.B., G.R., A.G., K.L., R.S., A.S.K.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kosinski</LastName>    <ForeName>Andrzej S</ForeName>    <Initials>AS</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine, Durham, North Carolina (A.L., S.M.A., L.S., R.C., E.D.B., G.R., A.G., K.L., R.S., A.S.K.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sanders</LastName>    <ForeName>Gillian D</ForeName>    <Initials>GD</Initials>    <AffiliationInfo>      <Affiliation>Duke University School of Medicine and Duke University, Durham, North Carolina (G.D.S.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType>  <PublicationType UI=""D013487"">Research Support, U.S. Gov't, P.H.S.</PublicationType>  <PublicationType UI=""D000078182"">Systematic Review</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>T32 GM007171</GrantID>    <Acronym>GM</Acronym>    <Agency>NIGMS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>T32 HL069749</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30383173,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>21</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000894"" MajorTopicYN=""N"">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000925"" MajorTopicYN=""N"">Anticoagulants</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D065427"" MajorTopicYN=""N"">Factor Xa Inhibitors</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000077425"" MajorTopicYN=""N"">Fondaparinux</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006470"" MajorTopicYN=""N"">Hemorrhage</DescriptorName>    <QualifierName UI=""Q000139"" MajorTopicYN=""N"">chemically induced</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006495"" MajorTopicYN=""N"">Heparin, Low-Molecular-Weight</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D035002"" MajorTopicYN=""N"">Lower Extremity</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016032"" MajorTopicYN=""N"">Randomized Controlled Trials as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012196"" MajorTopicYN=""N"">Review Literature as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D053828"" MajorTopicYN=""N"">Stockings, Compression</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013924"" MajorTopicYN=""N"">Thrombophlebitis</DescriptorName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D054556"" MajorTopicYN=""N"">Venous Thromboembolism</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1538-3598</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>320</Volume>    <Issue>22</Issue>    <PubDate>      <Year>2018</Year>      <Month>12</Month>      <Day>11</Day>    </PubDate>  </JournalIssue>  <Title>JAMA</Title>  <ISOAbbreviation>JAMA</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Di Nisio</LastName>    <ForeName>Marcello</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wichers</LastName>    <ForeName>Iris</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>Department of Guideline Development and Science, Dutch College of General Practitioners, Utrecht, the Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Middeldorp</LastName>    <ForeName>Saskia</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30383176,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D005380"" MajorTopicYN=""N"">Financing, Government</DescriptorName>    <QualifierName UI=""Q000379"" MajorTopicYN=""Y"">methods</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006526"" MajorTopicYN=""N"">Hepatitis C</DescriptorName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013221"" MajorTopicYN=""Y"">State Health Plans</DescriptorName>    <QualifierName UI=""Q000191"" MajorTopicYN=""N"">economics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"">United States</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1538-3598</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>320</Volume>    <Issue>19</Issue>    <PubDate>      <Year>2018</Year>      <Month>Nov</Month>      <Day>20</Day>    </PubDate>  </JournalIssue>  <Title>JAMA</Title>  <ISOAbbreviation>JAMA</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Sloan School of Management, Massachusetts Institute of Technology, Cambridge.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Trusheim</LastName>    <ForeName>Mark R</ForeName>    <Initials>MR</Initials>    <AffiliationInfo>      <Affiliation>Sloan School of Management, Massachusetts Institute of Technology, Cambridge.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cassidy</LastName>    <ForeName>William M</ForeName>    <Initials>WM</Initials>    <AffiliationInfo>      <Affiliation>US Senate.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Louisiana State University Health Sciences Center, Baton Rouge.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bach</LastName>    <ForeName>Peter B</ForeName>    <Initials>PB</Initials>    <AffiliationInfo>      <Affiliation>Health Outcomes Research Group, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30385465,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D048868"" MajorTopicYN=""N"">Adaptor Proteins, Signal Transducing</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019008"" MajorTopicYN=""N"">Drug Resistance, Neoplasm</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017353"" MajorTopicYN=""N"">Gene Deletion</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015972"" MajorTopicYN=""N"">Gene Expression Regulation, Neoplastic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055785"" MajorTopicYN=""N"">Gene Knockdown Techniques</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D052138"" MajorTopicYN=""Y"">Genes, Neoplasm</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D023281"" MajorTopicYN=""N"">Genomics</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D047908"" MajorTopicYN=""N"">Intracellular Signaling Peptides and Proteins</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008545"" MajorTopicYN=""N"">Melanoma</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008546"" MajorTopicYN=""N"">Melanoma, Experimental</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008565"" MajorTopicYN=""N"">Membrane Proteins</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020928"" MajorTopicYN=""N"">Mitogen-Activated Protein Kinases</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009092"" MajorTopicYN=""N"">Mucous Membrane</DescriptorName>    <QualifierName UI=""Q000201"" MajorTopicYN=""N"">enzymology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019009"" MajorTopicYN=""N"">Proto-Oncogene Proteins c-kit</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015398"" MajorTopicYN=""N"">Signal Transduction</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012878"" MajorTopicYN=""N"">Skin Neoplasms</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015027"" MajorTopicYN=""N"">Zebrafish</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6418</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>30</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"" EqualContrib=""Y"">    <LastName>Ablain</LastName>    <ForeName>Julien</ForeName>    <Initials>J</Initials>    <Identifier Source=""ORCID"">0000-0002-4509-3568</Identifier>    <AffiliationInfo>      <Affiliation>Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"" EqualContrib=""Y"">    <LastName>Xu</LastName>    <ForeName>Mengshu</ForeName>    <Initials>M</Initials>    <Identifier Source=""ORCID"">0000-0001-5329-9235</Identifier>    <AffiliationInfo>      <Affiliation>Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Dermatology, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rothschild</LastName>    <ForeName>Harriet</ForeName>    <Initials>H</Initials>    <Identifier Source=""ORCID"">0000-0001-5311-2872</Identifier>    <AffiliationInfo>      <Affiliation>Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jordan</LastName>    <ForeName>Richard C</ForeName>    <Initials>RC</Initials>    <AffiliationInfo>      <Affiliation>Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Orofacial Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mito</LastName>    <ForeName>Jeffrey K</ForeName>    <Initials>JK</Initials>    <AffiliationInfo>      <Affiliation>Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Daniels</LastName>    <ForeName>Brianne H</ForeName>    <Initials>BH</Initials>    <Identifier Source=""ORCID"">0000-0002-0866-1706</Identifier>    <AffiliationInfo>      <Affiliation>Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bell</LastName>    <ForeName>Caitlin F</ForeName>    <Initials>CF</Initials>    <Identifier Source=""ORCID"">0000-0001-7352-142X</Identifier>    <AffiliationInfo>      <Affiliation>Department of Medicine, Stanford University Medical Center, Stanford, CA 94305, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Joseph</LastName>    <ForeName>Nancy M</ForeName>    <Initials>NM</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wu</LastName>    <ForeName>Hong</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Fox Chase Cancer Center, Philadelphia, PA 19111, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"" EqualContrib=""Y"">    <LastName>Bastian</LastName>    <ForeName>Boris C</ForeName>    <Initials>BC</Initials>    <Identifier Source=""ORCID"">0000-0003-1836-6062</Identifier>    <AffiliationInfo>      <Affiliation>Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Dermatology, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"" EqualContrib=""Y"">    <LastName>Zon</LastName>    <ForeName>Leonard I</ForeName>    <Initials>LI</Initials>    <Identifier Source=""ORCID"">0000-0003-0860-926X</Identifier>    <AffiliationInfo>      <Affiliation>Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115, USA. iwei.yeh@ucsf.edu leonard.zon@enders.tch.harvard.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Howard Hughes Medical Institute, Boston Children's Hospital and Harvard University, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"" EqualContrib=""Y"">    <LastName>Yeh</LastName>    <ForeName>Iwei</ForeName>    <Initials>I</Initials>    <Identifier Source=""ORCID"">0000-0002-3941-3561</Identifier>    <AffiliationInfo>      <Affiliation>Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA. iwei.yeh@ucsf.edu leonard.zon@enders.tch.harvard.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Dermatology, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>T32 HL007627</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P01 CA163222</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA103846</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U24 CA196067</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>K99 CA201465</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R35 CA220481</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <Acronym>HHMI</Acronym>    <Agency>Howard Hughes Medical Institute</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30385548,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001562"" MajorTopicYN=""N"">Benzimidazoles</DescriptorName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001921"" MajorTopicYN=""N"">Brain</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016923"" MajorTopicYN=""N"">Cell Death</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D059290"" MajorTopicYN=""N"">Dopaminergic Neurons</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004789"" MajorTopicYN=""N"">Enzyme Activation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055786"" MajorTopicYN=""N"">Gene Knockout Techniques</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008810"" MajorTopicYN=""N"">Mice, Inbred C57BL</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018345"" MajorTopicYN=""N"">Mice, Knockout</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009569"" MajorTopicYN=""N"">Nitric Oxide</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010300"" MajorTopicYN=""N"">Parkinson Disease</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000071137"" MajorTopicYN=""N"">Poly (ADP-Ribose) Polymerase-1</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""N"">antagonists &amp; inhibitors</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011064"" MajorTopicYN=""N"">Poly Adenosine Diphosphate Ribose</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000067856"" MajorTopicYN=""N"">Poly(ADP-ribose) Polymerase Inhibitors</DescriptorName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011994"" MajorTopicYN=""N"">Recombinant Proteins</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051844"" MajorTopicYN=""N"">alpha-Synuclein</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6414</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>02</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Kam</LastName>    <ForeName>Tae-In</ForeName>    <Initials>TI</Initials>    <Identifier Source=""ORCID"">0000-0002-7241-4902</Identifier>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mao</LastName>    <ForeName>Xiaobo</ForeName>    <Initials>X</Initials>    <Identifier Source=""ORCID"">0000-0001-6587-556X</Identifier>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Park</LastName>    <ForeName>Hyejin</ForeName>    <Initials>H</Initials>    <Identifier Source=""ORCID"">0000-0001-5648-9683</Identifier>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chou</LastName>    <ForeName>Shih-Ching</ForeName>    <Initials>SC</Initials>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Karuppagounder</LastName>    <ForeName>Senthilkumar S</ForeName>    <Initials>SS</Initials>    <Identifier Source=""ORCID"">0000-0002-3281-9913</Identifier>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Umanah</LastName>    <ForeName>George Essien</ForeName>    <Initials>GE</Initials>    <Identifier Source=""ORCID"">0000-0002-1506-6139</Identifier>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yun</LastName>    <ForeName>Seung Pil</ForeName>    <Initials>SP</Initials>    <Identifier Source=""ORCID"">0000-0002-5151-8534</Identifier>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Brahmachari</LastName>    <ForeName>Saurav</ForeName>    <Initials>S</Initials>    <Identifier Source=""ORCID"">0000-0001-9864-3036</Identifier>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Panicker</LastName>    <ForeName>Nikhil</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Rong</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Andrabi</LastName>    <ForeName>Shaida A</ForeName>    <Initials>SA</Initials>    <Identifier Source=""ORCID"">0000-0002-4083-1998</Identifier>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Qi</LastName>    <ForeName>Chen</ForeName>    <Initials>C</Initials>    <Identifier Source=""ORCID"">0000-0002-2217-0698</Identifier>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Xin Hua Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Poirier</LastName>    <ForeName>Guy G</ForeName>    <Initials>GG</Initials>    <Identifier Source=""ORCID"">0000-0002-4869-1424</Identifier>    <AffiliationInfo>      <Affiliation>Centre de recherche du CHU de Qubec-Pavillon CHUL, Facult de Mdecine, Universit Laval, Qubec G1V 4G2, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pletnikova</LastName>    <ForeName>Olga</ForeName>    <Initials>O</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology (Neuropathology), Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Troncoso</LastName>    <ForeName>Juan C</ForeName>    <Initials>JC</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Pathology (Neuropathology), Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bekris</LastName>    <ForeName>Lynn M</ForeName>    <Initials>LM</Initials>    <Identifier Source=""ORCID"">0000-0002-2747-7672</Identifier>    <AffiliationInfo>      <Affiliation>Lerner Research Institute, Genomic Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Leverenz</LastName>    <ForeName>James B</ForeName>    <Initials>JB</Initials>    <AffiliationInfo>      <Affiliation>Lou Ruvo Center for Brain Health, Neurological Institute, and Department of Neurology, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pantelyat</LastName>    <ForeName>Alexander</ForeName>    <Initials>A</Initials>    <Identifier Source=""ORCID"">0000-0002-6427-7485</Identifier>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ko</LastName>    <ForeName>Han Seok</ForeName>    <Initials>HS</Initials>    <Identifier Source=""ORCID"">0000-0002-0864-5239</Identifier>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rosenthal</LastName>    <ForeName>Liana S</ForeName>    <Initials>LS</Initials>    <Identifier Source=""ORCID"">0000-0001-5140-3967</Identifier>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dawson</LastName>    <ForeName>Ted M</ForeName>    <Initials>TM</Initials>    <Identifier Source=""ORCID"">0000-0002-6459-0893</Identifier>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. tdawson@jhmi.edu vdawson1@jhmi.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dawson</LastName>    <ForeName>Valina L</ForeName>    <Initials>VL</Initials>    <Identifier Source=""ORCID"">0000-0002-2915-3970</Identifier>    <AffiliationInfo>      <Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. tdawson@jhmi.edu vdawson1@jhmi.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>U01 NS082133</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U01 NS100610</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P50 NS038377</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 NS107404</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R37 NS067525</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 NS082205</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U01 NS097049</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30385560,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>06</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009369"" MajorTopicYN=""N"">Neoplasms</DescriptorName>    <QualifierName UI=""Q000201"" MajorTopicYN=""Y"">enzymology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010300"" MajorTopicYN=""Y"">Parkinson Disease</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011064"" MajorTopicYN=""N"">Poly Adenosine Diphosphate Ribose</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6414</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>02</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Van Andel Research Institute, Center for Neurodegenerative Science, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA. patrik.brundin@vai.org.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Brundin</LastName>    <ForeName>Patrik</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Van Andel Research Institute, Center for Neurodegenerative Science, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA. patrik.brundin@vai.org.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wyse</LastName>    <ForeName>Richard</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>The Cure Parkinson's Trust, 120 Baker Street, London W1U 6TU, UK.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType>  <PublicationType UI=""D016420"">Comment</PublicationType></PublicationTypeList>",NA
30385580,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D057134"" MajorTopicYN=""N"">Antibodies, Neutralizing</DescriptorName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000648"" MajorTopicYN=""N"">ultrastructure</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000914"" MajorTopicYN=""N"">Antibodies, Viral</DescriptorName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000648"" MajorTopicYN=""N"">ultrastructure</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002161"" MajorTopicYN=""N"">Camelids, New World</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018360"" MajorTopicYN=""N"">Crystallography, X-Ray</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004285"" MajorTopicYN=""N"">Dogs</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019267"" MajorTopicYN=""N"">Hemagglutinin Glycoproteins, Influenza Virus</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016056"" MajorTopicYN=""N"">Immunodominant Epitopes</DescriptorName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009980"" MajorTopicYN=""N"">Influenza A virus</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009981"" MajorTopicYN=""N"">Influenza B virus</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007252"" MajorTopicYN=""N"">Influenza Vaccines</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D061985"" MajorTopicYN=""N"">Madin Darby Canine Kidney Cells</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008807"" MajorTopicYN=""N"">Mice, Inbred BALB C</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009500"" MajorTopicYN=""N"">Neutralization Tests</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009976"" MajorTopicYN=""N"">Orthomyxoviridae Infections</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019151"" MajorTopicYN=""N"">Peptide Library</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011994"" MajorTopicYN=""N"">Recombinant Proteins</DescriptorName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D061905"" MajorTopicYN=""N"">Single-Domain Antibodies</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6414</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>02</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Laursen</LastName>    <ForeName>Nick S</ForeName>    <Initials>NS</Initials>    <Identifier Source=""ORCID"">0000-0002-7512-2649</Identifier>    <AffiliationInfo>      <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Friesen</LastName>    <ForeName>Robert H E</ForeName>    <Initials>RHE</Initials>    <AffiliationInfo>      <Affiliation>Janssen Research and Development, Spring House, PA 19002, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhu</LastName>    <ForeName>Xueyong</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jongeneelen</LastName>    <ForeName>Mandy</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Janssen Vaccines and Prevention, Archimedesweg 4-6, 2333 CN, Leiden, Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Blokland</LastName>    <ForeName>Sven</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Janssen Vaccines and Prevention, Archimedesweg 4-6, 2333 CN, Leiden, Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Vermond</LastName>    <ForeName>Jan</ForeName>    <Initials>J</Initials>    <Identifier Source=""ORCID"">0000-0002-5766-8912</Identifier>    <AffiliationInfo>      <Affiliation>Janssen Prevention Center, Archimedesweg 6, 2333 CN, Leiden, Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>van Eijgen</LastName>    <ForeName>Alida</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Janssen Prevention Center, Archimedesweg 6, 2333 CN, Leiden, Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tang</LastName>    <ForeName>Chan</ForeName>    <Initials>C</Initials>    <Identifier Source=""ORCID"">0000-0002-1192-4116</Identifier>    <AffiliationInfo>      <Affiliation>Janssen Vaccines and Prevention, Archimedesweg 4-6, 2333 CN, Leiden, Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>van Diepen</LastName>    <ForeName>Harry</ForeName>    <Initials>H</Initials>    <Identifier Source=""ORCID"">0000-0002-4822-7445</Identifier>    <AffiliationInfo>      <Affiliation>Janssen Prevention Center, Archimedesweg 6, 2333 CN, Leiden, Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Obmolova</LastName>    <ForeName>Galina</ForeName>    <Initials>G</Initials>    <Identifier Source=""ORCID"">0000-0002-1045-7114</Identifier>    <AffiliationInfo>      <Affiliation>Janssen Research and Development, Spring House, PA 19002, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>van der Neut Kolfschoten</LastName>    <ForeName>Marijn</ForeName>    <Initials>M</Initials>    <Identifier Source=""ORCID"">0000-0003-4282-4588</Identifier>    <AffiliationInfo>      <Affiliation>Janssen Vaccines and Prevention, Archimedesweg 4-6, 2333 CN, Leiden, Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zuijdgeest</LastName>    <ForeName>David</ForeName>    <Initials>D</Initials>    <Identifier Source=""ORCID"">0000-0001-8234-201X</Identifier>    <AffiliationInfo>      <Affiliation>Janssen Vaccines and Prevention, Archimedesweg 4-6, 2333 CN, Leiden, Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Straetemans</LastName>    <ForeName>Roel</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Quantitative Sciences, Janssen Pharmaceutical Companies of Johnson and Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hoffman</LastName>    <ForeName>Ryan M B</ForeName>    <Initials>RMB</Initials>    <AffiliationInfo>      <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nieusma</LastName>    <ForeName>Travis</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pallesen</LastName>    <ForeName>Jesper</ForeName>    <Initials>J</Initials>    <Identifier Source=""ORCID"">0000-0002-3270-1587</Identifier>    <AffiliationInfo>      <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Turner</LastName>    <ForeName>Hannah L</ForeName>    <Initials>HL</Initials>    <AffiliationInfo>      <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bernard</LastName>    <ForeName>Steffen M</ForeName>    <Initials>SM</Initials>    <AffiliationInfo>      <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ward</LastName>    <ForeName>Andrew B</ForeName>    <Initials>AB</Initials>    <Identifier Source=""ORCID"">0000-0002-9778-1776</Identifier>    <AffiliationInfo>      <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Luo</LastName>    <ForeName>Jinquan</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Janssen Research and Development, Spring House, PA 19002, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Poon</LastName>    <ForeName>Leo L M</ForeName>    <Initials>LLM</Initials>    <AffiliationInfo>      <Affiliation>Center of Influenza Research and School of Public Health, The University of Hong Kong, Hong Kong SAR, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tretiakova</LastName>    <ForeName>Anna P</ForeName>    <Initials>AP</Initials>    <AffiliationInfo>      <Affiliation>Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wilson</LastName>    <ForeName>James M</ForeName>    <Initials>JM</Initials>    <Identifier Source=""ORCID"">0000-0002-9630-3131</Identifier>    <AffiliationInfo>      <Affiliation>Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Limberis</LastName>    <ForeName>Maria P</ForeName>    <Initials>MP</Initials>    <AffiliationInfo>      <Affiliation>Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Vogels</LastName>    <ForeName>Ronald</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Janssen Vaccines and Prevention, Archimedesweg 4-6, 2333 CN, Leiden, Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Brandenburg</LastName>    <ForeName>Boerries</ForeName>    <Initials>B</Initials>    <Identifier Source=""ORCID"">0000-0002-5025-3802</Identifier>    <AffiliationInfo>      <Affiliation>Janssen Vaccines and Prevention, Archimedesweg 4-6, 2333 CN, Leiden, Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kolkman</LastName>    <ForeName>Joost A</ForeName>    <Initials>JA</Initials>    <Identifier Source=""ORCID"">0000-0002-9621-3646</Identifier>    <AffiliationInfo>      <Affiliation>Janssen Infectious Diseases, Turnhoutseweg 30, 2340, Beerse, Belgium. wilson@scripps.edu jkolkman@its.jnj.com.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wilson</LastName>    <ForeName>Ian A</ForeName>    <Initials>IA</Initials>    <Identifier Source=""ORCID"">0000-0002-6469-2419</Identifier>    <AffiliationInfo>      <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. wilson@scripps.edu jkolkman@its.jnj.com.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType>  <PublicationType UI=""D013486"">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>P41 GM103393</GrantID>    <Acronym>GM</Acronym>    <Agency>NIGMS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R56 AI117675</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R56 AI127371</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>T32 AI007354</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30388443,<DateCompleted>  <Year>2019</Year>  <Month>07</Month>  <Day>29</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000904"" MajorTopicYN=""N"">Antibiotics, Antitubercular</DescriptorName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000494"" MajorTopicYN=""Y"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001665"" MajorTopicYN=""N"">Binding Sites</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018981"" MajorTopicYN=""N"">Congenital Disorders of Glycosylation</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004791"" MajorTopicYN=""N"">Enzyme Inhibitors</DescriptorName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000494"" MajorTopicYN=""Y"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D057809"" MajorTopicYN=""N"">HEK293 Cells</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D056945"" MajorTopicYN=""N"">Hep G2 Cells</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D050356"" MajorTopicYN=""N"">Lipid Metabolism</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D062105"" MajorTopicYN=""N"">Molecular Docking Simulation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009154"" MajorTopicYN=""N"">Mutation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017351"" MajorTopicYN=""N"">N-Acetylglucosaminyltransferases</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""N"">antagonists &amp; inhibitors</QualifierName>    <QualifierName UI=""Q000737"" MajorTopicYN=""Y"">chemistry</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011485"" MajorTopicYN=""N"">Protein Binding</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D061987"" MajorTopicYN=""N"">Sf9 Cells</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018411"" MajorTopicYN=""N"">Spodoptera</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014415"" MajorTopicYN=""N"">Tunicamycin</DescriptorName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014535"" MajorTopicYN=""N"">Uridine Diphosphate Glucuronic Acid</DescriptorName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>175</Volume>    <Issue>4</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>01</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Dong</LastName>    <ForeName>Yin Yao</ForeName>    <Initials>YY</Initials>    <AffiliationInfo>      <Affiliation>Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Hua</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Chemistry Research Laboratory, University of Oxford, Oxford, OX1 3TA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pike</LastName>    <ForeName>Ashley C W</ForeName>    <Initials>ACW</Initials>    <AffiliationInfo>      <Affiliation>Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cochrane</LastName>    <ForeName>Stephen A</ForeName>    <Initials>SA</Initials>    <AffiliationInfo>      <Affiliation>Chemistry Research Laboratory, University of Oxford, Oxford, OX1 3TA, UK; School of Chemistry and Chemical Engineering, Queen's University, Belfast, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hamedzadeh</LastName>    <ForeName>Sadra</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Chemistry Research Laboratory, University of Oxford, Oxford, OX1 3TA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wyszyski</LastName>    <ForeName>Filip J</ForeName>    <Initials>FJ</Initials>    <AffiliationInfo>      <Affiliation>Chemistry Research Laboratory, University of Oxford, Oxford, OX1 3TA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bushell</LastName>    <ForeName>Simon R</ForeName>    <Initials>SR</Initials>    <AffiliationInfo>      <Affiliation>Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Royer</LastName>    <ForeName>Sylvain F</ForeName>    <Initials>SF</Initials>    <AffiliationInfo>      <Affiliation>Chemistry Research Laboratory, University of Oxford, Oxford, OX1 3TA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Widdick</LastName>    <ForeName>David A</ForeName>    <Initials>DA</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular Microbiology, John Innes Centre, Norwich, NR4 7UH, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sajid</LastName>    <ForeName>Andaleeb</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Boshoff</LastName>    <ForeName>Helena I</ForeName>    <Initials>HI</Initials>    <AffiliationInfo>      <Affiliation>Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Park</LastName>    <ForeName>Yumi</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lucas</LastName>    <ForeName>Ricardo</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Chemistry Research Laboratory, University of Oxford, Oxford, OX1 3TA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Wei-Min</ForeName>    <Initials>WM</Initials>    <AffiliationInfo>      <Affiliation>Chemistry Research Laboratory, University of Oxford, Oxford, OX1 3TA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lee</LastName>    <ForeName>Seung Seo</ForeName>    <Initials>SS</Initials>    <AffiliationInfo>      <Affiliation>Chemistry Research Laboratory, University of Oxford, Oxford, OX1 3TA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Machida</LastName>    <ForeName>Takuya</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Chemistry Research Laboratory, University of Oxford, Oxford, OX1 3TA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Minall</LastName>    <ForeName>Leanne</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Chemistry Research Laboratory, University of Oxford, Oxford, OX1 3TA, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mehmood</LastName>    <ForeName>Shahid</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Chemistry, Oxford, OX1 3QZ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Belaya</LastName>    <ForeName>Katsiaryna</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Neurosciences Group, Nuffield Department of Clinical Neuroscience, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Wei-Wei</ForeName>    <Initials>WW</Initials>    <AffiliationInfo>      <Affiliation>Neurosciences Group, Nuffield Department of Clinical Neuroscience, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chu</LastName>    <ForeName>Amy</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Shrestha</LastName>    <ForeName>Leela</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mukhopadhyay</LastName>    <ForeName>Shubhashish M M</ForeName>    <Initials>SMM</Initials>    <AffiliationInfo>      <Affiliation>Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Strain-Damerell</LastName>    <ForeName>Claire</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chalk</LastName>    <ForeName>Rod</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Burgess-Brown</LastName>    <ForeName>Nicola A</ForeName>    <Initials>NA</Initials>    <AffiliationInfo>      <Affiliation>Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bibb</LastName>    <ForeName>Mervyn J</ForeName>    <Initials>MJ</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular Microbiology, John Innes Centre, Norwich, NR4 7UH, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Barry Iii</LastName>    <ForeName>Clifton E</ForeName>    <Initials>CE</Initials>    <AffiliationInfo>      <Affiliation>Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Robinson</LastName>    <ForeName>Carol V</ForeName>    <Initials>CV</Initials>    <AffiliationInfo>      <Affiliation>Department of Chemistry, Oxford, OX1 3QZ, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Beeson</LastName>    <ForeName>David</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Neurosciences Group, Nuffield Department of Clinical Neuroscience, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Davis</LastName>    <ForeName>Benjamin G</ForeName>    <Initials>BG</Initials>    <AffiliationInfo>      <Affiliation>Chemistry Research Laboratory, University of Oxford, Oxford, OX1 3TA, UK. Electronic address: Ben.Davis@chem.ox.ac.uk.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Carpenter</LastName>    <ForeName>Elisabeth P</ForeName>    <Initials>EP</Initials>    <AffiliationInfo>      <Affiliation>Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK. Electronic address: liz.carpenter@sgc.ox.ac.uk.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052060"">Research Support, N.I.H., Intramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>ZIA AI000693-26</GrantID>    <Acronym>ImNIH</Acronym>    <Agency>Intramural NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>BB/J006637/1</GrantID>    <Acronym>BB_</Acronym>    <Agency>Biotechnology and Biological Sciences Research Council</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>110270/A/15/Z</GrantID>    <Acronym>WT_</Acronym>    <Agency>Wellcome Trust</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>WT084655MA</GrantID>    <Acronym>WT_</Acronym>    <Agency>Wellcome Trust</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>MR/M006824/1</GrantID>    <Acronym>MRC_</Acronym>    <Agency>Medical Research Council</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>BB/J009725/1</GrantID>    <Acronym>BB_</Acronym>    <Agency>Biotechnology and Biological Sciences Research Council</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>106169/Z/14/Z</GrantID>    <Acronym>WT_</Acronym>    <Agency>Wellcome Trust</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>BB/J004561/1</GrantID>    <Acronym>BB_</Acronym>    <Agency>Biotechnology and Biological Sciences Research Council</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>MR/N020413/1</GrantID>    <Acronym>MRC_</Acronym>    <Agency>Medical Research Council</Agency>    <Country>United Kingdom</Country>  </Grant></GrantList>"
30388455,<DateCompleted>  <Year>2019</Year>  <Month>07</Month>  <Day>29</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000368"" MajorTopicYN=""N"">Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000369"" MajorTopicYN=""N"">Aged, 80 and over</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000970"" MajorTopicYN=""N"">Antineoplastic Agents</DescriptorName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D045744"" MajorTopicYN=""N"">Cell Line, Tumor</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051358"" MajorTopicYN=""N"">Cyclin-Dependent Kinase 4</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""Y"">antagonists &amp; inhibitors</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051361"" MajorTopicYN=""N"">Cyclin-Dependent Kinase 6</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""Y"">antagonists &amp; inhibitors</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007167"" MajorTopicYN=""N"">Immunotherapy</DescriptorName>    <QualifierName UI=""Q000379"" MajorTopicYN=""N"">methods</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008545"" MajorTopicYN=""N"">Melanoma</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""N"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008810"" MajorTopicYN=""N"">Mice, Inbred C57BL</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D061026"" MajorTopicYN=""N"">Programmed Cell Death 1 Receptor</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""N"">antagonists &amp; inhibitors</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D047428"" MajorTopicYN=""N"">Protein Kinase Inhibitors</DescriptorName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013601"" MajorTopicYN=""N"">T-Lymphocytes</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019139"" MajorTopicYN=""Y"">Tumor Escape</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>175</Volume>    <Issue>4</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>01</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Jerby-Arnon</LastName>    <ForeName>Livnat</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Shah</LastName>    <ForeName>Parin</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cuoco</LastName>    <ForeName>Michael S</ForeName>    <Initials>MS</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rodman</LastName>    <ForeName>Christopher</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Su</LastName>    <ForeName>Mei-Ju</ForeName>    <Initials>MJ</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Melms</LastName>    <ForeName>Johannes C</ForeName>    <Initials>JC</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Leeson</LastName>    <ForeName>Rachel</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kanodia</LastName>    <ForeName>Abhay</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mei</LastName>    <ForeName>Shaolin</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lin</LastName>    <ForeName>Jia-Ren</ForeName>    <Initials>JR</Initials>    <AffiliationInfo>      <Affiliation>Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Shu</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rabasha</LastName>    <ForeName>Bokang</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>David</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Gao</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Molecular &amp; Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Margolais</LastName>    <ForeName>Claire</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ashenberg</LastName>    <ForeName>Orr</ForeName>    <Initials>O</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ott</LastName>    <ForeName>Patrick A</ForeName>    <Initials>PA</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Buchbinder</LastName>    <ForeName>Elizabeth I</ForeName>    <Initials>EI</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Haq</LastName>    <ForeName>Rizwan</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hodi</LastName>    <ForeName>F Stephen</ForeName>    <Initials>FS</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Boland</LastName>    <ForeName>Genevieve M</ForeName>    <Initials>GM</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sullivan</LastName>    <ForeName>Ryan J</ForeName>    <Initials>RJ</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Frederick</LastName>    <ForeName>Dennie T</ForeName>    <Initials>DT</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Miao</LastName>    <ForeName>Benchun</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Moll</LastName>    <ForeName>Tabea</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Flaherty</LastName>    <ForeName>Keith T</ForeName>    <Initials>KT</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Herlyn</LastName>    <ForeName>Meenhard</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Molecular &amp; Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jenkins</LastName>    <ForeName>Russell W</ForeName>    <Initials>RW</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Massachusetts General Hospital Cancer Center, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Thummalapalli</LastName>    <ForeName>Rohit</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kowalczyk</LastName>    <ForeName>Monika S</ForeName>    <Initials>MS</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA; Celsius Therapeutics, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Caadas</LastName>    <ForeName>Israel</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Schilling</LastName>    <ForeName>Bastian</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium, Essen, Germany; Department of Dermatology, Venereology and Allergology, University Hospital Wrzburg, Wrzburg, Germany.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cartwright</LastName>    <ForeName>Adam N R</ForeName>    <Initials>ANR</Initials>    <AffiliationInfo>      <Affiliation>Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Luoma</LastName>    <ForeName>Adrienne M</ForeName>    <Initials>AM</Initials>    <AffiliationInfo>      <Affiliation>Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Malu</LastName>    <ForeName>Shruti</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hwu</LastName>    <ForeName>Patrick</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bernatchez</LastName>    <ForeName>Chantale</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Forget</LastName>    <ForeName>Marie-Andre</ForeName>    <Initials>MA</Initials>    <AffiliationInfo>      <Affiliation>Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Barbie</LastName>    <ForeName>David A</ForeName>    <Initials>DA</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Shalek</LastName>    <ForeName>Alex K</ForeName>    <Initials>AK</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tirosh</LastName>    <ForeName>Itay</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sorger</LastName>    <ForeName>Peter K</ForeName>    <Initials>PK</Initials>    <AffiliationInfo>      <Affiliation>Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wucherpfennig</LastName>    <ForeName>Kai</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Van Allen</LastName>    <ForeName>Eliezer M</ForeName>    <Initials>EM</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Schadendorf</LastName>    <ForeName>Dirk</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium, Essen, Germany.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Johnson</LastName>    <ForeName>Bruce E</ForeName>    <Initials>BE</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rotem</LastName>    <ForeName>Asaf</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rozenblatt-Rosen</LastName>    <ForeName>Orit</ForeName>    <Initials>O</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Garraway</LastName>    <ForeName>Levi A</ForeName>    <Initials>LA</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA; Ludwig Center for Cancer Research at Harvard, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yoon</LastName>    <ForeName>Charles H</ForeName>    <Initials>CH</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Department of Surgical Oncology, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Izar</LastName>    <ForeName>Benjamin</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA; Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Ludwig Center for Cancer Research at Harvard, Boston, MA, USA. Electronic address: benjamin_izar@dfci.harvard.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Regev</LastName>    <ForeName>Aviv</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA; Ludwig Center for Cancer Research at MIT, Boston, MA, USA; Massachusetts Institute of Technology, Department of Biology, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>U24 CA180922</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA173750</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P30 CA010815</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>K08 CA222663</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <Acronym>HHMI</Acronym>    <Agency>Howard Hughes Medical Institute</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P30 CA014051</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R33 CA202820</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>T32 CA207021</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30388456,<DateCompleted>  <Year>2019</Year>  <Month>07</Month>  <Day>29</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D061067"" MajorTopicYN=""N"">Antibodies, Monoclonal, Humanized</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015703"" MajorTopicYN=""N"">Antigens, CD</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000074322"" MajorTopicYN=""N"">Antineoplastic Agents, Immunological</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001081"" MajorTopicYN=""N"">Apyrase</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""N"">antagonists &amp; inhibitors</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018414"" MajorTopicYN=""N"">CD8-Positive T-Lymphocytes</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D045744"" MajorTopicYN=""N"">Cell Line, Tumor</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007167"" MajorTopicYN=""N"">Immunotherapy</DescriptorName>    <QualifierName UI=""Q000379"" MajorTopicYN=""Y"">methods</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017493"" MajorTopicYN=""N"">Leukocyte Common Antigens</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""N"">antagonists &amp; inhibitors</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008545"" MajorTopicYN=""N"">Melanoma</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""N"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008807"" MajorTopicYN=""N"">Mice, Inbred BALB C</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008810"" MajorTopicYN=""N"">Mice, Inbred C57BL</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051822"" MajorTopicYN=""N"">T Cell Transcription Factor 1</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D059467"" MajorTopicYN=""Y"">Transcriptome</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>175</Volume>    <Issue>4</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>01</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Sade-Feldman</LastName>    <ForeName>Moshe</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yizhak</LastName>    <ForeName>Keren</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bjorgaard</LastName>    <ForeName>Stacey L</ForeName>    <Initials>SL</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ray</LastName>    <ForeName>John P</ForeName>    <Initials>JP</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>de Boer</LastName>    <ForeName>Carl G</ForeName>    <Initials>CG</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jenkins</LastName>    <ForeName>Russell W</ForeName>    <Initials>RW</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lieb</LastName>    <ForeName>David J</ForeName>    <Initials>DJ</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Jonathan H</ForeName>    <Initials>JH</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Pathology, Massachusetts General Hospital, HMS, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Frederick</LastName>    <ForeName>Dennie T</ForeName>    <Initials>DT</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Barzily-Rokni</LastName>    <ForeName>Michal</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Freeman</LastName>    <ForeName>Samuel S</ForeName>    <Initials>SS</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Biomedical Informatics, HMS, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Reuben</LastName>    <ForeName>Alexandre</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hoover</LastName>    <ForeName>Paul J</ForeName>    <Initials>PJ</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Brigham &amp; Women's Hospital, Division of Rheumatology, Immunology and Allergy, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Villani</LastName>    <ForeName>Alexandra-Chlo</ForeName>    <Initials>AC</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ivanova</LastName>    <ForeName>Elena</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA; Belfer Center for Applied Cancer Science, Dana Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Portell</LastName>    <ForeName>Andrew</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA; Belfer Center for Applied Cancer Science, Dana Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lizotte</LastName>    <ForeName>Patrick H</ForeName>    <Initials>PH</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA; Belfer Center for Applied Cancer Science, Dana Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Aref</LastName>    <ForeName>Amir R</ForeName>    <Initials>AR</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA; Belfer Center for Applied Cancer Science, Dana Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Eliane</LastName>    <ForeName>Jean-Pierre</ForeName>    <Initials>JP</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology, Massachusetts General Hospital, HMS, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hammond</LastName>    <ForeName>Marc R</ForeName>    <Initials>MR</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Vitzthum</LastName>    <ForeName>Hans</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Blackmon</LastName>    <ForeName>Shauna M</ForeName>    <Initials>SM</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Li</LastName>    <ForeName>Bo</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Virology, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gopalakrishnan</LastName>    <ForeName>Vancheswaran</ForeName>    <Initials>V</Initials>    <AffiliationInfo>      <Affiliation>Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Reddy</LastName>    <ForeName>Sangeetha M</ForeName>    <Initials>SM</Initials>    <AffiliationInfo>      <Affiliation>Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cooper</LastName>    <ForeName>Zachary A</ForeName>    <Initials>ZA</Initials>    <AffiliationInfo>      <Affiliation>Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Paweletz</LastName>    <ForeName>Cloud P</ForeName>    <Initials>CP</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA; Belfer Center for Applied Cancer Science, Dana Farber Cancer Institute, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Barbie</LastName>    <ForeName>David A</ForeName>    <Initials>DA</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Stemmer-Rachamimov</LastName>    <ForeName>Anat</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology, Massachusetts General Hospital, HMS, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Flaherty</LastName>    <ForeName>Keith T</ForeName>    <Initials>KT</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wargo</LastName>    <ForeName>Jennifer A</ForeName>    <Initials>JA</Initials>    <AffiliationInfo>      <Affiliation>Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Boland</LastName>    <ForeName>Genevieve M</ForeName>    <Initials>GM</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Department of Surgery, Massachusetts General Hospital, HMS, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sullivan</LastName>    <ForeName>Ryan J</ForeName>    <Initials>RJ</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Getz</LastName>    <ForeName>Gad</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Pathology, Massachusetts General Hospital, HMS, Boston, MA, USA; Department of Pathology, Harvard Medical School, Boston, MA, USA. Electronic address: gadgetz@broadinstitute.org.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hacohen</LastName>    <ForeName>Nir</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA. Electronic address: nhacohen@mgh.harvard.edu.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>U54 HG003067</GrantID>    <Acronym>HG</Acronym>    <Agency>NHGRI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>S10 OD016372</GrantID>    <Acronym>OD</Acronym>    <Agency>NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U01 CA214381</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>S10 OD012027</GrantID>    <Acronym>OD</Acronym>    <Agency>NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U54 CA224068</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>S10 RR023440</GrantID>    <Acronym>RR</Acronym>    <Agency>NCRR NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>T32 CA207021</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA208756</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>F32 AI129249</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA190394</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>S10 RR020936</GrantID>    <Acronym>RR</Acronym>    <Agency>NCRR NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30392956,<DateCompleted>  <Year>2019</Year>  <Month>08</Month>  <Day>27</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020170"" MajorTopicYN=""N"">Caspase 1</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020169"" MajorTopicYN=""N"">Caspases</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D053471"" MajorTopicYN=""N"">Caspases, Initiator</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007113"" MajorTopicYN=""Y"">Immunity, Innate</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058847"" MajorTopicYN=""N"">Inflammasomes</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020382"" MajorTopicYN=""N"">Interleukin-18</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D053583"" MajorTopicYN=""N"">Interleukin-1beta</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008070"" MajorTopicYN=""N"">Lipopolysaccharides</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008089"" MajorTopicYN=""N"">Listeria monocytogenes</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008088"" MajorTopicYN=""N"">Listeriosis</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018345"" MajorTopicYN=""N"">Mice, Knockout</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011956"" MajorTopicYN=""N"">Receptors, Cell Surface</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013682"" MajorTopicYN=""N"">Teichoic Acids</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>175</Volume>    <Issue>6</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>29</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: hhara@med.umich.edu.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Hara</LastName>    <ForeName>Hideki</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: hhara@med.umich.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Seregin</LastName>    <ForeName>Sergey S</ForeName>    <Initials>SS</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yang</LastName>    <ForeName>Dahai</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fukase</LastName>    <ForeName>Koichi</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Department of Chemistry, Graduate School of Science, Osaka University, Toyonaka, Osaka 560-0043, Japan.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chamaillard</LastName>    <ForeName>Mathias</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>CIIL-Centre d'Infection et d'Immunit de Lille, Universit de Lille, CNRS, Inserm, CHRU Lille, Institut Pasteur de Lille, U1019-UMR 8204, F-59000, Lille, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Alnemri</LastName>    <ForeName>Emad S</ForeName>    <Initials>ES</Initials>    <AffiliationInfo>      <Affiliation>Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Inohara</LastName>    <ForeName>Naohiro</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Grace Y</ForeName>    <Initials>GY</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nez</LastName>    <ForeName>Gabriel</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: gabriel.nunez@umich.edu.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>R01 DK091191</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>F32 CA200144</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 AR055398</GrantID>    <Acronym>AR</Acronym>    <Agency>NIAMS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA166879</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R37 AI063331</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 AI063331</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30392959,<DateCompleted>  <Year>2019</Year>  <Month>08</Month>  <Day>27</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000225"" MajorTopicYN=""N"">Adenine</DescriptorName>    <QualifierName UI=""Q000031"" MajorTopicYN=""Y"">analogs &amp; derivatives</QualifierName>    <QualifierName UI=""Q000032"" MajorTopicYN=""N"">analysis</QualifierName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000368"" MajorTopicYN=""N"">Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000071498"" MajorTopicYN=""N"">AlkB Homolog 1, Histone H2a Dioxygenase</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""N"">antagonists &amp; inhibitors</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001253"" MajorTopicYN=""N"">Astrocytes</DescriptorName>    <QualifierName UI=""Q000166"" MajorTopicYN=""N"">cytology</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001932"" MajorTopicYN=""N"">Brain Neoplasms</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000401"" MajorTopicYN=""N"">mortality</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015687"" MajorTopicYN=""N"">Cell Hypoxia</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002648"" MajorTopicYN=""N"">Child</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019175"" MajorTopicYN=""Y"">DNA Methylation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D057890"" MajorTopicYN=""N"">Epigenomics</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005909"" MajorTopicYN=""N"">Glioblastoma</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000401"" MajorTopicYN=""N"">mortality</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006570"" MajorTopicYN=""N"">Heterochromatin</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006657"" MajorTopicYN=""N"">Histones</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D053208"" MajorTopicYN=""N"">Kaplan-Meier Estimate</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014411"" MajorTopicYN=""N"">Neoplastic Stem Cells</DescriptorName>    <QualifierName UI=""Q000166"" MajorTopicYN=""N"">cytology</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D034622"" MajorTopicYN=""N"">RNA Interference</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D034741"" MajorTopicYN=""N"">RNA, Small Interfering</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016159"" MajorTopicYN=""N"">Tumor Suppressor Protein p53</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>175</Volume>    <Issue>5</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>15</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Xie</LastName>    <ForeName>Qi</ForeName>    <Initials>Q</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wu</LastName>    <ForeName>Tao P</ForeName>    <Initials>TP</Initials>    <AffiliationInfo>      <Affiliation>Department of Genetics and Yale Stem Cell Center, Yale School of Medicine, New Haven, CT 06520, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gimple</LastName>    <ForeName>Ryan C</ForeName>    <Initials>RC</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, USA; Department of Pathology, Case Western Reserve University, Cleveland, OH 44120, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Li</LastName>    <ForeName>Zheng</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Department of Genetics and Yale Stem Cell Center, Yale School of Medicine, New Haven, CT 06520, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Prager</LastName>    <ForeName>Briana C</ForeName>    <Initials>BC</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, USA; Department of Pathology, Case Western Reserve University, Cleveland, OH 44120, USA; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH 44195, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wu</LastName>    <ForeName>Qiulian</ForeName>    <Initials>Q</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yu</LastName>    <ForeName>Yang</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Chemistry, University of California, Riverside, Riverside, CA 92521, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Pengcheng</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Department of Chemistry, University of California, Riverside, Riverside, CA 92521, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Yinsheng</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Chemistry, University of California, Riverside, Riverside, CA 92521, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gorkin</LastName>    <ForeName>David U</ForeName>    <Initials>DU</Initials>    <AffiliationInfo>      <Affiliation>Center for Epigenomics, Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Cheng</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Center for Epigenomics, Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dowiak</LastName>    <ForeName>Alexis V</ForeName>    <Initials>AV</Initials>    <AffiliationInfo>      <Affiliation>Center for Epigenomics, Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lin</LastName>    <ForeName>Kaixuan</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Department of Genetics and Yale Stem Cell Center, Yale School of Medicine, New Haven, CT 06520, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zeng</LastName>    <ForeName>Chun</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Departments of Pediatrics and Cellular and Molecular Medicine, Pediatric Diabetes Research Center, University of California, San Diego, La Jolla, CA, 92093, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sui</LastName>    <ForeName>Yinghui</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Departments of Pediatrics and Cellular and Molecular Medicine, Pediatric Diabetes Research Center, University of California, San Diego, La Jolla, CA, 92093, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kim</LastName>    <ForeName>Leo J Y</ForeName>    <Initials>LJY</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, USA; Department of Pathology, Case Western Reserve University, Cleveland, OH 44120, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Miller</LastName>    <ForeName>Tyler E</ForeName>    <Initials>TE</Initials>    <AffiliationInfo>      <Affiliation>Department of Pathology, Case Western Reserve University, Cleveland, OH 44120, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jiang</LastName>    <ForeName>Li</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lee</LastName>    <ForeName>Christine H</ForeName>    <Initials>CH</Initials>    <AffiliationInfo>      <Affiliation>Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44195, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Huang</LastName>    <ForeName>Zhi</ForeName>    <Initials>Z</Initials>    <AffiliationInfo>      <Affiliation>Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fang</LastName>    <ForeName>Xiaoguang</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhai</LastName>    <ForeName>Kui</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mack</LastName>    <ForeName>Stephen C</ForeName>    <Initials>SC</Initials>    <AffiliationInfo>      <Affiliation>Department of Pediatrics, Division of Hematology and Oncology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sander</LastName>    <ForeName>Maike</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Departments of Pediatrics and Cellular and Molecular Medicine, Pediatric Diabetes Research Center, University of California, San Diego, La Jolla, CA, 92093, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bao</LastName>    <ForeName>Shideng</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kerstetter-Fogle</LastName>    <ForeName>Amber E</ForeName>    <Initials>AE</Initials>    <AffiliationInfo>      <Affiliation>Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA; Department of Neurological Surgery, University Hospitals - Cleveland Medical Center, Cleveland, OH 44106, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sloan</LastName>    <ForeName>Andrew E</ForeName>    <Initials>AE</Initials>    <AffiliationInfo>      <Affiliation>Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA; Department of Neurological Surgery, University Hospitals - Cleveland Medical Center, Cleveland, OH 44106, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Xiao</LastName>    <ForeName>Andrew Z</ForeName>    <Initials>AZ</Initials>    <AffiliationInfo>      <Affiliation>Department of Genetics and Yale Stem Cell Center, Yale School of Medicine, New Haven, CT 06520, USA. Electronic address: andrew.xiao@yale.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rich</LastName>    <ForeName>Jeremy N</ForeName>    <Initials>JN</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, USA; Department of Neurosciences, University of California, San Diego, School of Medicine, La Jolla, CA 92037, USA. Electronic address: drjeremyrich@gmail.com.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType>  <PublicationType UI=""D013486"">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>R01 CA171652</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R35 CA197718</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 NS089272</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>F30 CA217066</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 NS087913</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>F30 CA217065</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA184090</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 DK078803</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 DK068471</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 NS099175</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 NS091080</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>F30 CA203101</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA169117</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 GM114205</GrantID>    <Acronym>GM</Acronym>    <Agency>NIGMS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA154130</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 NS103434</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>DP3 DK112155</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>T32 GM007250</GrantID>    <Acronym>GM</Acronym>    <Agency>NIGMS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>UC4 DK104202</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 CA187780</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30398529,<DateCompleted>  <Year>2019</Year>  <Month>09</Month>  <Day>03</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D002487"" MajorTopicYN=""N"">Centers for Disease Control and Prevention, U.S.</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058872"" MajorTopicYN=""N"">Epidemics</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006266"" MajorTopicYN=""N"">Health Education</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006291"" MajorTopicYN=""Y"">Health Policy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000070516"" MajorTopicYN=""N"">Intersectoral Collaboration</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007857"" MajorTopicYN=""N"">Leadership</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009293"" MajorTopicYN=""N"">Opioid-Related Disorders</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>    <QualifierName UI=""Q000453"" MajorTopicYN=""Y"">epidemiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011159"" MajorTopicYN=""N"">Population Surveillance</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"" Type=""Geographic"">United States</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1539-3704</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>169</Volume>    <Issue>10</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>20</Day>    </PubDate>  </JournalIssue>  <Title>Annals of internal medicine</Title>  <ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Vermont Department of Health, Burlington, Vermont (M.L.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Levine</LastName>    <ForeName>Mark</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Vermont Department of Health, Burlington, Vermont (M.L.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fraser</LastName>    <ForeName>Michael</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Association of State and Territorial Health Officials, Arlington, Virginia (M.F.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30398581,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>16</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001766"" MajorTopicYN=""N"">Blindness</DescriptorName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D065150"" MajorTopicYN=""Y"">Cellular Reprogramming</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D063928"" MajorTopicYN=""N"">Ependymoglial Cells</DescriptorName>    <QualifierName UI=""Q000166"" MajorTopicYN=""Y"">cytology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018014"" MajorTopicYN=""N"">Gene Transfer Techniques</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012038"" MajorTopicYN=""Y"">Regeneration</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012160"" MajorTopicYN=""N"">Retina</DescriptorName>    <QualifierName UI=""Q000166"" MajorTopicYN=""Y"">cytology</QualifierName>    <QualifierName UI=""Q000502"" MajorTopicYN=""N"">physiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013234"" MajorTopicYN=""N"">Stem Cells</DescriptorName>    <QualifierName UI=""Q000502"" MajorTopicYN=""N"">physiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1538-3598</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>320</Volume>    <Issue>17</Issue>    <PubDate>      <Year>2018</Year>      <Month>Nov</Month>      <Day>06</Day>    </PubDate>  </JournalIssue>  <Title>JAMA</Title>  <ISOAbbreviation>JAMA</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Hampton</LastName>    <ForeName>Tracy</ForeName>    <Initials>T</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30398591,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>16</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D015444"" MajorTopicYN=""N"">Exercise</DescriptorName>    <QualifierName UI=""Q000502"" MajorTopicYN=""N"">physiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005221"" MajorTopicYN=""N"">Fatigue</DescriptorName>    <QualifierName UI=""Q000266"" MajorTopicYN=""Y"">history</QualifierName>    <QualifierName UI=""Q000503"" MajorTopicYN=""N"">physiopathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D049673"" MajorTopicYN=""N"">History, 20th Century</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008889"" MajorTopicYN=""N"">Military Personnel</DescriptorName>    <QualifierName UI=""Q000266"" MajorTopicYN=""Y"">history</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010807"" MajorTopicYN=""N"">Physical Endurance</DescriptorName>    <QualifierName UI=""Q000502"" MajorTopicYN=""N"">physiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005082"" MajorTopicYN=""N"">Physical Exertion</DescriptorName>    <QualifierName UI=""Q000502"" MajorTopicYN=""Y"">physiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1538-3598</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>320</Volume>    <Issue>17</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>06</Day>    </PubDate>  </JournalIssue>  <Title>JAMA</Title>  <ISOAbbreviation>JAMA</ISOAbbreviation></Journal>",NA,NA,"<PublicationTypeList>  <PublicationType UI=""D016419"">Classical Article</PublicationType>  <PublicationType UI=""D016456"">Historical Article</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30401435,<DateCompleted>  <Year>2019</Year>  <Month>07</Month>  <Day>29</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002478"" MajorTopicYN=""N"">Cells, Cultured</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003924"" MajorTopicYN=""N"">Diabetes Mellitus, Type 2</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>    <QualifierName UI=""Q000382"" MajorTopicYN=""N"">microbiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000069196"" MajorTopicYN=""Y"">Gastrointestinal Microbiome</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D057809"" MajorTopicYN=""N"">HEK293 Cells</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006639"" MajorTopicYN=""N"">Histidine</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007093"" MajorTopicYN=""N"">Imidazoles</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007328"" MajorTopicYN=""N"">Insulin</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008099"" MajorTopicYN=""N"">Liver</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000076222"" MajorTopicYN=""N"">Mechanistic Target of Rapamycin Complex 1</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008810"" MajorTopicYN=""N"">Mice, Inbred C57BL</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000071456"" MajorTopicYN=""N"">Sequestosome-1 Protein</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015398"" MajorTopicYN=""Y"">Signal Transduction</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D048051"" MajorTopicYN=""N"">p38 Mitogen-Activated Protein Kinases</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>175</Volume>    <Issue>4</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>01</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Koh</LastName>    <ForeName>Ara</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Molinaro</LastName>    <ForeName>Antonio</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sthlman</LastName>    <ForeName>Marcus</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Khan</LastName>    <ForeName>Muhammad Tanweer</ForeName>    <Initials>MT</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Schmidt</LastName>    <ForeName>Caroline</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Manners-Holm</LastName>    <ForeName>Louise</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wu</LastName>    <ForeName>Hao</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Carreras</LastName>    <ForeName>Alba</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jeong</LastName>    <ForeName>Heeyoon</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Department of Life Sciences, Pohang University of Science and Technology, Pohang 37673, Republic of Korea.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Olofsson</LastName>    <ForeName>Louise E</ForeName>    <Initials>LE</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bergh</LastName>    <ForeName>Per-Olof</ForeName>    <Initials>PO</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gerdes</LastName>    <ForeName>Victor</ForeName>    <Initials>V</Initials>    <AffiliationInfo>      <Affiliation>Slotervaart Hospital, Amsterdam, the Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hartstra</LastName>    <ForeName>Annick</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>de Brauw</LastName>    <ForeName>Maurits</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Slotervaart Hospital, Amsterdam, the Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Perkins</LastName>    <ForeName>Rosie</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nieuwdorp</LastName>    <ForeName>Max</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; VU University Medical Center, Free University Amsterdam, Amsterdam, the Netherlands.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bergstrm</LastName>    <ForeName>Gran</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bckhed</LastName>    <ForeName>Fredrik</ForeName>    <Initials>F</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden; Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address: fredrik@wlab.gu.se.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>",NA
30401691,<DateCompleted>  <Year>2019</Year>  <Month>02</Month>  <Day>25</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D064420"" MajorTopicYN=""N"">Drug-Related Side Effects and Adverse Reactions</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017410"" MajorTopicYN=""N"">Practice Guidelines as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010818"" MajorTopicYN=""Y"">Practice Patterns, Physicians'</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055553"" MajorTopicYN=""N"">Prescription Drugs</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>Nov</Month>      <Day>06</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham B18 7QH, UK r.e.ferner@bham.ac.uk.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Ferner</LastName>    <ForeName>Robin E</ForeName>    <Initials>RE</Initials>    <AffiliationInfo>      <Affiliation>West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham B18 7QH, UK r.e.ferner@bham.ac.uk.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>McGettigan</LastName>    <ForeName>Patricia</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30401700,<DateCompleted>  <Year>2019</Year>  <Month>03</Month>  <Day>21</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000305"" MajorTopicYN=""N"">Adrenal Cortex Hormones</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058666"" MajorTopicYN=""N"">Adrenergic beta-2 Receptor Agonists</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001993"" MajorTopicYN=""N"">Bronchodilator Agents</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004359"" MajorTopicYN=""N"">Drug Therapy, Combination</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005541"" MajorTopicYN=""N"">Forced Expiratory Volume</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018727"" MajorTopicYN=""N"">Muscarinic Antagonists</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D029424"" MajorTopicYN=""N"">Pulmonary Disease, Chronic Obstructive</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""Y"">drug therapy</QualifierName>    <QualifierName UI=""Q000503"" MajorTopicYN=""N"">physiopathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011788"" MajorTopicYN=""N"">Quality of Life</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>Nov</Month>      <Day>06</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Laboratory of Physiological Sciences and Department of Pharmacy of the Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, China.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Zheng</LastName>    <ForeName>Yayuan</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Laboratory of Physiological Sciences and Department of Pharmacy of the Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhu</LastName>    <ForeName>Jianhong</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Pharmacy, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Yuyu</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Pharmacology, Guangdong Medical University, Zhanjiang, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lai</LastName>    <ForeName>Weiguang</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>Department of Respiratory Medicine, Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, No 57, South of Renmin Avenue, Zhanjiang 524001, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lin</LastName>    <ForeName>Chunyu</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Respiratory Medicine, Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, No 57, South of Renmin Avenue, Zhanjiang 524001, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Qiu</LastName>    <ForeName>Kaifen</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Department of Pharmacy, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wu</LastName>    <ForeName>Junyan</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Pharmacy, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yao</LastName>    <ForeName>Weimin</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>Department of Respiratory Medicine, Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, No 57, South of Renmin Avenue, Zhanjiang 524001, China yaoweimin2014@yeah.net.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D017418"">Meta-Analysis</PublicationType>  <PublicationType UI=""D000078182"">Systematic Review</PublicationType></PublicationTypeList>",NA
30403945,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>16</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D048128"" MajorTopicYN=""N"">Casein Kinase Ialpha</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""Y"">antagonists &amp; inhibitors</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D042863"" MajorTopicYN=""N"">Cyclin-Dependent Kinase 9</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""Y"">antagonists &amp; inhibitors</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018844"" MajorTopicYN=""N"">Cyclin-Dependent Kinases</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""Y"">antagonists &amp; inhibitors</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004195"" MajorTopicYN=""N"">Disease Models, Animal</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006410"" MajorTopicYN=""N"">Hematopoiesis</DescriptorName>    <QualifierName UI=""Q000187"" MajorTopicYN=""N"">drug effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015470"" MajorTopicYN=""N"">Leukemia, Myeloid, Acute</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""Y"">drug therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014407"" MajorTopicYN=""N"">Tumor Cells, Cultured</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>19</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>08</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the Dana-Farber Cancer Institute, Boston (B.L.E.); and the Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany (J.K.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Ebert</LastName>    <ForeName>Benjamin L</ForeName>    <Initials>BL</Initials>    <AffiliationInfo>      <Affiliation>From the Dana-Farber Cancer Institute, Boston (B.L.E.); and the Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany (J.K.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Krnke</LastName>    <ForeName>Jan</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>From the Dana-Farber Cancer Institute, Boston (B.L.E.); and the Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany (J.K.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>P01 CA066996</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 HL082945</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30403946,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>16</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000900"" MajorTopicYN=""N"">Anti-Bacterial Agents</DescriptorName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D024881"" MajorTopicYN=""Y"">Drug Resistance, Bacterial</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006069"" MajorTopicYN=""N"">Gonorrhea</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""N"">complications</QualifierName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>    <QualifierName UI=""Q000453"" MajorTopicYN=""Y"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017048"" MajorTopicYN=""N"">Health Care Costs</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009344"" MajorTopicYN=""N"">Neisseria gonorrhoeae</DescriptorName>    <QualifierName UI=""Q000187"" MajorTopicYN=""Y"">drug effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"" Type=""Geographic"">United States</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055815"" MajorTopicYN=""N"">Young Adult</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>19</Issue>    <PubDate>      <Year>2018</Year>      <Month>Nov</Month>      <Day>08</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the Division of Disease Control, New York City Department of Health and Mental Hygiene, New York (S.B., D.C.D.); and the Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta (S.B.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Blank</LastName>    <ForeName>Susan</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Disease Control, New York City Department of Health and Mental Hygiene, New York (S.B., D.C.D.); and the Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta (S.B.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Daskalakis</LastName>    <ForeName>Demetre C</ForeName>    <Initials>DC</Initials>    <AffiliationInfo>      <Affiliation>From the Division of Disease Control, New York City Department of Health and Mental Hygiene, New York (S.B., D.C.D.); and the Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta (S.B.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30405233,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>03</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D003093"" MajorTopicYN=""N"">Colitis, Ulcerative</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003106"" MajorTopicYN=""N"">Colon</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007420"" MajorTopicYN=""N"">Intestine, Large</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019108"" MajorTopicYN=""N"">Tight Junctions</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>563</Volume>    <Issue>7730</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Eisenstein</LastName>    <ForeName>Michael</ForeName>    <Initials>M</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30405234,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>03</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D003093"" MajorTopicYN=""N"">Colitis, Ulcerative</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>    <QualifierName UI=""Q000503"" MajorTopicYN=""N"">physiopathology</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>563</Volume>    <Issue>7730</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Eisenstein</LastName>    <ForeName>Michael</ForeName>    <Initials>M</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D054711"">Introductory Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>",NA
30405245,<DateCompleted>  <Year>2019</Year>  <Month>05</Month>  <Day>20</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000284"" MajorTopicYN=""N"">Administration, Oral</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000429"" MajorTopicYN=""N"">Alcohol Oxidoreductases</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""N"">antagonists &amp; inhibitors</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001327"" MajorTopicYN=""N"">Autoimmune Diseases</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001708"" MajorTopicYN=""N"">Biopterin</DescriptorName>    <QualifierName UI=""Q000031"" MajorTopicYN=""Y"">analogs &amp; derivatives</QualifierName>    <QualifierName UI=""Q000096"" MajorTopicYN=""N"">biosynthesis</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D045744"" MajorTopicYN=""N"">Cell Line, Tumor</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D049109"" MajorTopicYN=""N"">Cell Proliferation</DescriptorName>    <QualifierName UI=""Q000187"" MajorTopicYN=""N"">drug effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003067"" MajorTopicYN=""N"">Coenzymes</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004791"" MajorTopicYN=""N"">Enzyme Inhibitors</DescriptorName>    <QualifierName UI=""Q000008"" MajorTopicYN=""N"">administration &amp; dosage</QualifierName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006136"" MajorTopicYN=""N"">GTP Cyclohydrolase</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006967"" MajorTopicYN=""N"">Hypersensitivity</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007501"" MajorTopicYN=""N"">Iron</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007737"" MajorTopicYN=""N"">Kynurenine</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000494"" MajorTopicYN=""N"">pharmacology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008810"" MajorTopicYN=""N"">Mice, Inbred C57BL</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008928"" MajorTopicYN=""N"">Mitochondria</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009369"" MajorTopicYN=""N"">Neoplasms</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013601"" MajorTopicYN=""N"">T-Lymphocytes</DescriptorName>    <QualifierName UI=""Q000166"" MajorTopicYN=""Y"">cytology</QualifierName>    <QualifierName UI=""Q000187"" MajorTopicYN=""N"">drug effects</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>563</Volume>    <Issue>7732</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Cronin</LastName>    <ForeName>Shane J F</ForeName>    <Initials>SJF</Initials>    <AffiliationInfo>      <Affiliation>IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>FM Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Seehus</LastName>    <ForeName>Corey</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>FM Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Weidinger</LastName>    <ForeName>Adelheid</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Center, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Talbot</LastName>    <ForeName>Sebastien</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>FM Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Dpartement de Pharmacologie et Physiologie, Universit de Montral, Montral, Qubec, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Reissig</LastName>    <ForeName>Sonja</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Seifert</LastName>    <ForeName>Markus</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine II (Infectious Diseases, Immunology, Rheumatology and Pneumology), Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pierson</LastName>    <ForeName>Yann</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Institute of Chemical Sciences and Engineering, Institute of Bioengineering, National Centre of Competence in Research (NCCR) in Chemical Biology, cole Polytechnique Fdrale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>McNeill</LastName>    <ForeName>Eileen</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Wellcome Trust Centre for Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Longhi</LastName>    <ForeName>Maria Serena</ForeName>    <Initials>MS</Initials>    <AffiliationInfo>      <Affiliation>Division of Gastroenterology and Liver Center, Department of Medicine, Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School (HMS), Harvard University, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Turnes</LastName>    <ForeName>Bruna Lenfers</ForeName>    <Initials>BL</Initials>    <AffiliationInfo>      <Affiliation>LABOX, Departamento de Bioqumica, Universidade Federal de Santa Catarina, Florianpolis, Brazil.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kreslavsky</LastName>    <ForeName>Taras</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Research Institute of Molecular Pathology, Vienna Biocenter, Campus-Vienna-Biocenter 1, Vienna, Austria.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Karolinska Institute, Department of Medicine Solna, Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kogler</LastName>    <ForeName>Melanie</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hoffmann</LastName>    <ForeName>David</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ticevic</LastName>    <ForeName>Melita</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>da Luz Scheffer</LastName>    <ForeName>Dbora</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>LABOX, Departamento de Bioqumica, Universidade Federal de Santa Catarina, Florianpolis, Brazil.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tortola</LastName>    <ForeName>Luigi</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cikes</LastName>    <ForeName>Domagoj</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jais</LastName>    <ForeName>Alexander</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rangachari</LastName>    <ForeName>Manu</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurosciences, Centre de Recherche de CHU de Qubec-Universit Laval, Qubec, Qubec, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Molecular Medicine, Faculty of Medicine, Universit Laval, Qubec, Quebec, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rao</LastName>    <ForeName>Shuan</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Paolino</LastName>    <ForeName>Magdalena</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Karolinska Institute, Department of Medicine Solna, Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Novatchkova</LastName>    <ForeName>Maria</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Research Institute of Molecular Pathology, Vienna Biocenter, Campus-Vienna-Biocenter 1, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Aichinger</LastName>    <ForeName>Martin</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Research Institute of Molecular Pathology, Vienna Biocenter, Campus-Vienna-Biocenter 1, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Barrett</LastName>    <ForeName>Lee</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>FM Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Latremoliere</LastName>    <ForeName>Alban</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Neurosurgery Department, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wirnsberger</LastName>    <ForeName>Gerald</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Apeiron Biologics AG, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lametschwandtner</LastName>    <ForeName>Guenther</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Apeiron Biologics AG, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Busslinger</LastName>    <ForeName>Meinrad</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Research Institute of Molecular Pathology, Vienna Biocenter, Campus-Vienna-Biocenter 1, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zicha</LastName>    <ForeName>Stephen</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Quartet Medicine, 400 Technology Square, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Latini</LastName>    <ForeName>Alexandra</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>FM Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>LABOX, Departamento de Bioqumica, Universidade Federal de Santa Catarina, Florianpolis, Brazil.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Robson</LastName>    <ForeName>Simon C</ForeName>    <Initials>SC</Initials>    <AffiliationInfo>      <Affiliation>Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Wellcome Trust Centre for Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Waisman</LastName>    <ForeName>Ari</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Andrews</LastName>    <ForeName>Nick</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>FM Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Costigan</LastName>    <ForeName>Michael</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>FM Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Anesthesia, Harvard Medical School, Boston, MA, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Boston Children's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Channon</LastName>    <ForeName>Keith M</ForeName>    <Initials>KM</Initials>    <AffiliationInfo>      <Affiliation>Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Wellcome Trust Centre for Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Weiss</LastName>    <ForeName>Guenter</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine II (Infectious Diseases, Immunology, Rheumatology and Pneumology), Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kozlov</LastName>    <ForeName>Andrey V</ForeName>    <Initials>AV</Initials>    <AffiliationInfo>      <Affiliation>Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Center, Vienna, Austria.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tebbe</LastName>    <ForeName>Mark</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular Medicine, Faculty of Medicine, Universit Laval, Qubec, Quebec, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Johnsson</LastName>    <ForeName>Kai</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Institute of Chemical Sciences and Engineering, Institute of Bioengineering, National Centre of Competence in Research (NCCR) in Chemical Biology, cole Polytechnique Fdrale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Chemical Biology, Max-Planck Institute for Medical Research, Heidelberg, Germany.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Woolf</LastName>    <ForeName>Clifford J</ForeName>    <Initials>CJ</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA, USA. clifford.woolf@childrens.harvard.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>FM Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA. clifford.woolf@childrens.harvard.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Penninger</LastName>    <ForeName>Josef M</ForeName>    <Initials>JM</Initials>    <AffiliationInfo>      <Affiliation>IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria. josef.penninger@imba.oeaw.ac.at.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>R35 NS105076</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R21 CA221702</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 DK108894</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>RG/17/10/32859</GrantID>    <Acronym>BHF_</Acronym>    <Agency>British Heart Foundation</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>RG/07/003/23133</GrantID>    <Acronym>BHF_</Acronym>    <Agency>British Heart Foundation</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>RG/12/5/29576</GrantID>    <Acronym>BHF_</Acronym>    <Agency>British Heart Foundation</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>R37 NS039518</GrantID>    <Acronym>NS</Acronym>    <Agency>NINDS NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30409774,<DateCompleted>  <Year>2019</Year>  <Month>03</Month>  <Day>20</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000911"" MajorTopicYN=""N"">Antibodies, Monoclonal</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D061067"" MajorTopicYN=""N"">Antibodies, Monoclonal, Humanized</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000074322"" MajorTopicYN=""N"">Antineoplastic Agents, Immunological</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000971"" MajorTopicYN=""N"">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017322"" MajorTopicYN=""N"">Clinical Trials, Phase II as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017326"" MajorTopicYN=""N"">Clinical Trials, Phase III as Topic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D064420"" MajorTopicYN=""N"">Drug-Related Side Effects and Adverse Reactions</DescriptorName>    <QualifierName UI=""Q000209"" MajorTopicYN=""Y"">etiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000074324"" MajorTopicYN=""N"">Ipilimumab</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009369"" MajorTopicYN=""N"">Neoplasms</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""Y"">drug therapy</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000071076"" MajorTopicYN=""N"">Network Meta-Analysis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000077594"" MajorTopicYN=""N"">Nivolumab</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016032"" MajorTopicYN=""N"">Randomized Controlled Trials as Topic</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>Nov</Month>      <Day>08</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Xu</LastName>    <ForeName>Cheng</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Yu-Pei</ForeName>    <Initials>YP</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Du</LastName>    <ForeName>Xiao-Jing</ForeName>    <Initials>XJ</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Jin-Qi</ForeName>    <Initials>JQ</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Huang</LastName>    <ForeName>Cheng-Long</ForeName>    <Initials>CL</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Lei</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhou</LastName>    <ForeName>Guan-Qun</ForeName>    <Initials>GQ</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Li</LastName>    <ForeName>Wen-Fei</ForeName>    <Initials>WF</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mao</LastName>    <ForeName>Yan-Ping</ForeName>    <Initials>YP</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hsu</LastName>    <ForeName>Chiun</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Qing</ForeName>    <Initials>Q</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lin</LastName>    <ForeName>Ai-Hua</ForeName>    <Initials>AH</Initials>    <AffiliationInfo>      <Affiliation>Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tang</LastName>    <ForeName>Ling-Long</ForeName>    <Initials>LL</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sun</LastName>    <ForeName>Ying</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ma</LastName>    <ForeName>Jun</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China majun2@mail.sysu.edu.cn.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D017418"">Meta-Analysis</PublicationType>  <PublicationType UI=""D000078182"">Systematic Review</PublicationType></PublicationTypeList>",NA
30409805,<DateCompleted>  <Year>2019</Year>  <Month>02</Month>  <Day>14</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D021581"" MajorTopicYN=""N"">Active Transport, Cell Nucleus</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000222"" MajorTopicYN=""N"">Adaptation, Physiological</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002154"" MajorTopicYN=""N"">Calpain</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006332"" MajorTopicYN=""N"">Cardiomegaly</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>    <QualifierName UI=""Q000503"" MajorTopicYN=""N"">physiopathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002467"" MajorTopicYN=""N"">Cell Nucleus</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D056966"" MajorTopicYN=""N"">Excitation Contraction Coupling</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005786"" MajorTopicYN=""Y"">Gene Expression Regulation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D064326"" MajorTopicYN=""N"">MEF2 Transcription Factors</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008565"" MajorTopicYN=""N"">Membrane Proteins</DescriptorName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008810"" MajorTopicYN=""N"">Mice, Inbred C57BL</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008822"" MajorTopicYN=""N"">Mice, Transgenic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009124"" MajorTopicYN=""N"">Muscle Proteins</DescriptorName>    <QualifierName UI=""Q000737"" MajorTopicYN=""N"">chemistry</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""Y"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009200"" MajorTopicYN=""N"">Myocardial Contraction</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D032383"" MajorTopicYN=""N"">Myocytes, Cardiac</DescriptorName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D059748"" MajorTopicYN=""N"">Proteolysis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014158"" MajorTopicYN=""N"">Transcription, Genetic</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020257"" MajorTopicYN=""N"">Ventricular Remodeling</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6421</Issue>    <PubDate>      <Year>2018</Year>      <Month>12</Month>      <Day>21</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Guo</LastName>    <ForeName>Ang</ForeName>    <Initials>A</Initials>    <Identifier Source=""ORCID"">0000-0002-5551-2279</Identifier>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Yihui</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Emergency Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Biyi</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Yunhao</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yuan</LastName>    <ForeName>Jinxiang</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Liyang</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hall</LastName>    <ForeName>Duane</ForeName>    <Initials>D</Initials>    <Identifier Source=""ORCID"">0000-0003-2228-0966</Identifier>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wu</LastName>    <ForeName>Jennifer</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Shi</LastName>    <ForeName>Yun</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhu</LastName>    <ForeName>Qi</ForeName>    <Initials>Q</Initials>    <Identifier Source=""ORCID"">0000-0003-3965-8419</Identifier>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Pharmacology, School of Pharmacy, Nantong University, Nantong, Jiangsu 226001, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Cheng</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Emergency Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Thiel</LastName>    <ForeName>William H</ForeName>    <Initials>WH</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhan</LastName>    <ForeName>Xin</ForeName>    <Initials>X</Initials>    <Identifier Source=""ORCID"">0000-0002-4765-316X</Identifier>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Weiss</LastName>    <ForeName>Robert M</ForeName>    <Initials>RM</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhan</LastName>    <ForeName>Fenghuang</ForeName>    <Initials>F</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Musselman</LastName>    <ForeName>Catherine A</ForeName>    <Initials>CA</Initials>    <AffiliationInfo>      <Affiliation>Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pufall</LastName>    <ForeName>Miles</ForeName>    <Initials>M</Initials>    <Identifier Source=""ORCID"">0000-0002-7022-6916</Identifier>    <AffiliationInfo>      <Affiliation>Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhu</LastName>    <ForeName>Weizhong</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>Department of Pharmacology, School of Pharmacy, Nantong University, Nantong, Jiangsu 226001, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Au</LastName>    <ForeName>Kin Fai</ForeName>    <Initials>KF</Initials>    <Identifier Source=""ORCID"">0000-0002-9222-4241</Identifier>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hong</LastName>    <ForeName>Jiang</ForeName>    <Initials>J</Initials>    <Identifier Source=""ORCID"">0000-0002-3745-5549</Identifier>    <AffiliationInfo>      <Affiliation>Department of Emergency Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Anderson</LastName>    <ForeName>Mark E</ForeName>    <Initials>ME</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Grueter</LastName>    <ForeName>Chad E</ForeName>    <Initials>CE</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Fraternal Order of Eagles Diabetes Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Song</LastName>    <ForeName>Long-Sheng</ForeName>    <Initials>LS</Initials>    <Identifier Source=""ORCID"">0000-0002-6035-8106</Identifier>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA. long-sheng-song@uiowa.edu.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Fraternal Order of Eagles Diabetes Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Iowa City Veterans Affairs Medical Center, Iowa City, IA 52242, USA.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>R01 HG008759</GrantID>    <Acronym>HG</Acronym>    <Agency>NHGRI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 HL130346</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P30 CA086862</GrantID>    <Acronym>CA</Acronym>    <Agency>NCI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 HL125436</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R35 HL140034</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>P30 DK054759</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R01 HL090905</GrantID>    <Acronym>HL</Acronym>    <Agency>NHLBI NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>S10 OD019941</GrantID>    <Acronym>OD</Acronym>    <Agency>NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>I01 BX002334</GrantID>    <Acronym>BX</Acronym>    <Agency>BLRD VA</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30409859,<DateCompleted>  <Year>2019</Year>  <Month>05</Month>  <Day>08</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000074183"" MajorTopicYN=""N"">ATPases Associated with Diverse Cellular Activities</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000485"" MajorTopicYN=""N"">Allergens</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000707"" MajorTopicYN=""N"">Anaphylaxis</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001808"" MajorTopicYN=""N"">Blood Vessels</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055252"" MajorTopicYN=""N"">Cell-Derived Microparticles</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003713"" MajorTopicYN=""N"">Dendritic Cells</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D056827"" MajorTopicYN=""N"">Endosomal Sorting Complexes Required for Transport</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D037181"" MajorTopicYN=""N"">Lectins, C-Type</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008407"" MajorTopicYN=""N"">Mast Cells</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D051379"" MajorTopicYN=""N"">Mice</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008810"" MajorTopicYN=""N"">Mice, Inbred C57BL</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008817"" MajorTopicYN=""N"">Mice, Mutant Strains</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D061251"" MajorTopicYN=""N"">Primary Cell Culture</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012867"" MajorTopicYN=""N"">Skin</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6415</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>09</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA. haewoong.choi@duke.edu.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Choi</LastName>    <ForeName>Hae Woong</ForeName>    <Initials>HW</Initials>    <Identifier Source=""ORCID"">0000-0001-9372-1875</Identifier>    <AffiliationInfo>      <Affiliation>Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA. haewoong.choi@duke.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Suwanpradid</LastName>    <ForeName>Jutamas</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Dermatology, Duke University Medical Center, Durham, NC 27710, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kim</LastName>    <ForeName>Il Hwan</ForeName>    <Initials>IH</Initials>    <AffiliationInfo>      <Affiliation>Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Staats</LastName>    <ForeName>Herman F</ForeName>    <Initials>HF</Initials>    <Identifier Source=""ORCID"">0000-0003-1039-1087</Identifier>    <AffiliationInfo>      <Affiliation>Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Haniffa</LastName>    <ForeName>Muzlifah</ForeName>    <Initials>M</Initials>    <Identifier Source=""ORCID"">0000-0002-3927-2084</Identifier>    <AffiliationInfo>      <Affiliation>Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Dermatology, Newcastle upon Tyne NHS Trust, Newcastle upon Tyne NE1 4LP, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>MacLeod</LastName>    <ForeName>Amanda S</ForeName>    <Initials>AS</Initials>    <AffiliationInfo>      <Affiliation>Department of Dermatology, Duke University Medical Center, Durham, NC 27710, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Abraham</LastName>    <ForeName>Soman N</ForeName>    <Initials>SN</Initials>    <Identifier Source=""ORCID"">0000-0002-1662-2096</Identifier>    <AffiliationInfo>      <Affiliation>Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Program in Emerging Infectious Diseases, Duke-National University of Singapore, Singapore 169857, Singapore.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>R01 AI096305</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R21 AI128727</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>R56 DK095198</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant>  <Grant>    <GrantID>U01 AI082107</GrantID>    <Acronym>AI</Acronym>    <Agency>NIAID NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30409869,<DateCompleted>  <Year>2019</Year>  <Month>05</Month>  <Day>08</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001733"" MajorTopicYN=""N"">Bites and Stings</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003064"" MajorTopicYN=""N"">Cnidarian Venoms</DescriptorName>    <QualifierName UI=""Q000506"" MajorTopicYN=""Y"">poisoning</QualifierName>    <QualifierName UI=""Q000633"" MajorTopicYN=""N"">toxicity</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D037462"" MajorTopicYN=""N"">Cubozoa</DescriptorName>    <QualifierName UI=""Q000033"" MajorTopicYN=""N"">anatomy &amp; histology</QualifierName>    <QualifierName UI=""Q000472"" MajorTopicYN=""Y"">pathogenicity</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012867"" MajorTopicYN=""N"">Skin</DescriptorName>    <QualifierName UI=""Q000293"" MajorTopicYN=""N"">injuries</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""N"">pathology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1095-9203</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>362</Volume>    <Issue>6415</Issue>    <PubDate>      <Year>2018</Year>      <Month>Nov</Month>      <Day>09</Day>    </PubDate>  </JournalIssue>  <Title>Science (New York, N.Y.)</Title>  <ISOAbbreviation>Science</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Talao-talao, the Philippines.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Law</LastName>    <ForeName>Yao-Hua</ForeName>    <Initials>YH</Initials>    <AffiliationInfo>      <Affiliation>Talao-talao, the Philippines.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30419097,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>21</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D019496"" MajorTopicYN=""N"">Cancer Vaccines</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007167"" MajorTopicYN=""Y"">Immunotherapy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009369"" MajorTopicYN=""N"">Neoplasms</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1538-3598</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>320</Volume>    <Issue>21</Issue>    <PubDate>      <Year>2018</Year>      <Month>Dec</Month>      <Day>04</Day>    </PubDate>  </JournalIssue>  <Title>JAMA</Title>  <ISOAbbreviation>JAMA</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Schlom</LastName>    <ForeName>Jeffrey</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gulley</LastName>    <ForeName>James L</ForeName>    <Initials>JL</Initials>    <AffiliationInfo>      <Affiliation>Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Medical Oncology Service, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>ZIA BC010425-18</GrantID>    <Agency>Intramural NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30422251,<DateCompleted>  <Year>2018</Year>  <Month>12</Month>  <Day>21</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019458"" MajorTopicYN=""Y"">Insurance Coverage</DescriptorName>    <QualifierName UI=""Q000639"" MajorTopicYN=""N"">trends</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007676"" MajorTopicYN=""N"">Kidney Failure, Chronic</DescriptorName>    <QualifierName UI=""Q000401"" MajorTopicYN=""Y"">mortality</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""N"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008484"" MajorTopicYN=""Y"">Medicaid</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017057"" MajorTopicYN=""N"">Medically Uninsured</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009026"" MajorTopicYN=""N"">Mortality</DescriptorName>    <QualifierName UI=""Q000639"" MajorTopicYN=""N"">trends</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058991"" MajorTopicYN=""Y"">Patient Protection and Affordable Care Act</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006435"" MajorTopicYN=""N"">Renal Dialysis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"" Type=""Geographic"">United States</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1538-3598</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>320</Volume>    <Issue>21</Issue>    <PubDate>      <Year>2018</Year>      <Month>12</Month>      <Day>04</Day>    </PubDate>  </JournalIssue>  <Title>JAMA</Title>  <ISOAbbreviation>JAMA</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Swaminathan</LastName>    <ForeName>Shailender</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Providence VA Medical Center, Providence, Rhode Island.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Public Health Foundation of India, New Delhi, India.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>SRM University, Amaravati, India.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sommers</LastName>    <ForeName>Benjamin D</ForeName>    <Initials>BD</Initials>    <AffiliationInfo>      <Affiliation>Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Thorsness</LastName>    <ForeName>Rebecca</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mehrotra</LastName>    <ForeName>Rajnish</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Department of Medicine, University of Washington School of Medicine, Seattle.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lee</LastName>    <ForeName>Yoojin</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Trivedi</LastName>    <ForeName>Amal N</ForeName>    <Initials>AN</Initials>    <AffiliationInfo>      <Affiliation>Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Providence VA Medical Center, Providence, Rhode Island.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D052061"">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>R01 DK113298</GrantID>    <Acronym>DK</Acronym>    <Agency>NIDDK NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30424891,<DateCompleted>  <Year>2019</Year>  <Month>01</Month>  <Day>09</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000068896"" MajorTopicYN=""N"">Canagliflozin</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003924"" MajorTopicYN=""Y"">Diabetes Mellitus, Type 2</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007004"" MajorTopicYN=""N"">Hypoglycemic Agents</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055502"" MajorTopicYN=""N"">Secondary Prevention</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000077203"" MajorTopicYN=""Y"">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1474-547X</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>393</Volume>    <Issue>10166</Issue>    <PubDate>      <Year>2019</Year>      <Month>01</Month>      <Day>05</Day>    </PubDate>  </JournalIssue>  <Title>Lancet (London, England)</Title>  <ISOAbbreviation>Lancet</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto M5B 1W8, ON, Canada; Applied Health Research Centre, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, ON, Canada. Electronic address: vermasu@smh.ca.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Verma</LastName>    <ForeName>Subodh</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto M5B 1W8, ON, Canada; Applied Health Research Centre, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, ON, Canada. Electronic address: vermasu@smh.ca.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jni</LastName>    <ForeName>Peter</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Applied Health Research Centre, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mazer</LastName>    <ForeName>C David</ForeName>    <Initials>CD</Initials>    <AffiliationInfo>      <Affiliation>Applied Health Research Centre, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType>  <PublicationType UI=""D016420"">Comment</PublicationType></PublicationTypeList>",NA
30424892,<DateCompleted>  <Year>2019</Year>  <Month>01</Month>  <Day>14</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D002318"" MajorTopicYN=""N"">Cardiovascular Diseases</DescriptorName>    <QualifierName UI=""Q000209"" MajorTopicYN=""N"">etiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003924"" MajorTopicYN=""N"">Diabetes Mellitus, Type 2</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""N"">complications</QualifierName>    <QualifierName UI=""Q000188"" MajorTopicYN=""Y"">drug therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003928"" MajorTopicYN=""N"">Diabetic Nephropathies</DescriptorName>    <QualifierName UI=""Q000209"" MajorTopicYN=""N"">etiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011322"" MajorTopicYN=""N"">Primary Prevention</DescriptorName>    <QualifierName UI=""Q000379"" MajorTopicYN=""N"">methods</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055502"" MajorTopicYN=""N"">Secondary Prevention</DescriptorName>    <QualifierName UI=""Q000379"" MajorTopicYN=""N"">methods</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000077203"" MajorTopicYN=""N"">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1474-547X</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>393</Volume>    <Issue>10166</Issue>    <PubDate>      <Year>2019</Year>      <Month>01</Month>      <Day>05</Day>    </PubDate>  </JournalIssue>  <Title>Lancet (London, England)</Title>  <ISOAbbreviation>Lancet</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Zelniker</LastName>    <ForeName>Thomas A</ForeName>    <Initials>TA</Initials>    <AffiliationInfo>      <Affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wiviott</LastName>    <ForeName>Stephen D</ForeName>    <Initials>SD</Initials>    <AffiliationInfo>      <Affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Raz</LastName>    <ForeName>Itamar</ForeName>    <Initials>I</Initials>    <AffiliationInfo>      <Affiliation>The Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Im</LastName>    <ForeName>Kyungah</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Goodrich</LastName>    <ForeName>Erica L</ForeName>    <Initials>EL</Initials>    <AffiliationInfo>      <Affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bonaca</LastName>    <ForeName>Marc P</ForeName>    <Initials>MP</Initials>    <AffiliationInfo>      <Affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mosenzon</LastName>    <ForeName>Ofri</ForeName>    <Initials>O</Initials>    <AffiliationInfo>      <Affiliation>The Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kato</LastName>    <ForeName>Eri T</ForeName>    <Initials>ET</Initials>    <AffiliationInfo>      <Affiliation>Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cahn</LastName>    <ForeName>Avivit</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>The Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Furtado</LastName>    <ForeName>Remo H M</ForeName>    <Initials>RHM</Initials>    <AffiliationInfo>      <Affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bhatt</LastName>    <ForeName>Deepak L</ForeName>    <Initials>DL</Initials>    <AffiliationInfo>      <Affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Leiter</LastName>    <ForeName>Lawrence A</ForeName>    <Initials>LA</Initials>    <AffiliationInfo>      <Affiliation>Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>McGuire</LastName>    <ForeName>Darren K</ForeName>    <Initials>DK</Initials>    <AffiliationInfo>      <Affiliation>Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wilding</LastName>    <ForeName>John P H</ForeName>    <Initials>JPH</Initials>    <AffiliationInfo>      <Affiliation>Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sabatine</LastName>    <ForeName>Marc S</ForeName>    <Initials>MS</Initials>    <AffiliationInfo>      <Affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: msabatine@bwh.harvard.edu.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D017418"">Meta-Analysis</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType>  <PublicationType UI=""D000078182"">Systematic Review</PublicationType></PublicationTypeList>",NA
30425053,<DateCompleted>  <Year>2019</Year>  <Month>03</Month>  <Day>25</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D059248"" MajorTopicYN=""Y"">Chemoradiotherapy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019317"" MajorTopicYN=""N"">Evidence-Based Medicine</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D061214"" MajorTopicYN=""N"">Patient Safety</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012004"" MajorTopicYN=""N"">Rectal Neoplasms</DescriptorName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D057832"" MajorTopicYN=""Y"">Watchful Waiting</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>13</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Surgery, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK fraser.smith@rlbuht.nhs.uk.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Smith</LastName>    <ForeName>Fraser M</ForeName>    <Initials>FM</Initials>    <AffiliationInfo>      <Affiliation>Department of Surgery, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK fraser.smith@rlbuht.nhs.uk.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Institute of Translational Medicine, University of Liverpool, Liverpool, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cresswell</LastName>    <ForeName>Katharine</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>NIHR Biomedical Research Centre Patient and Public Cancer Research Advisory Group, Public Programmes Team, Manchester University NHS Foundation Trust; and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Myint</LastName>    <ForeName>Arthur Sun</ForeName>    <Initials>AS</Initials>    <AffiliationInfo>      <Affiliation>Clatterbridge Cancer Centre, Bebington, Wirral, UK.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Institute of Translational Medicine, University of Liverpool, Liverpool, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Renehan</LastName>    <ForeName>Andrew G</ForeName>    <Initials>AG</Initials>    <AffiliationInfo>      <Affiliation>Manchester Cancer Research Centre, NIHR Manchester Biomedical Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Colorectal and Peritoneal Oncology Centre, Christie NHS Foundation Trust, Manchester, UK.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D013485"">Research Support, Non-U.S. Gov't</PublicationType>  <PublicationType UI=""D016454"">Review</PublicationType></PublicationTypeList>",NA
30428274,<DateCompleted>  <Year>2019</Year>  <Month>01</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000368"" MajorTopicYN=""N"">Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000701"" MajorTopicYN=""N"">Analgesics, Opioid</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D065326"" MajorTopicYN=""N"">Children's Health Insurance Program</DescriptorName>    <QualifierName UI=""Q000331"" MajorTopicYN=""N"">legislation &amp; jurisprudence</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D035082"" MajorTopicYN=""N"">Federal Government</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007231"" MajorTopicYN=""N"">Infant, Newborn</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007880"" MajorTopicYN=""Y"">Legislation, Drug</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009292"" MajorTopicYN=""N"">Narcotic Antagonists</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009293"" MajorTopicYN=""N"">Opioid-Related Disorders</DescriptorName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011247"" MajorTopicYN=""N"">Pregnancy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"" Type=""Geographic"">United States</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>380</Volume>    <Issue>1</Issue>    <PubDate>      <Year>2019</Year>      <Month>Jan</Month>      <Day>03</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the Network for Public Health Law, Los Angeles.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Davis</LastName>    <ForeName>Corey S</ForeName>    <Initials>CS</Initials>    <AffiliationInfo>      <Affiliation>From the Network for Public Health Law, Los Angeles.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30428289,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>26</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000368"" MajorTopicYN=""N"">Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001416"" MajorTopicYN=""N"">Back Pain</DescriptorName>    <QualifierName UI=""Q000209"" MajorTopicYN=""N"">etiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001859"" MajorTopicYN=""N"">Bone Neoplasms</DescriptorName>    <QualifierName UI=""Q000150"" MajorTopicYN=""N"">complications</QualifierName>    <QualifierName UI=""Q000556"" MajorTopicYN=""Y"">secondary</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001943"" MajorTopicYN=""N"">Breast Neoplasms</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000473"" MajorTopicYN=""Y"">pathology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018275"" MajorTopicYN=""N"">Carcinoma, Lobular</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000556"" MajorTopicYN=""Y"">secondary</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D066246"" MajorTopicYN=""N"">ErbB Receptors</DescriptorName>    <QualifierName UI=""Q000032"" MajorTopicYN=""N"">analysis</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D047628"" MajorTopicYN=""N"">Estrogen Receptor alpha</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009154"" MajorTopicYN=""Y"">Mutation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017699"" MajorTopicYN=""N"">Pelvic Pain</DescriptorName>    <QualifierName UI=""Q000209"" MajorTopicYN=""N"">etiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011987"" MajorTopicYN=""N"">Receptors, Steroid</DescriptorName>    <QualifierName UI=""Q000032"" MajorTopicYN=""N"">analysis</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>20</Issue>    <PubDate>      <Year>2018</Year>      <Month>Nov</Month>      <Day>15</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the Departments of Medicine (A.B.), Radiology (M.D.H.), and Pathology (E.F.B., V.N.), Massachusetts General Hospital, and the Departments of Medicine (A.B.), Radiology (M.D.H.), and Pathology (E.F.B., V.N.), Harvard Medical School - both in Boston.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Bardia</LastName>    <ForeName>Aditya</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>From the Departments of Medicine (A.B.), Radiology (M.D.H.), and Pathology (E.F.B., V.N.), Massachusetts General Hospital, and the Departments of Medicine (A.B.), Radiology (M.D.H.), and Pathology (E.F.B., V.N.), Harvard Medical School - both in Boston.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hovnanian</LastName>    <ForeName>Meline D</ForeName>    <Initials>MD</Initials>    <AffiliationInfo>      <Affiliation>From the Departments of Medicine (A.B.), Radiology (M.D.H.), and Pathology (E.F.B., V.N.), Massachusetts General Hospital, and the Departments of Medicine (A.B.), Radiology (M.D.H.), and Pathology (E.F.B., V.N.), Harvard Medical School - both in Boston.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Brachtel</LastName>    <ForeName>Elena F</ForeName>    <Initials>EF</Initials>    <AffiliationInfo>      <Affiliation>From the Departments of Medicine (A.B.), Radiology (M.D.H.), and Pathology (E.F.B., V.N.), Massachusetts General Hospital, and the Departments of Medicine (A.B.), Radiology (M.D.H.), and Pathology (E.F.B., V.N.), Harvard Medical School - both in Boston.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nardi</LastName>    <ForeName>Valentina</ForeName>    <Initials>V</Initials>    <AffiliationInfo>      <Affiliation>From the Departments of Medicine (A.B.), Radiology (M.D.H.), and Pathology (E.F.B., V.N.), Massachusetts General Hospital, and the Departments of Medicine (A.B.), Radiology (M.D.H.), and Pathology (E.F.B., V.N.), Harvard Medical School - both in Boston.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D002363"">Case Reports</PublicationType>  <PublicationType UI=""D016429"">Clinical Conference</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30428298,<DateCompleted>  <Year>2018</Year>  <Month>11</Month>  <Day>26</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D014150"" MajorTopicYN=""N"">Antipsychotic Agents</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D002140"" MajorTopicYN=""N"">California</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003134"" MajorTopicYN=""N"">Commitment of Mentally Ill</DescriptorName>    <QualifierName UI=""Q000331"" MajorTopicYN=""N"">legislation &amp; jurisprudence</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006212"" MajorTopicYN=""Y"">Hallucinations</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006703"" MajorTopicYN=""N"">Homeless Persons</DescriptorName>    <QualifierName UI=""Q000523"" MajorTopicYN=""Y"">psychology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006760"" MajorTopicYN=""Y"">Hospitalization</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D062528"" MajorTopicYN=""Y"">Medicalization</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055118"" MajorTopicYN=""N"">Medication Adherence</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001523"" MajorTopicYN=""N"">Mental Disorders</DescriptorName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D012936"" MajorTopicYN=""N"">Social Medicine</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <Issue>20</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>      <Day>15</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>From the University of California, Los Angeles, Los Angeles (J.T.B.); and Brown University, Providence, RI (L.M.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Braslow</LastName>    <ForeName>Joel T</ForeName>    <Initials>JT</Initials>    <AffiliationInfo>      <Affiliation>From the University of California, Los Angeles, Los Angeles (J.T.B.); and Brown University, Providence, RI (L.M.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Messac</LastName>    <ForeName>Luke</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>From the University of California, Los Angeles, Los Angeles (J.T.B.); and Brown University, Providence, RI (L.M.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D002363"">Case Reports</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>K23 MH001856</GrantID>    <Acronym>MH</Acronym>    <Agency>NIMH NIH HHS</Agency>    <Country>United States</Country>  </Grant></GrantList>"
30429124,<DateCompleted>  <Year>2019</Year>  <Month>03</Month>  <Day>21</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000671"" MajorTopicYN=""N"">Amputation</DescriptorName>    <QualifierName UI=""Q000706"" MajorTopicYN=""N"">statistics &amp; numerical data</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D001559"" MajorTopicYN=""N"">Benzhydryl Compounds</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000068896"" MajorTopicYN=""N"">Canagliflozin</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015331"" MajorTopicYN=""N"">Cohort Studies</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003718"" MajorTopicYN=""N"" Type=""Geographic"">Denmark</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003924"" MajorTopicYN=""N"">Diabetes Mellitus, Type 2</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""Y"">drug therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016883"" MajorTopicYN=""N"">Diabetic Ketoacidosis</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D050723"" MajorTopicYN=""N"">Fractures, Bone</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005960"" MajorTopicYN=""N"">Glucosides</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D007004"" MajorTopicYN=""N"">Hypoglycemic Agents</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016015"" MajorTopicYN=""N"">Logistic Models</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010195"" MajorTopicYN=""N"">Pancreatitis</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D057216"" MajorTopicYN=""N"">Propensity Score</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000077203"" MajorTopicYN=""N"">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""Y"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013548"" MajorTopicYN=""N"" Type=""Geographic"">Sweden</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014552"" MajorTopicYN=""N"">Urinary Tract Infections</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D054556"" MajorTopicYN=""N"">Venous Thromboembolism</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>Nov</Month>      <Day>14</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Clinical Epidemiology Division, Department of Medicine, Solna, Eugeniahemmet, T2, Karolinska University Hospital, 17176 Stockholm, Sweden peter.ueda@ki.se.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Ueda</LastName>    <ForeName>Peter</ForeName>    <Initials>P</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0002-3275-8743</Identifier>    <AffiliationInfo>      <Affiliation>Clinical Epidemiology Division, Department of Medicine, Solna, Eugeniahemmet, T2, Karolinska University Hospital, 17176 Stockholm, Sweden peter.ueda@ki.se.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Svanstrm</LastName>    <ForeName>Henrik</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Clinical Epidemiology Division, Department of Medicine, Solna, Eugeniahemmet, T2, Karolinska University Hospital, 17176 Stockholm, Sweden.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Melbye</LastName>    <ForeName>Mads</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Eliasson</LastName>    <ForeName>Bjrn</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Svensson</LastName>    <ForeName>Ann-Marie</ForeName>    <Initials>AM</Initials>    <AffiliationInfo>      <Affiliation>The Swedish National Diabetes Register, Vstra Gtalandsregionen, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Franzn</LastName>    <ForeName>Stefan</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>The Swedish National Diabetes Register, Vstra Gtalandsregionen, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gudbjrnsdottir</LastName>    <ForeName>Soffia</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>The Swedish National Diabetes Register, Vstra Gtalandsregionen, Gothenburg, Sweden.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hveem</LastName>    <ForeName>Kristian</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>KG Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>HUNT Research Center, Faculty of Medicine, Norwegian University of Science and Technology, Levanger, Norway.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jonasson</LastName>    <ForeName>Christian</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>KG Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>HUNT Research Center, Faculty of Medicine, Norwegian University of Science and Technology, Levanger, Norway.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pasternak</LastName>    <ForeName>Bjrn</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Clinical Epidemiology Division, Department of Medicine, Solna, Eugeniahemmet, T2, Karolinska University Hospital, 17176 Stockholm, Sweden.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30429137,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>01</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D015023"" MajorTopicYN=""N"" Type=""Geographic"">Democratic Republic of the Congo</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004196"" MajorTopicYN=""N"">Disease Outbreaks</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D029043"" MajorTopicYN=""N"">Ebolavirus</DescriptorName>    <QualifierName UI=""Q000187"" MajorTopicYN=""N"">drug effects</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""Y"">genetics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019142"" MajorTopicYN=""N"">Hemorrhagic Fever, Ebola</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>    <QualifierName UI=""Q000401"" MajorTopicYN=""N"">mortality</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010820"" MajorTopicYN=""N"">Physicians</DescriptorName>    <QualifierName UI=""Q000458"" MajorTopicYN=""Y"">organization &amp; administration</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D036302"" MajorTopicYN=""N"">Therapeutic Human Experimentation</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006113"" MajorTopicYN=""N"" Type=""Geographic"">United Kingdom</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>363</Volume>    <PubDate>      <Year>2018</Year>      <Month>Nov</Month>      <Day>14</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>",<AffiliationInfo>  <Affiliation>The BMJ.</Affiliation></AffiliationInfo>,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Shepherd</LastName>    <ForeName>Alison</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>The BMJ.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30429566,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>29</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000225"" MajorTopicYN=""N"">Adenine</DescriptorName>    <QualifierName UI=""Q000031"" MajorTopicYN=""N"">analogs &amp; derivatives</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000077329"" MajorTopicYN=""N"">Agammaglobulinaemia Tyrosine Kinase</DescriptorName>    <QualifierName UI=""Q000037"" MajorTopicYN=""Y"">antagonists &amp; inhibitors</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000818"" MajorTopicYN=""N"">Animals</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004195"" MajorTopicYN=""N"">Disease Models, Animal</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004285"" MajorTopicYN=""N"">Dogs</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017277"" MajorTopicYN=""N"">Drug Approval</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004345"" MajorTopicYN=""N"">Drug Industry</DescriptorName>    <QualifierName UI=""Q000191"" MajorTopicYN=""N"">economics</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020522"" MajorTopicYN=""N"">Lymphoma, Mantle-Cell</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""N"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008228"" MajorTopicYN=""N"">Lymphoma, Non-Hodgkin</DescriptorName>    <QualifierName UI=""Q000201"" MajorTopicYN=""N"">enzymology</QualifierName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000628"" MajorTopicYN=""Y"">therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058990"" MajorTopicYN=""Y"">Molecular Targeted Therapy</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010880"" MajorTopicYN=""N"">Piperidines</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D057285"" MajorTopicYN=""N"">Precision Medicine</DescriptorName>    <QualifierName UI=""Q000639"" MajorTopicYN=""Y"">trends</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011720"" MajorTopicYN=""N"">Pyrazoles</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011743"" MajorTopicYN=""N"">Pyrimidines</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014481"" MajorTopicYN=""N"" Type=""Geographic"">United States</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014486"" MajorTopicYN=""N"">United States Food and Drug Administration</DescriptorName>    <QualifierName UI=""Q000331"" MajorTopicYN=""N"">legislation &amp; jurisprudence</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008258"" MajorTopicYN=""N"">Waldenstrom Macroglobulinemia</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>563</Volume>    <Issue>7731</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Dolgin</LastName>    <ForeName>Elie</ForeName>    <Initials>E</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
30429570,<DateCompleted>  <Year>2019</Year>  <Month>04</Month>  <Day>29</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D057134"" MajorTopicYN=""N"">Antibodies, Neutralizing</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019496"" MajorTopicYN=""N"">Cancer Vaccines</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""Y"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020031"" MajorTopicYN=""N"">Epstein-Barr Virus Infections</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>    <QualifierName UI=""Q000821"" MajorTopicYN=""N"">virology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004854"" MajorTopicYN=""N"">Herpesvirus 4, Human</DescriptorName>    <QualifierName UI=""Q000254"" MajorTopicYN=""N"">growth &amp; development</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""Y"">immunology</QualifierName>    <QualifierName UI=""Q000472"" MajorTopicYN=""Y"">pathogenicity</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006689"" MajorTopicYN=""N"">Hodgkin Disease</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""Y"">prevention &amp; control</QualifierName>    <QualifierName UI=""Q000821"" MajorTopicYN=""Y"">virology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D016219"" MajorTopicYN=""N"">Immunotherapy, Adoptive</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009103"" MajorTopicYN=""N"">Multiple Sclerosis</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>    <QualifierName UI=""Q000821"" MajorTopicYN=""N"">virology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009303"" MajorTopicYN=""N"">Nasopharyngeal Neoplasms</DescriptorName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>    <QualifierName UI=""Q000821"" MajorTopicYN=""N"">virology</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D022223"" MajorTopicYN=""N"">Vaccines, Subunit</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D014763"" MajorTopicYN=""N"">Viral Matrix Proteins</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000276"" MajorTopicYN=""N"">immunology</QualifierName>    <QualifierName UI=""Q000378"" MajorTopicYN=""N"">metabolism</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D017735"" MajorTopicYN=""N"">Virus Latency</DescriptorName>    <QualifierName UI=""Q000235"" MajorTopicYN=""N"">genetics</QualifierName>    <QualifierName UI=""Q000502"" MajorTopicYN=""N"">physiology</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>563</Volume>    <Issue>7731</Issue>    <PubDate>      <Year>2018</Year>      <Month>11</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>",NA,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Ainsworth</LastName>    <ForeName>Claire</ForeName>    <Initials>C</Initials>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
